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Jennifer Thomson is one of the world’s leading advisors on genetically modified crops. 
In Food for Africa she traces, through anecdote and science, her career and the develop-
ment of this area of research — from the dawn of genetic engineering in the USA in 
1974, through the early stages of its testing in Europe and regulation in South Africa, to 
the latest developments in South Africa, where an updated Bioeconomy Strategy was 
approved in early 2013. 
As a young scientist she chose to study bacterial genetics, negotiating her way in a very 
male-dominated arena.  It led to her path-breaking involvement in the development 
of GM research in South Africa — where approximately 80% of maize grown currently 
is genetically modified for insect and herbicide resistance  — and the spread of this 
technology to other parts of Africa.  Experiments conducted with smallholder farmers 
in Kenya, Uganda, Tanzania and Mozambique now mean that insect-resistant cowpea, 
disease-resistant bananas, virus-resistant cassava, drought-tolerant maize and vitamin-
enriched sorghum can be grown in Africa successfully. 
This book describes a remarkable personal and scientific evolution and looks to a future 
in which GM technology allows for the possibility of achieving food security throughout 
Africa by means of staple crops grown in difficult conditions by smallholder farmers.
Food for Africa
The life and work of a scientist 
in GM crops
Jennifer Thomson
Food for Africa_Prelims.indd   iii 4/26/13   1:54 PM
Food for Africa: The life and work of a scientist in GM crops
First published 2013
Print edition first published 2013
©2013 University of Cape Town Press





ISBN 978 1 9204 9981 5 (Parent)
ISBN 978 1 7758 2048 2 (WebPDF)
All rights reserved. No part of this electronic publication may be reproduced or transmitted in any form or by 
any means, electronic or mechanical, including photocopying, recording, or any information storage or retrieval 
system, without prior permission in writing from the publisher. Subject to any applicable licensing terms and 
conditions in the case of electronically supplied publications, a person may engage in fair dealing with a copy of 
this publication for his or her personal or private use, or his or her research or private study. See Section 12(1)(a) 
of the Copyright Act 98 of 1978.
Project manager: Karen Froneman
Editor: Leonie Hofmeyr-Juritz
Proofreader: Lee-Ann Ashcroft
Cover designer: Monique Cleghorn
Typesetter: Integra Software Service Pvt. Ltd
The authors and the publisher have made every effort to obtain permission for and acknowledge the use of 
copyright material. Should any infringement of copyright have occurred, please contact the publisher, and every 




List of acronyms .................................................................... ix
Introduction ........................................................................... 1
Chapter 1: The SAGENE years  ............................................ 19
Chapter 2: From SAGENE to the GMO Act ......................... 31 
Chapter 3: Into Africa .......................................................... 49 
Chapter 4: To Davos and further into Africa ........................ 63 
Chapter 5:  A South African National Biotechnology 
Strategy ............................................................... 87 
Chapter 6:  African National Biotechnology Strategies ......... 97 
Chapter 7: The maize streak virus story ............................ 107
Chapter 8: David vs Goliath ............................................... 121
Chapter 9: Food for Africa ................................................. 133
Glossary ............................................................................. 151
Bibliography  ...................................................................... 153
Index .................................................................................. 163
Food for Africa_Prelims.indd   v 4/26/13   1:54 PM
Foreword
I am a woman of science, having studied medicine and qualifi ed 
as a doctor, as well as achieving diplomas in tropical medicine and 
hygiene, and in public health. And I am actively interested in the 
health of Africans. During my anti-apartheid activist years in the 
1970s I was involved in organising and working with community 
development programmes like the Zanempilo Community Health 
Centre in Zinyoka (a village outside King William’s Town in the 
Eastern Cape), one of the fi rst primary healthcare initiatives 
which was outside the public sector in South Africa. Banished by 
the apartheid government in 1977 to a remote town in the north, 
Tzaneen, I formed the Isutheng Community Health Programme, 
where one of the projects I encouraged was one in which women 
established vegetable gardens. So I have seen at grassroots level 
what struggles the rural poor face in getting access to enough food. 
And as a managing director of the World Bank I have helped create 
programmes that enable the poor in developing countries to shape a 
better future for themselves.
Jennifer Thomson’s life as a woman scientist, as told in this book, 
is one with which I can identify. So is her journey to the top rungs 
of the ladder from which she has addressed the world’s leaders. 
And her remarkable role in the evolution of her chosen fi eld should 
be celebrated. But it is not just as a laboratory scientist in a white 
coat bent over her microscope that she has made her mark. She has 
also thrown herself wholeheartedly into assisting government in 
developing policies for a technological future.
I deeply appreciate the issues of food security that confront 
Africans. Programmes that involve and assist smallholder farmers 
to provide food sustainably, for themselves and their communities, 
should be supported. And Professor Thomson’s enthusiastic efforts 
outside the laboratory to mobilise governments and big business 
have resulted in them financing the experiments and projects 
that are leading to the creation of more abundant and reliable 
crops. She is indeed a role model—for women as well as budding 
scientists.
The work of Jennifer Thomson has been transformational in 
demonstrating the value of biotechnology to food security on a 
continent that suffers from droughts and adverse weather patterns. 
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The suspicions around the African continent towards scientifi c 
interventions can only be dispelled by work such as she is championing 
to make science work for society.
Dr Mamphela Ramphele
Chair of the Technical Innovation Agency (TIA)
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Introduction
I am having lunch with Kofi  Annan in his private dining room on the 
top fl oor of the United Nations. In a short while I will try to convince 
UN ambassadors that GM crops can help to feed hungry Africans. Kofi  
Annan is jovial, all smiles: ‘Nothing happens till I get there.’ I sweat 
slightly as I wait to give what could be the most important lecture I 
have ever given. Zambia has just said no to food aid because it might 
contain GM maize. Farmers might plant it, instead of eating it, even 
though their families are starving. But if they plant it, Zambia might 
lose its GM-free status for its food exports to Europe. African leaders 
are thus caught on the horns of a dilemma. Will I be able to convince 
them to embrace this technology when Europeans and others are 
telling them it could poison their people or, worse still, make them 
sterile?
From Sunday school teacher to scientist
I began teaching at the age of 13. My father ran a Methodist Sunday 
school in our rural Johannesburg suburb of Bryanston. There was a 
rough and tumble ‘hall’ in which the whole school would gather on a 
Sunday morning. Beforehand, Dad, my brother Rob and I, together 
with early arrivals, would collect benches from the basement of the 
grocery shop across the road. After assembly, during which we would 
sing choruses accompanied by my brother on his piano accordion, we 
would break up into our age groups and a ‘teacher’ would engage us. 
After a few years Dad suggested I work with one of the groups of 
younger children. He thought I could get rather good at this. He had 
noticed how the children sat enthralled as they watched me telling 
and acting out the Bible stories. And so began my ambition to become 
a school teacher, but somehow things didn’t quite work out that way.
After I matriculated from high school I had no idea what to study 
at the University of Cape Town (UCT), but when I discovered that 
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most of my friends were planning to do a BA degree I decided to 
register for a BSc, just to do something different. In my fi rst year I 
enjoyed zoology the most, so I chose that as my major. In the second 
year the class made our zoology laboratory (the Zoo II lab) ‘home’, 
returning there whenever we had a break from lectures. We went on 
a fi eld trip to Langebaan, a coastal resort up the west coast, staying in 
some rather dilapidated dormitories. Mornings were spent collecting 
specimens of coastal marine life; afternoons were taken up with 
identifying and classifying them. I became the champion collector 
of bloodworms, digging them up from the mud fl ats, often up to my 
shoulders in oozing wet sand. And in the evenings we partied! 
It was during this second year that the fi rst change in my plan 
to become a school teacher occurred. My favourite lecturer was 
George Branch. He was then a very new lecturer but subsequently 
rose to become a professor and head of the Zoology Department at 
UCT. He and his wife Margo Branch are joint authors of the widely 
acclaimed The Living Shores of Southern Africa (Branch and Branch, 
1981). When George announced that he needed scorpions for a class 
dissection, I offered to take him into the forest above our house, where 
I knew these arthropods lurked in abundance. Afterwards I took him 
home to have tea with Mom and he asked what I planned to do after 
fi nishing my degree. ‘Become a school teacher’, I replied, with great 
certainty. He thought about this for a while and then suggested that 
I might consider studying further before making up my mind. During 
a visit to Europe at the end of that year, I visited Oxford and decided 
I wanted to study there. But ‘No,’ said George. ‘Oxford is for the arts 
and Cambridge is for science’. ‘Fine’, I said, ‘I’ll go to Cambridge’—a 
life-changing decision.
My parents weren’t particularly thrilled about the prospect of 
my studying zoology in the same department where my uncle had 
committed suicide some years earlier, but they bravely consented, 
as long as Aunt Margaret agreed. Aunt Margaret, who was really a 
cousin, was the headmistress of Rustenburg Girls’ High School in Cape 
Town and, as such, had to give her approval on all academic matters 
in our family. When we broached the subject with her, she thought it 
would be a good idea. However, knowing the high standards required 
to gain entrance to Cambridge, she added that it was highly unlikely 
that I would get in. Always keen to rise to a challenge, I wrote the 
entrance exam during my fi nal Zoology III exams, and was accepted.
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To college at Cambridge
In September 1968, I arrived at Newnham College, the women’s 
college at Cambridge to which I had been assigned, where I was to 
study for Part II of the Natural Sciences Tripos. When I fi rst walked 
into the darkly imposing entrance hall of the Zoology Department, 
I looked at the board showing the names of staff members, and was 
completely overawed—it appeared just like a list of illustrious names 
on the cover of an undergraduate textbook. 
Unfortunately, I was to fi nd the people in the department cold and 
unfriendly, completely unlike the department at UCT. In addition I 
was assigned a rather aloof tutor, and the situation didn’t improve 
when I received something like 40 per cent for my fi rst essay (I was 
used to receiving fi rsts). Then I went on a fi eld trip to Plymouth in 
the Easter vacation to study marine life. The weather was foul, I was 
seasick most of the time, and our digs were basic if not primitive. I was 
rapidly becoming disenchanted with zoology, a situation exacerbated 
by the discovery that I was expected to spend the summer vacation 
working in the department. What to do? My parents were coming 
over in July and we had planned to travel in Norway, after which I 
was to go on a month’s sightseeing in Greece with a friend. Taking 
my courage in both hands, I cycled out to the Genetics Department, 
which was a little way out of Cambridge on the road to the cathedral 
town of Ely. I met the head of department, told him that I had studied 
genetics for about a week at UCT, and asked, ‘Please can I switch 
from zoology?’ I’ll be eternally grateful to him for agreeing. And so my 
academic future changed dramatically.
Life in the Genetics Department was very different. For a start it 
taught me the importance of competition—during our lunch breaks 
we played ‘killer’ darts in winter and ‘killer’ croquet in summer. It 
also taught me a bit about the diffi culties women students and staff 
were encountering in the male-dominated Oxbridge universities. A 
professor from Oxford came over once a week during the fi rst term 
to teach us ecological genetics. One day a few of the male members 
of our class of 12 were absent, so the professor grandly told us, 
‘Gentlemen, we do not have a quorum; I will not lecture today’, and 
with that he packed up his lantern slides and left! Although women 
were allowed to graduate from Oxford as early as 1920, this was 
deplored as a dangerous and radical enterprise in Cambridge. A 
document circulated to the Senate described Oxford’s move as ‘a dark 
and diffi cult adventure, the outcome of which no man can foresee’. 
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There was to be no female graduate of Cambridge for another 28 
years (Robinson, 2009).
Even in 1968 there were only three women’s colleges at Cambridge; 
the male-to-female ratio was about 10 to 1 (great for our social lives) 
and mixed colleges were not even dreamt of. I was required to eat one 
meal a week in college and the only reason I was happy to do so was 
because it gave me a free meal. I would otherwise have steered clear, 
as the women were somewhat frightening. They were so earnest and 
single-minded—true ‘bluestockings’—which they doubtless had to 
have been to get there in the fi rst place. 
Along with a modicum of genetics, the Genetics Department also 
taught me the importance of speed in research. We did small projects, 
and initially mine focused on that workhorse of classical genetics, 
the fruit fl y (Drosophila), and on fungi. Drosophila take about a week 
to grow, and although fungi are somewhat quicker they are messy, 
with spores that can fl y around and contaminate things. I therefore 
fi gured that bacteria were the organisms to work with for really fast 
results: they can grow overnight from one microscopic cell to a visible 
colony. So I decided to do my PhD on the genetics of bacteria.
South African PhD
I returned to Cape Town facing two choices of supervisor: Prof 
Jack de Wet, at the University of Pretoria, or Dr David Woods, who 
had recently returned to Rhodes University from his post-doctoral 
fellowship at Oxford. Despite the fact that Dr Woods was rather an 
unknown entity and I had never visited Grahamstown, where Rhodes 
is situated, Prof de Wet was a decidedly known entity—most students 
regarded him as terrifying. So I went to Rhodes.
The Leather Research Institute was located in Grahamstown and 
they had brought a problem to Dr Woods’s attention. The cured cow 
hides used in the production of leather were being spoiled, possibly 
by bacteria and their viruses. Researching these organisms and 
this possibility became my project. At the end of that year, I had 
a marvellous break. Shell SA announced that they would give a 
bursary to a PhD student who was working on a research project 
that could have national importance. I went for an interview in Cape 
Town, where the Shell head offi ce is located, and I won the bursary! 
At the time it was the most lucrative in the country, so after a frugal 
existence in which I had depended on my generous Dad for support, 
Food for Africa_Intro.indd   4 06/05/13   10:08 AM
 Introduction 5
I now lived much more comfortably, and was even able to buy a 
second-hand car.
One of the advantages of doing research at Rhodes University in 
those days was its small size. For a period of a few months I had to 
add reagents to an experiment every four hours, day and night. I 
had no problem at all with putting on a dressing gown and a pair of 
slippers and going off to the lab at night to do the necessary. Years 
later, a former student who had shared my residence, Lillian Britten, 
(where I was the warden), told me she remembered this vividly, and 
that the whole house had thought I was slightly crazy. 
Towards the end of my PhD I was awarded a Rotary Foundation 
post-doctoral fellowship to study in the United States. Where to go? I 
wrote numerous letters to a range of scientists, some quite famous and 
some who even bothered to reply. The problem was solved when I met 
Graeme Hardie, a South African living in Tucson, Arizona. During a 
whirlwind visit to America we became engaged. He was planning to 
study at the Massachusetts Institute of Technology (MIT) so I decided 
to try for nearby Harvard, and was accepted by the Department of 
Microbiology and Molecular Genetics at the Medical School.
Harvard post-doc
We arrived in Boston, newly married, in September 1974. En route we 
had honeymooned in Sweden and, as David Woods was on sabbatical 
leave in Norway at the time, he and his family joined us at a friend’s 
home near Stockholm. He showed me a Time magazine article about 
a new technique called ‘genetic engineering’ in which scientists 
spliced genes together from any organism and transferred them into 
bacteria. They did this by cloning the gene into a plasmid that could 
be used as a vector to transfer the gene into the bacterium of choice. 
‘Ground-breaking stuff,’ he said. Little did I know I was hearing about 
a technique that would become the basis for my life’s work.
I had chosen Harvard mainly for its proximity to MIT and my 
husband, but it turned out to be an excellent choice for my career. My 
supervisor, Dan Fraenkel, worked in the fi eld of central metabolism, 
using Escherichia coli (E. coli), the workhorse of bacterial genetics. 
Central metabolism, or glycolysis, is the metabolic pathway that 
converts sugars, such as glucose, into energy in the form of ATP. 
This was a totally unknown fi eld to me. Fortunately Rick Wolf, a 
senior post-doctoral fellow in Dan’s lab, took me under his wing and 
was an invaluable source of help and information. My project was 
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to identify and map on the E. coli chromosome the gene coding for 
phosphofructokinase (Pfk), the enzyme responsible for catalysing 
the phosphorylation of fructose 6-phosphate to form fructose 
1,6-bisphosphate. I relied heavily on Rick to understand the details of 
both central metabolism and the Pfk enzyme, and I would really have 
struggled without him.
A problem for me at Harvard was that South African PhDs 
follow the UK system, whereby one learns a great deal about 
one’s thesis subject, and very little else. In America, on the other 
hand, they follow a far more generalised approach and students 
take a considerable number of intense courses, given—in the case 
of Harvard—by experts in the fi eld. American PhD students are 
therefore well rounded and extremely knowledgeable. I felt like a 
total ignoramus and hardly dared to say a word in the communal 
tea room for at least six months. However, when I gave a seminar 
on my thesis, ‘Genetic studies on collagenolytic Achromobacter 
strains and their bacteriophages’, the topic was totally foreign to 
my colleagues and this, somehow, led to their respect. As a post-doc 
I was able to sit in on some of the courses and so managed to catch 
up on at least some of the body of knowledge that Harvard PhDs 
took for granted.
Another lesson, this time about women in science, came home to 
me after I had been at Harvard for more than a year. I had made 
friends with another post-doctoral fellow working in the lab across 
the corridor. We worked in different fi elds but found we could discuss 
our work easily together. It was only when she invited Graeme and 
me to dinner in her home that I discovered she was working under 
her married name. When she told me her maiden name, I realised 
that I had quoted her research papers a number of times in my PhD 
thesis. Moral: if you have published under your maiden name, stick 
to it. I have done so ever since.
The debate begins
The new science of genetic engineering was highly controversial. 
Even among scientists it was a fi ercely debated topic. No-one in 
our department had used the technique and indeed some of them, 
belonging to a group called Science for the People, vehemently opposed 
it. The potential hazard of recombinant DNA technology had fi rst 
been brought to the attention of the public by scientists—principally 
by Paul Berg. In their letter to the president of the National Academy 
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of Science of the USA (Berg et al., 1974), these scientists requested 
that the president appoint an ad hoc committee to study the biosafety 
ramifi cations of this new technology. He did, and this committee 
decided that an international conference was necessary to resolve 
the issue and until that time scientists should halt experiments 
involving this new technology. Accordingly, in 1974 Paul Berg 
convened what came to be known as the Asilomar Conference, held 
at the conference centre of that name in Monterey, California. The 
conference concluded with a suggested set of guidelines under which 
rDNA (as the recombinant DNA technique became known) could be 
carried out, depending on the level of perceived risk. These were 
later fl eshed out by the National Institutes of Health Recombinant 
DNA Committee, and became the basis of regulations worldwide.
Ironically, Paul Berg shared the 1980 Nobel Prize for Chemistry 
with Walter Gilbert, who received the prize for his pioneering work on 
DNA sequencing. Gilbert manned a stand at a weekly market with a 
DNA helix in hand, trying to explain recombitant DNA to passers-by. 
I remember his seminar on DNA sequencing, the fi rst time many of 
us in the audience had even heard that it could be possible to read the 
nucleotide sequence of a piece of DNA—amazing stuff then, but today 
just a matter of course.
Although the scientists left Asilomar thinking that they had 
allayed public fears about their work, they had only managed to fan 
them. The cover of Time magazine on 18 April 1977 shows a sinister-
looking scientist peering with obvious malicious intent at an evil-
looking pink brew of DNA. In fact, if the DNA in the test tube had 
turned pink it would have been due to impurities in the phenol used to 
extract it, and the DNA would have been shattered into so many tiny 
fragments that it would have been unusable in an rDNA experiment. 
But of course a test tube containing colourless DNA wouldn’t have 
looked half as dramatic. 
The main Harvard campus is located in Cambridge, where Mayor 
Vellucci had a somewhat confrontational Town vs Gown approach. 
He used the genetic engineering controversy to proclaim that no 
such experiments could be carried out in his city. (Fortunately, 
the medical school where I worked was across the River Cam in 
Boston.) ‘Something could crawl out of the laboratory, such as a 
Frankenstein,’ he is reported to have said in Time magazine in 1977 
(Jaroff et al., 1977).
The fi re continued to be fuelled by scientifi c controversy. Caltech’s 
Robert Sinsheimer proclaimed: ‘Biologists have become, without 
wanting it, the custodians of great and terrible power. It is idle to 
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pretend otherwise.’ Columbia’s Erwin Chargaff further built on this 
with ‘Have we the right to counteract, irreversibly, the evolutionary 
wisdom of millions of years in order to satisfy the ambition and 
the curiosity of a few scientists?’ This was countered by Harvard’s 
Bernard Davis who was so sure the new technique was safe that 
he publicly offered to drink rDNA. He was supported by Stanford’s 
Stanley Cohen, who wrote, with undisguised sarcasm, that it was 
Chargaff ’s ‘evolutionary wisdom that gave us the gene combinations 
for bubonic plague, smallpox, yellow fever, typhoid, polio and cancer’ 
(Jaroff et al., 1977).
A few weeks later the letters in Time magazine, 9 May 1977, 
refl ected the ongoing debates (which persist to this day): 
 ‘Regulation seems to be necessary, if only to placate an aroused public, 
but the guidelines for DNA recombination should arise from within 
science and not from Government or other third parties.’ 
 ‘Once the doors to genetic engineering are thrust wide open, it will be 
pursued to its ultimate end: man transformed into a biological machine 
manipulated and controlled by the few.’
 ‘In view of the fact that our so-called human intelligence has already 
driven some species to extinction, there is only one commandment for 
us in nature’s bible: Thou shalt not tamper.’
 ‘The act of living, as opposed to existing, requires the taking of 
chances—and perhaps a little faith. The worlds that may be opened by 
genetic research seem well worth a risk.’
Illustrating the contemporary nature of these debates, the following 
petition appeared on the Internet in October 2011 under the headline: 
‘UK plant scientists call on Europe to change current laws and adopt 
science-based GM regulations’:
We the undersigned share the views of 41 leading Swedish plant 
scientists that current legislation of GM crops is not based on science, 
ignores recent evidence, blocks opportunities to increase agricultural 
sustainability and stops the public sector and small companies from 
contributing solutions.
We call on pressure groups and organic trade associations to cease and 
desist from blocking genetic solutions to crop problems, and on Europe 
to change current laws and adopt science-based GM regulations (http://
www.ipetitions.com/petition/changeeugmlegislation/).
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The controversy is my solution
I had spent the fi rst year of my post-doc tackling the E. coli pfk 
gene using classical bacterial genetics approaches and I was getting 
nowhere. But in 1976 I found the solution. I could solve the problem 
using the methods of that hot topic—genetic engineering. On a 
memorable holiday to visit the historical town of Williamsburg with 
Rick Wolf and his wife, I tried out the idea on him. He was very 
enthusiastic and encouraged me to go for it. But when I told Dan 
Fraenkel that I wanted to use this new rDNA technique he was 
somewhat sceptical (after all, he was paying) and, although he agreed, 
he said that I was on my own.
What I wanted to do was to clone the pfk gene, introduce it into 
an E. coli strain lacking this gene and show that the resulting strain 
now produced the Pfk enzyme. Fortunately for me, a group in the 
US had recently made a gene bank of random fragments of E. coli 
DNA cloned into a plasmid. I obtained this bank from a scientist in 
California and selected the one I wanted by transferring all the hybrid 
plasmids into a strain of E. coli lacking this gene. When I found one 
that could complement the pfk-strain and allow it to grow on glucose, 
I had the plasmid I wanted. I purifi ed it and used this hybrid plasmid 
to prime an in vitro transcription/translation extract. When I tell my 
students today that I personally made the in vitro cell extract they 
are open-mouthed with amazement. What took me nearly six months 
to make and get to work, they can buy off the shelf today. However, 
make it I did, and then precipitated the radioactively labelled Pfk 
protein using a specifi c antibody. The moment of truth would come 
when I ran the products on a gel, cut this into one millimetre slices 
and ran the fractions through a liquid scintillation counter.
That moment of truth came exactly seven months after I had 
started the project. In the middle of the night on 17 September 1976, 
as I huddled over the scintillation counter, mesmerised by the print-
out, suddenly there it was—the most perfect single peak at precisely 
the point at which I expected the Pfk enzyme to appear (Figure 1). 
Despite the lateness of the hour I just had to call Dan to tell him the 
good news.
The next day I wrote up the results for publication and when my 
fi rst draft was complete, I handed it to Dan, with both our names as 
co-authors. But when he handed it back to me with the corrections, 
he had crossed out his name. I was mortifi ed. I thought he had 
considered the paper to be so bad that he didn’t want to be associated 
with it. When I fi nally plucked up the courage to ask him he replied 
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that he couldn’t claim co-authorship to the paper as it had been my 
work entirely, from concept, through experimental ups and downs, 
until the fi nal successful completion.
Figure 1 The Pfk peak
So I am the proud possessor of a single author paper from Harvard 
Medical School (Thomson, 1977), an achievement reached from the 
starting point of a fi xed desire to become a high school teacher. My 
path had led me from zoology to a degree in genetics from Cambridge, 
to a PhD in bacterial genetics at Rhodes University, and placed me 
neatly at Harvard Medical School just as my destined fi eld of genetic 
engineering was at its start.
Frequent debates
As an adviser on genetically modifi ed organisms (GMOs), I’ve had many 
interesting interviews over the years, and frequently had to answer 
the same questions. One request came in 2010 from the Canadian 
Broadcasting Corporation when I was at the African Agricultural 
Technology Foundation (AATF) in Nairobi (see Chapter 4). Could 
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David Suzuki interview me for a radio programme? He was a well-
known geneticist, turned populariser of science through newspaper 
columns, television and radio, so I was thrilled. Fortunately Nancy 
Muchiri, head of communications for the AATF, did a background 
search on him. In 1977 he had written ‘I feel compelled to take the 
position that … no such experiments [on recombinant DNA] will be 
done in my lab; reports of such experiments will not acknowledge 
my grants; and I will not knowingly be listed as an author of a 
paper involving recombinant DNA’. In this personal perspective on 
biotechnology, put out by the David Suzuki Foundation, he further 
wrote: ‘Feeding the starving masses through biotech in the near 
future is a cruel hoax that cannot be taken seriously’. And I was 
about to be interviewed by him on the role GM crops could play in 
fi ghting hunger.
David (we were immediately on fi rst name terms) was very 
charming but clearly wasn’t a neutral interviewer. He seemed to 
assume that the AATF was simply importing American GM crops to 
use in Africa. When I asked, ‘David, have you ever been on a farm 
in Africa?’, he replied that he had not, so I had to explain to him 
how all GM crops used in Africa have to be varieties bred for the 
specifi c climate, pests and soil conditions. At the end he said he had 
more hope for GM crops than he had entertained before, but I have no 
illusions that I changed his mind.
One subject that often comes up in debates is the issue of 
labelling. Some people contend that all items on sale should be 
labelled to indicate whether they contain any component that has 
been subjected to genetic modifi cation. This means that an item 
will be labelled not on its content but on the way its content has 
been produced. If this were to occur, logically all food items should 
be labelled in a similar fashion. What about the pesticide sprays 
that have been applied to the apples in a can? What about whether 
the tomatoes were hand - or machine - picked? Product labelling 
that conveys essential information is important, but if methods 
of production are to be labelled, then this should be across the 
board. Who would monitor this? Do we even have the technological 
capability of testing whether what is written on the label is true? 
And who would pay for it?
Newspaper billboards appeared in Cape Town in March 2012 
proclaiming ‘GM scare in baby food’. The regulations governing the 
Consumer Protection Act had come into effect on 1 October 2011 
and investigators had subsequently found that certain infant foods 
contained more than fi ve per cent GM products, that being the 
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cut-off level above which labelling is required. Indeed, food should 
be labelled (and the labelling paid for) now that South Africa has 
such a law, but a ‘GM scare’? Considering that organisations such 
as the British Medical Association, the European Union Research 
Directorate, both French Academies (of Medicine and Science), and 
the Union of German Academies of Science and Humanities, among 
others, have declared food derived from GM plants to be safe for 
human consumption (including babies) (see Chapter 9), its presence 
can hardly constitute a ‘scare’.
On the question of labelling, as early as 2009, 16 Nobel Prize 
Laureates warned against legislation targeting the process of 
developing transgenic plants, and not the product itself. They 
unanimously stated that:
there is no scientifi c justifi cation for additional specifi c legislation 
regulating recombinant research per se. Any rules or legislation should 
only apply to the safety of products according to their properties, 
rather than according to the methods used to generate them (Sehnal and 
Drobnik, 2009:13).
Another subject that often comes up in debates is the question of 
animal genes in GM crops. Vegetarians and vegans, in particular, 
are often outraged at this prospect. They cite the example where 
scientists introduced an anti-freeze gene from fl ounder fi sh into 
strawberries to try to prevent frost damage. The experiment didn’t 
work so the project was abandoned—but not by the anti-GMO 
lobby. In fact, no animal gene has yet been introduced into a plant 
for commercial use. However, as humans share about 50 per cent 
of their genes with bananas, one might be hard pressed to defi ne 
an animal gene.
The question of allergies is also raised on occasion. What if genes 
from peanuts or Brazil nuts, both foods having well-known allergenic 
properties, were to fi nd their way into maize or wheat? This is taken 
very seriously by regulatory authorities, and applicants seeking 
approval of a GM crop have to provide stringent experimental and 
in silico data (many allergenic proteins contain signature amino acid 
sequences) to prove that their plants do not contain any introduced 
allergenic proteins.
A further subject that frequently arises during debates is the 
‘confl ict’ between organic farming and the use of GM crops. I write 
‘confl ict’ as I will never understand how a gene, a quintessential 
organic compound, cannot be compatible with organic farming. 
However, the International Federation of Organic Agriculture 
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Movements (IFOAM) states that organic agriculture dramatically 
reduces external inputs by refraining from the use of synthetic 
fertilisers and pesticides, genetically modifi ed organisms and 
pharmaceuticals (IFOAM, 2005).
Interestingly enough, although organic farmers espouse the 
writings of Rachel Carson in Silent Spring (Carson, 1962), it has been 
pointed out that the explosive uptake by farmers around the world of 
GM crops, wherever they have been allowed access, is that they have 
brought life to the vision of the future fi rst articulated by her when 
she described the new paradigm she hoped for in the relationship 
between humans and our environment (Giddings et al., 2012). She 
wrote:
A truly extraordinary variety of alternatives to the chemical control 
of insects is available. Some are already in use and have achieved 
brilliant success. Others are in the stage of laboratory testing. Still 
others are little more than ideas in the minds of imaginative scientists, 
waiting for the opportunity to put them to the test. All have this in 
common: they are biological solutions, based on an understanding of 
the living organisms they seek to control, and of the whole fabric of 
life to which these organisms belong. Specialists representing various 
areas of the vast fi eld of biology are contributing—entomologists, 
pathologists, geneticists, physiologists, biochemists and ecologists—
all pouring their knowledge and their creative inspirations into the 
formation of a new science of biotic controls (Carson, 1962:240).
Rachel Carson pre-empted the development of insect-resistant GM 
crops by some 30 years!
The recent Séralini saga
On 18 October 2012, a headline in the South African Cape Times 
read: ‘GM maize scare for SA after rats fed on product develop 
tumours’. A group in France, led by Professor Gilles-Eric Séralini, 
had fed rats herbicide-resistant GM maize for two years and 
found that they developed higher levels of cancers than rats 
fed on non-GM maize. Their publication in the peer-reviewed 
American journal Food and Chemical Toxicology caused a storm of 
controversy, with the anti-GM lobby calling for a ban on planting 
of such maize.
However, these voices were soon quashed by the European Food 
Safety Authority (EFSA), which issued a press release (http://www.
efsa.europa.eu/en/press/news/121004.htm) in which it concluded 
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that the study was so seriously fl awed that the data could not be 
considered reliable. Similar views were expressed by six European 
Union member states (including France), as well as regulatory 
authorities in Canada, Brazil, Australia and New Zealand.
Some of the shortcomings include that:
 ● the strain of rat used in the two-year study is prone to developing 
tumours during their life expectancy of approximately two 
years; for this reason, the standard toxicological tests on these 
rats, used worldwide for products such as food additives, 
fl avourings, etc., are done over a period of 90 days
 ● the authors split the rats into 10 treatment sets, but established 
only one control group; this resulted in some 40 per cent of the 
animals not having appropriate controls, a fatal fl aw in any 
tests of this nature
 ● the paper did not comply with the internationally recognised 
standard protocols that have been developed by the OECD 
(Organisation for Economic Cooperation and Development)—
for instance, these protocols specify the need for a minimum of 
50 rats per treatment group; the authors used only 10
 ● the paper does not employ commonly used statistical analysis 
methods. 
Unfortunately these comments received very little publicity compared 
to the original scare articles which appeared in many countries. 
How could a study almost universally regarded as seriously fl awed 
and misleading be published in a respected journal? The fact that an 
article is peer reviewed does not bring fi nality to the fi ndings in the 
article, nor does peer review always meet the goals of ensuring that 
the results are valid and meaningful. Peer review is merely the fi rst 
check in establishing the veracity of published scientifi c information. 
This is followed by analysis by the scientifi c community as a whole, 
during which the published information is more widely examined 
and critiqued. Finally, additional studies may be conducted when 
necessary to clarify any important issues raised. Clearly, the Séralini 
study has now gone through the second phase, and has failed this 
review (ABNE, 2012).
Writing on science 
In 1977 I took my fi rst step in writing on science for the public. A friend 
in California wrote for the American Association of Retired Persons 
and, when he heard me talking about genetic engineering, suggested 
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I write an article for the division of the National Retired Teachers 
Association. My article, ‘Biology’s “atomic bomb”’, appeared in their 
January edition, written under my married name (Hardie, 1977). 
Even then I was passionate about unbundling the negative debate 
that was raging in America at the time, talking about the technique 
‘gathering its own mushroom cloud of “hot air” over itself ’. I ended by 
saying: ‘We are all passengers on earth—we come and we go; and as 
we pass by we, too, will leave the earth for future generations. Let us 
leave it a little better off than before, by the time we go.’
My second step into writing on science for the public came early 
in 2001. I received a call from the editor of UCT Press asking me if 
I would like to write a book on genetic engineering with an African 
slant. There were a few books on genetic engineering available for 
the layperson at the time. The Thread of Life: The Story of Genes and 
Genetic Engineering (Aldridge, 1996) was excellent, but went into 
many aspects of genetics other than genetic engineering. Genetic 
Engineering—Dream or Nightmare: Turning the Tide on the Brave New 
World of Bad Science and Big Business was written by Mae-Wan Ho 
(2000), a well known anti-GMO activist, and Redesigning Life? The 
Worldwide Challenge to Genetic Engineering was also up front in its 
opposition to this technology (Tokar, 2001). 
In 2002 I published Genes for Africa (Thomson, 2002). The launch 
took place on the pavement outside the Village Bookshop in the main 
road of Plettenberg Bay, a holiday town on the southern Cape coast. I 
think I sold four copies.
My second book came about as a result of a review of Genes for 
Africa in the journal Nature. The review was written by Gordon 
Conway, who was then president of the Rockefeller Foundation, and 
in it he wrote:
This is a gem of a book. It is clear and concise, it makes the complex seem 
simple without losing the essential truths, and, as far as I can tell, it is 
accurate, with no innuendo, no half-truth and no wild extrapolation. 
[…] The remaining concerns centre on the probability of gene fl ow, 
providing wild relatives with competitive advantages that could 
signifi cantly change natural ecosystems. I think the jury is still out 
on this, and I feel that she could have expanded further on these topics 
(but then I am an ecologist). [...] I recently had a long conversation 
with President Museveni of Uganda. He asked many thoughtful and 
penetrating questions about GM technologies. After our talk I sent him 
a copy of Genes for Africa. I know it will have given him many of the 
answers he is seeking.
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I therefore decided I needed to write another book concentrating on 
GM crops, considering their environmental impacts.
By this time a number of additional books had been published 
on the subject of genetic engineering. Dinner at the New Gene Café: 
How Genetic Engineering is Changing What We Eat, How We Live, and 
the Global Politics of Food (Lambrecht, 2002) talked of an impending 
clash between a powerful but unproved technology and gathering 
resistance from people worried about its safety. Playing God? Human 
Genetic Engineering and the Rationalization of Public Bioethical 
Debate (Evans, 2002) and Redesigning Humans: Choosing our Genes, 
Changing our Future (Stock, 2003) discussed the technology as 
applied to humans. Shrinking the Cat: Genetic Engineering Before 
We Knew About Genes (Hubbell, 2002) contended that the concept of 
genetic engineering is hardly new, as humans have been tinkering 
with genetics for centuries. The author focused on four specifi c 
examples: corn, silkworms, domestic cats and apples. And The Hope, 
Hype, and Reality of Genetic Engineering: Remarkable Stories from 
Agriculture, Industry, Medicine, and the Environment (Avise, 2004) 
was rather sensational. There was clearly room for a book dealing 
with agricultural biotechnology, written for the interested layperson.
There are two titles to my second book—an interesting result 
of the intervention of two publishers: Cornell University Press 
published it as Seeds for the Future, and the Commonwealth Scientifi c 
and Industrial Research Organisation (CSIRO) Press published it as 
GM Crops: The Impact and the Potential (Thomson, 2006).
This third book, Food for Africa, looks at the development of 
agricultural biotechnology in the form of genetically modifi ed crops 
in sub-Saharan Africa. The raison d’être for the development of these 
crops is to alleviate hunger and achieve food security on the sub-
continent. 
Food security has been defi ned as a situation in which all people, 
at all times, have physical and economic access to suffi cient, safe and 
nutritious food to meet their dietary needs and food preferences for 
an active healthy life (Rome Declaration, 1996). This is affected by a 
complexity of factors including:
 ● unstable social and political environments leading to war and 
civil strife
 ● trade imbalances
 ● natural resource constraints such as lack of water, and natural 
disasters such as fl oods and locust infestations
 ● poor human resources
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 ● gender inequality 
 ● inadequate education
 ● poor health
 ● absence of good governance.
Most of these are beyond the scope of this book, although I will touch 
on trade imbalances, lack of water, poor human resources, gender 
inequality, inadequate education and absence of good governance.
It does not take a rocket scientist to conclude that the root cause 
of food insecurity in developing countries is the inability of people to 
gain access to food due to poverty. This was highlighted in a book I co-
edited for the InterAcademy Council, entitled Realizing the Promise 
and Potential of African Agriculture (2004). While the rest of the world 
has made signifi cant progress towards poverty alleviation, Africa—
in particular sub-Saharan Africa—continues to lag behind. Over 
70 per cent of its food-insecure people live in rural areas (Heidhues 
et al., 2004). It follows, therefore, that a major intervention to help 
in achieving food security should be made in agriculture. This book 
sets out to show the role that the not-so-new technology of genetic 
modifi cation can play in this process.
I have been fortunate to be closely involved in the development 
of genetic modifi cation since 1977, fi rst in South Africa and then in a 
number of mainly southern and East African countries. My involvement 
has been not only in the regulatory aspects of genetic engineering. I 
have also helped in the development of organisms, including plants. 
It has been, and continues to be, a long, sometimes arduous, but 
ultimately rewarding experience. A friend once told me that in order 
to be successful in developing a genetically modifi ed crop, you don’t 
just need a good idea (or two). What you really need is perseverance. 
Fortunately, the perseverance fairy was present at my birth.
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The SAGENE years
After my post-doc at Harvard Medical School ended in 1977, I took up 
a lectureship back in South Africa, in the Genetics Department at the 
University of the Witwatersrand (Wits) in Johannesburg. I applied to 
the Council for Scientifi c and Industrial Research (CSIR), which was, 
in those days, the government agency dispensing research grants, for 
funds to continue my work on genetically modifi ed bacteria. When 
the Head of the Genetics Department, Nancy van Schaik, read my 
application, she wrote to the CSIR, pointing out that this was a fi eld 
of research which had caused a great deal of discussion worldwide and 
that they might want to consider some guidelines for South Africa. 
She didn’t know whether the people reading my application would be 
up to date with what was going on elsewhere. The National Institutes 
of Health (NIH) of the US had published their guidelines in 1976 
for research involving recombinant DNA molecules and, on receiving 
Nancy’s letter, the CSIR realised they had better set up some sort of 
a body to ensure that these guidelines were implemented in South 
Africa. They accordingly established the South African Committee for 
Genetic Experimentation (SAGENE). To help them in their task they 
invited Herb Boyer to visit.
In 1976, together with the venture capitalist, Bob Swanson, Herb 
had co-founded Genentech, the fi rst biotechnology company based 
on GMOs, and served as vice-president of the company until his 
retirement in 1991. Herb, working at the University of California, San 
Francisco, had been one of the fi rst scientists to discover that genes 
from bacteria could be combined with genes from higher organisms, 
eukaryotes, to create recombinant (or genetically modifi ed) organisms. 
In 1977, he and his collaborators synthesised the gene coding for the 
human growth hormone inhibitor, somatostatin. He transferred it into 
the bacterium, Escherichia coli (E. coli), and developed the product 
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in a fermenter. This was followed by the production of synthetic 
human insulin. Prior to that, diabetics worldwide had been treated 
with insulin extracted from the pancreas of animals such as pigs or 
cattle. Not only was this expensive, but some sufferers experienced 
allergic reactions to the foreign hormone. Herb’s team solved these 
problems in one fell swoop, but helped to create a whole new problem, 
in the form of the soon-to-be-maligned fi eld of genetically modifi ed 
organisms (GMOs).
An extremely positive outcome of Herb’s visit was the role of SAGENE 
in the certifi cation of laboratories for the use of GMOs. Before a scientist 
could apply to the CSIR for research funding in this fi eld, SAGENE had 
to approve the laboratories in question as being compliant with the US 
NIH guidelines. As many universities in the country were keen to foster 
this type of research, they were forced to upgrade and equip laboratories 
to a given standard. The scientists in question also had to give evidence 
of having been trained in the correct safety standards. This led to the 
running of a number of training courses, resulting in a network of 
scientists working on a variety of projects using GMOs. This certainly 
stimulated the growth of modern biotechnology in South Africa.
A visit to Basel
In 1978, a year after I had joined Wits University, I attended a life-
changing three-week course on genetic engineering in the Basel 
laboratory of Werner Arber, who was shortly to receive the Nobel Prize 
for his pioneering work in this fi eld. Werner Arber had discovered 
restriction enzymes which are able to cut DNA at specifi c sequences. 
This allowed other scientists to splice any piece of DNA together as 
long as the specifi c sequences at their ends matched—hence the term 
‘genetic engineering’.
The course was held under the auspices of the European Molecular 
Biology Organisation. Usually, South Africans were excluded from 
attending, because of our government’s apartheid policy. But somehow, 
someone pulled strings, and against all odds I was accepted to attend 
the course. What an experience! Genetic engineering was only about 
fi ve years old and we were learning techniques from the very people 
who had developed them, and using the earliest bacteriophage vectors. 
Among these pioneers were professors Ken and Noreen Murray. Ken’s 
group developed the vaccine against hepatitis B, the fi rst vaccine to 
be made using genetic engineering. He was also one of the founders 
of the UK-based biotechnology company, Biogen, and was knighted 
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in 1993. Noreen held a personal Chair in Molecular Genetics at the 
University of Edinburgh and was made a Commander of the Order 
of the British Empire in the 2002 New Year Honours list. Sir Ken 
and Lady Noreen founded the Darwin Trust of Edinburgh, a charity 
which supports young biologists in their doctoral studies.
We were taught plant transformation by Marc van Montagu who, 
together with Jeff Schell and Mary-Dell Chilton, developed the fi rst 
plant vectors based on bacterial plasmids and worked out how to 
introduce foreign genes into plants. They discovered the gene transfer 
mechanism between the soil bacterium, Agrobacterium tumefaciens, 
and plants, which resulted in the development of methods to 
convert Agrobacterium into an effi cient delivery system for genetic 
engineering and thus create transgenic plants. Marc was granted the 
title of baron by King Baudouin of Belgium in 1990. In 1982, he and 
Jeff founded the biotechnology company, Plant Genetic Systems Inc., 
in Belgium. It is now part of Bayer CropScience. Jeff was also made 
a baron, and they both visited South Africa on a number of occasions 
to help in the development of plant biotechnology. Mary-Dell is a 
Distinguished Science Fellow at Syngenta Biotechnology, Inc. and in 
2002 Syngenta created the Mary-Dell Chilton Center, a conference 
centre at their facility in Research Triangle Park, North Carolina.
We learned how to do Southern blots from their inventor, Ed 
Southern. These blots are used for DNA analysis and were routinely 
used for genetic fi ngerprinting and paternity testing prior to the 
development of microsatellite markers for this purpose. Ed also 
used the concept of Southern blots in the development of modern 
microarray slides. He founded the company Oxford Gene Technology 
based on this process and was made a knight bachelor in the June 
2003 birthday honours. He is the founder and chair of the Scottish 
charity, The Kirkhouse Trust, which focuses on agricultural crop 
improvement research for the developing world, and specifi cally on 
legumes.
When Werner Arber’s Nobel Prize was announced I wrote to 
congratulate him. His young daughter, Silvia, wrote a charming reply:
When I come to the laboratory of my father, I usually see some plates 
lying on the tables. These plates contain colonies of bacteria. These 
colonies remind me of a city with many inhabitants. In each bacterium 
there is a king. He is very long, but skinny. The king has many 
servants. These are thick and short, almost like balls. My father calls 
the king DNA, and the servants, enzymes. The king is like a book, in 
which everything is noted on the work to be done by the servants. For us 
human beings these instructions of the king are a mystery. My father 
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has discovered a servant who serves as a pair of scissors. If a foreign 
king invades a bacterium, this servant can cut him in small fragments, 
but he does not do any harm to his own king. Clever people use the 
servant with the scissors to fi nd out the secrets of the kings. To do so, 
they collect many servants with scissors and put them onto a king, so 
that the king is cut into pieces. With the resulting little pieces it is much 
easier to investigate the secrets. For this reason my father received the 
Nobel Prize for the discovery of the servant with the scissors.
One evening, walking the wet streets of Basel to dinner, Marc van 
Montagu asked me about my future plans. I told him that I wanted to 
work in the fi eld of plant genetic engineering but didn’t know how to 
go about it. He invited me to spend time in his lab in Ghent. 
The Ledeganck Street lab, Ghent
I spent an eye-opening month with Marc’s students in the Ledeganck 
Street lab, as we called it. Cramped would be too generous a name for 
the conditions they worked in. Corridors had been turned into labs, 
cupboards had become electron microscope units, and at times people 
resorted to working in shifts in order to get access to equipment. How 
different from Wits, where space was abundant but skilled people 
were in severely short supply. What I learned in that month, and 
from many more shorter visits to Marc’s lab, set me up for my future 
career in plant genetic engineering, but it would take 10 more years 
before I fi nally landed in the right environment, at the University of 
Cape Town, to put these plans into action. 
Marc was born in 1933 in Ghent in a period of great economic 
recession. He was raised in a working-class neighbourhood. The cotton 
factories where most of the men, and even young boys, worked at the 
time were dark, noisy and fi lled with clouds of dust fl oating around the 
spinning machines. As Marc wrote of these factories in his article ‘It is a 
long way to GM agriculture’: ‘They were so frightening and convincingly 
repulsive that I felt I never wanted to be obliged to work there’ (Van 
Montagu, 2011). Perhaps it was this that spurred him on to do well 
in school, helped by a school teacher uncle who insisted he go to the 
best primary school within walking distance. He started his PhD in the 
heady days of the birth of the new science called molecular genetics, 
but his fi rst job was as the deputy director of an institute for training 
technicians and technical engineers for the nuclear industry. He soon 
saw the light, however, and joined the physiological chemistry laboratory 
of the University of Ghent. At the end of the sixties he was joined in 
the Ledeganck Street lab by his friend, Jeff Schell, and together with 
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Mary-Dell Chilton, working at Washington University, St Louis, 
Missouri, they founded the fi eld of plant genetic engineering.
To get there, however, they had to fi nd a workable plant gene vector 
to transfer genes into plant cells. The race was fi erce between Ghent 
and St. Louis, with both labs using the new technique of Southern 
blots to demonstrate that foreign genes were integrated in the plant 
genome. The battle to publish fi rst was won by Mary-Dell (we will 
meet her again in Chapter 7) and the only record of the Ledeganck 
Street lab data is a talk given at a Cold Spring Harbor Symposium in 
1978 (Van Montagu, 2011). 
My own laboratory
Back in Johannesburg, all was not well with me and the Genetics 
Department at Wits. I was a bacterial geneticist and needed to 
supervise postgraduate students in that discipline. But most of the 
students interested in pursuing this line of research were registered 
in the Microbiology Department and I had no access to them. Feeling 
uncertain, I left in mid-1982 for a sabbatical year at the Massachusetts 
Institute of Technology (MIT). 
This was a heady time for industrial biotechnology. New 
companies were starting up all around me, many involving people I 
was working with at MIT. For instance, Charlie Cooney, in whose lab 
I was working, was one of the founders of Genzyme, which began life 
close to the MIT lab in Cambridge and is now a multimillion dollar 
Figure 1.1 Marc van Montagu Figure 1.2 Jeff Schell pointing something out on a 
yacht in Table Bay harbour
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company (2010 revenues were in the order of US$ 4 billion) with some 
10 000 employees working in countries throughout the world. They 
now concentrate on medical applications, but in the early days their 
focus—as the name implies—was on genetically engineered enzymes. 
Indeed, my work in Charlie’s lab involved cloning the enzyme 
heparinase, produced by the bacterium Flavobacterium heparinum. 
Heparin is an anticoagulant used in medical procedures such as 
heart surgery and excessive use can cause unwanted bleeding. It 
was thought that heparinase, which degrades heparin, could prevent 
such side effects. In fact, the enzyme, whose gene was fi nally cloned 
in 1996, is now used primarily for the preparation of breakdown 
products of heparin for research purposes.
I got caught up in this excitement and, uneasy about my future 
at Wits, started a job hunt for a position with one of the start-up 
biotechnology companies in America. News of my enquiries reached 
South Africa and, before I could make any plans, I was summoned to 
meet Dr RR Arndt, the Deputy President of the CSIR, in Washington 
DC, where he was on business. He asked me whether I would like to 
start a Laboratory for Molecular and Cell Biology (LMCB) at Wits.
The LMCB premises started small, on the top fl oor of the 
Gatehouse Building at Wits University, in which my former home, 
the Genetics Department, was located. After four years it numbered 
some 30 people, including a group at the Onderstepoort Veterinary 
Research Institute in Pretoria, who were involved in animal nutrition. 
One of our research interests became the use of naturally occurring 
and genetically modifi ed bacteria in the gut of ruminants such as 
cows and sheep, to improve animal nutrition.
With the memories of the start-up companies in America fresh in 
my mind, I decided to test the waters in South Africa for a similar 
venture. Together with a business friend I drew up an investment 
proposal for ‘South Africa’s fi rst biotechnology company based on 
genetic engineering—AFROGEN’. The scientifi c advisory board 
was to include colleagues at Wits and Onderstepoort, and Dr Dave 
Woods. The projects would be largely Africa-specifi c and would include 
diagnostics for plant and animal diseases, as well as animal vaccines. 
The research was to be carried out mainly in the LMCB, but some 
would also be done in the laboratories of members of the advisory 
board. The estimated costs for the fi rst three years of operation, 1985 
to 1987, were R3 403 000, equivalent in today’s terms to R32.8 million 
(about US$ 3.8 million). Start-up funding included money for market 
research to estimate returns on investments.
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The Industrial Development Corporation and an organisation 
called the South African Inventions Development Corporation 
showed some initial interest, but after numerous meetings with 
business leaders, I came to realise that, in South Africa at that 
time, venture capital meant investment in a concept for which there 
were already orders in place, such as a fork-lift on the back of a 
truck. The suggestion was then made that the concept be modifi ed 
and renamed AFROGEN Technology Transfers, which would act 
as an intermediary between existing research laboratories and the 
marketplace, closing the technology transfer gap between researchers 
and the marketplace. This was clearly not my fi eld of expertise, so 
the idea of AFROGEN quietly died. Little did I know that in 2003 I 
would become the fi rst chair of the board of a similar organisation 
concentrating on agricultural biotechnology, the African Agricultural 
Technology Foundation. 
Restructuring the CSIR
During this period I reported regularly to Dr Arndt, as well as to 
James Bull, chief director of the National Chemistry Research 
Laboratory, and Brian Clark, Head of the National Institute 
for Materials Science. At this time, the government, which had 
previously paid for almost all the CSIR’s expenses, decided that the 
organisation should become more self-suffi cient, a change which 
Brian viewed with great enthusiasm. He played a major role in the 
subsequent reorganisation of the CSIR and eventually became their 
next president. This led to the departure of many scientists, including 
James and me. James became head of the Department of Chemistry 
and was appointed Head of the Department of Microbiology at the 
University of Cape Town (UCT). I wrote up this transition in 1993 with 
Johan Lutjeharms (previously in the National Research Institute 
of Oceanology at the CSIR and, by that year, Head of the Ocean 
Climatology Research Group in the Department of Oceanography 
at UCT) in an article entitled ‘Commercializing the CSIR and the 
death of science’ (Lutjeharms and Thomson,1993). I had wanted to 
call it ‘Commercializing the CSIR and the prostitution of science’, 
but we felt that might be a bit too provocative.
The CSIR had been established in 1945 with the express aim of 
bringing into existence a South African national research organisation 
to address national technological problems and to serve as a central 
scientifi c powerhouse. Over the years, as industries and government 
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identifi ed certain scientifi c or technological problems and recognised 
the CSIR’s potential ability to investigate them, a number of requests 
for directed research were passed on to it. After 40 years, the breadth 
and scope of research activities of the CSIR were wide and included 
an eclectic mixture of basic and applied sciences. The activities of 
some of the CSIR’s institutes were almost totally directed towards the 
research needs of a particular industry and could receive most of their 
funding from such contract research. In the ideal case, an institute 
would have about half its scientists at any time working on external 
contract work, while the other half would be occupied with more basic 
research, but directed towards aspects that were considered to be of 
national interest. Undirected basic research hardly ever exceeded 
10 per cent or so of the total budget.
The CSIR thus fi lled an important research niche between the 
more esoteric basic research carried out at academic institutions 
and the narrowly focused product research of factory laboratories. 
However, by the time I joined the CSIR bureaucracy had overgrown 
much of the enterprise and a stultifying ‘civil service’ attitude of 
rules, regulation and forms-in-triplicate was prevalent. Indeed, that 
was one of the reasons I had stipulated that my LMCB was not to be 
established on the CSIR campus in Pretoria but at Wits University. 
I didn’t want my staff to be run over in the 4.15 pm rush for the exit 
gates. So restructuring was defi nitely required. But what did that 
entail?
The 23 research institutes, some with an enviable scientifi c 
tradition, were scrapped and replaced by 11 divisions, each aimed at 
the perceived needs of a ‘market segment’. For instance, scientists 
from the LMCB were earmarked to move, in groups of three or four, 
into about six different divisions, regardless of the need for a critical 
mass of skilled scientists to carry out molecular and cell biology 
research. As time went on, all groups as well as individuals were to be 
judged by fi nancial returns or potential returns, a survival-mode way 
of thinking, leading to what may best be called a ‘fast-buck syndrome’.
The philosophy of a ‘market orientation’ for science on which the 
changes to the CSIR were being built was not entirely original. It had 
previously been the vogue in Britain, the US and elsewhere. It had 
been widely and loudly criticised by such notables as the president of 
the Royal Society of London for implying that the government thought 
that the management of scientifi c creativity was no different from the 
management of chain stores or the running of betting shops. By the 
end of 1989 the pendulum had swung and the then prime minister, 
Margaret Thatcher, was quoted as saying: ‘The greatest economic 
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benefi ts of scientifi c research have always resulted from advances 
in fundamental knowledge rather than the search for specifi c 
applications’ (Kenward, 1989). Present funders of biotechnology in 
South Africa could well take note.
It became clear that my lab was about to be abolished and the staff 
were told they would be accommodated in other CSIR departments—
that is, except for me, for whom there was no suitable position 
available. We all disliked this prospect immensely as we believed 
that one couldn’t do good molecular biology without a critical mass, 
which there had been at the LMCB but would certainly not be in the 
new dispensation. I, together with members of the LMCB, therefore 
approached African Explosives and Chemical Industries (AECI) for 
a potential solution. Why, of all saviours, approach an explosives 
company?
In the 1980s AECI were looking to diversify, and amino acids such 
as lysine came onto their horizon. Lysine is a limiting amino acid in 
the feed of animals such as pigs and chickens. Lysine supplementation 
of feed allows for the use of low-cost plant protein such as maize and 
soya, which are defi cient in lysine, while maintaining high animal 
growth rates. AECI had also been supporting the LMCB fi nancially to 
a fairly small but reliable extent, since its inception. The company was 
particularly interested in our emphasis on improved animal nutrition 
through natural and genetically modifi ed ruminant bacteria. They 
were planning a new building to house a lysine production facility, 
and we suggested they build a set of molecular biology laboratories 
adjacent to this with a library and meeting facility in between … and, 
of primary importance, they employ most of the members of our staff 
involved in research into ruminant digestion. To our delight they 
eventually agreed, and everyone (except for the powers that be at the 
CSIR) was extremely happy.
Thus it came about that the CSIR lost a golden opportunity to 
establish itself as a force in the country in biotechnology. Indeed, you 
will be hard pressed to fi nd the word in their organisational structure, 
despite the following statement in the Department of Science and 
Technology’s 10-year innovation plan for South Africa (2008–2018): 
Over the next decade South Africa must work to become a world leader in 
biotechnology. Since the introduction of the fi rst commercial genetically 
modifi ed crops in 1995, more than 400-million hectares have been 
planted, 40 percent of which are grown in the developing world. And it 
is the developing world where the need for biotechnological innovation 
to solve basic problems, from health care to industrial applications, is 
most apparent.
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The role of SAGENE
During the LMCB years, from 1984 to 1987, the South African 
Committee for Genetic Experimentation fulfi lled an excellent 
developmental role. It forced universities to improve laboratory 
standards in order for their academic staff to obtain research grants 
if they were using GMOs. They organised training courses, which 
had the added benefi t of developing a closely knit body of scientists 
involved in diverse research fi elds but united in their use of common 
techniques.
In other parts of the world, especially in countries like the US 
and, to a lesser extent, in Europe, where biotechnology companies 
were springing up, regulatory authorities were constantly vigilant 
in ensuring that no harmful effects accrued to humans, animals or 
the environment. However, because GM technology was in those 
days mainly confi ned to recombinant microorganisms such as 
bacteria and yeast, the concerns were largely around laboratory 
and production plant safety. The US Recombinatory DNA (rDNA) 
Advisory Committee formed in 1976 was followed by other regulatory 
offi ces in the US Department of Agriculture (USDA), Environmental 
Protection Agency (EPA) and the Food and Drug Administration 
(FDA). In 1982 the Organisation for Economic Co-operation and 
Development (OECD) released a report for Europe into the potential 
hazards of releasing GMOs into the environment (Bull et al., 1982). 
The World Health Organization was particularly involved in safety 
assessment of food additives and contaminants (WHO, 1987; 1991).
As the technology improved and genetically modifi ed organisms 
moved from models to commercial products, the US established a 
committee at the Offi ce of Science and Technology (OSTP) to develop 
mechanisms to regulate the developing technology (McHughen and 
Smyth, 2008). In 1986 the OSTP assigned regulatory approval of 
genetically modifi ed plants in the US to the USDA, FDA and EPA 
(US Offi ce of Science and Technology, 1986). Countries in Africa, Asia 
and South America, as well as Australia and New Zealand, became 
seriously involved only when GM crops appeared on their doorsteps.
After some years, SAGENE felt it had accomplished much of what 
it was set up to achieve and therefore went into abeyance during 
the late 1980s, although it continued to meet from time to time. 
By this time I was not only a member but also the chair. However, 
this semi-retirement was to change radically with the advent of 
genetically modifi ed crops. In 1990 we received an application from 
the multinational company Calgene Inc for fi eld trials of GM cotton 
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resistant to the herbicide bromoxynil (BXMTM). These trials were 
permitted by SAGENE following guidelines and regulations that 
were applicable in the US.
Shortly thereafter, an application by Clark Cotton to conduct 
a US ‘winter nursery production’ of Bollgard® cotton seed in South 
Africa was also approved. Many crops, including cotton, maize and 
sugarcane, suffer from infestation by the larvae of certain insects. 
These larvae bore into the cotton boll, or the stalks, of maize and 
sugarcane, damaging the interiors and resulting in extremely low 
yields. Although some farmers use sprays to kill the pests, this is 
rather like shutting the door after the horse has bolted, as the spray 
remains on the outside of the plant while the larvae devour the 
insides. Moreover, as many of the cotton farmers in South Africa are 
poor with very small holdings, they cannot afford costly insecticides.
One of the sprays used for many years, and especially favoured 
by organic farmers, is based on the bacterium, Bacillus thuringiensis 
(Bt). This harmless soil bacterium produces a protein which is toxic 
to the larvae of insects. What scientists have done is to introduce the 
gene encoding this toxin into cotton plants. Thus, when the larvae 
bore into the cotton boll they ingest the toxin, which kills them. 
The trick is, of course, that the toxin is produced inside the plant. The 
basis of the toxicity is that the protein binds specifi cally to target cells 
that line the inside of the larval gut. Once bound, the protein causes 
the gut cells to lyse, resulting in rapid larval death. The reason that 
the toxin kills insect larvae only is that the guts of other animals—
birds, fi sh and humans—do not contain the target cells to which the 
protein binds. The insect-resistant crops so developed are referred 
to as Bt plants, and Monsanto applied to carry out fi eld trials of Bt 
cotton in South Africa.
 Faced with these applications, the government offi cially 
reconstituted the SAGENE committee, announcing it in the 
Government Gazette of 15 May 1992. And that, followed by the road to 
the GMO Act in 1997, is the subject of the next chapter.
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From SAGENE to the GMO Act
The announcement in the Government Gazette of 15 May 1992, that 
the SAGENE committee was to be re-established, allowed SAGENE 
to represent the interests not only of the scientifi c community, but 
of the public as well. In addition it could advise mero motu (by free 
will) rather than only on request, and was empowered to liaise 
with relevant international groups concerned with biotechnology. 
Furthermore, it could advise on legislation or controls with respect to 
importation or environmental release of organisms with recombinant 
DNA. The terms of reference were amended on 14 January 1994 
to broaden the scope from ‘organisms with recombinant DNA’ to 
‘genetically modifi ed organisms’, the term used internationally.
SAGENE was to be jointly managed by the CSIR, the Agricultural 
Research Council (ARC), the Medical Research Council (MRC) 
and the Foundation for Research Development (FRD), the agency 
responsible for allocating and distributing research grants. Each 
organisation would nominate a committee member, preferably a 
‘molecular biologist of international standing, active in the training 
and/or research in recombinant DNA and molecular genetics’. There 
were also representatives from a few government departments, 
including Health and Environment Affairs, universities, a legally 
qualifi ed person to represent the interests of the public in general, a 
member from the SA Institute of Ecologists, and a representative of 
the business community or industry. 
The terms of reference were that the committee would act as a 
national advisory body, liaise with relevant international groups, and 
advise on the research and application of GMOs, including possible 
effects on the environment as well as on their importation and/or 
release. The fi rst chair was Jane Morris, whom I had recruited in 
1986 to join the LMCB from her position as Research Fellow in the 
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Department of Microbiology at the University of British Columbia in 
Canada. Jane had moved to AECI when the LMCB closed and her main 
reason for becoming involved in SAGENE was that AECI was showing 
an interest in developing GM crops. In this they were following the 
British company, Imperial Chemicals Industry, which was a major 
shareholder in AECI. Jane felt there were signifi cant regulatory gaps 
in the procedures for allowing the use of GM crops in South Africa and 
that they could prevent, or at least hinder, commercial development.
Jane was an excellent choice. Not only was she skilled in the 
science of recombinant DNA, but she was also a stickler for detail. It 
is largely thanks to her skilled leadership in those rather exploratory 
years that SAGENE was able to carry out its tasks so effi ciently.
Establishing procedures
SAGENE’s fi rst task was to draw up procedures for assessing 
whether or not to approve applications for importation, trial release 
or general release of GMOs. I was given the job of drafting the 
questionnaire for this and I searched through similar documents 
followed by various other countries. I fi nally decided to base ours on 
the Australian questionnaire, due in part to its relative simplicity and 
the similarity of the Australian development of GMOs with those in 
South Africa. These, and the guidelines and procedures based on the 
UK documents, were fi ne-tuned by the committee and published in 
March 1996 as ‘Guidelines and procedures for work with genetically 
modifi ed organisms’. The document contained two questionnaires: one 
for the trial release of GMOs, which included fi eld trials for GM crops; 
and one for the general release of GM plants. The risk assessment 
document was also based on that of the UK.
In 1994, I visited the Californian biotechnology company, Calgene, 
while attending a conference nearby. A few years earlier Calgene had 
contacted SAGENE about testing bromoxynil-resistant plants in 
South Africa, so I went there to discuss the SAGENE questionnaires 
with their regulatory team, and was delighted that they considered 
our regulations to be tough but fair. 
GM tomatoes
Calgene had just launched the fi rst genetically modifi ed tomato on the 
market. These were the Flavr Savr tomatoes, so called as they had 
been genetically modifi ed to improve their fl avour by delaying fruit 
ripening. Calgene did this by slowing down the action of the enzyme 
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polygalacturonase, which degrades the pectin in cell walls. This 
degradation results in the softening of fruit, which makes them more 
susceptible to damage. Unmodifi ed tomatoes are picked before fully 
ripening and are then artifi cially ripened using ethylene gas, which 
acts as a plant hormone. Picking the fruit while unripe allows for easier 
handling and extended shelf-life, but prevents them from developing 
the fl avour they would have if allowed to stay on the vine longer. Flavr 
Savr tomatoes would hopefully delay this ripening process and result 
in more fl avoursome tomatoes. Calgene hoped that its tomatoes would 
taste more like the home-grown variety, picked just before eating.
I visited a local supermarket to buy some of their tomatoes. They 
were on a special wagon in the store, clearly labelled as having been 
genetically modifi ed and every fruit had a McGregor sticker denoting 
the tomatoes’ trade name. Unfortunately, I couldn’t taste any difference 
between them and the unmodifi ed tomatoes in the store, but it is my 
opinion that most tomatoes sold in the US taste of cardboard anyway. 
Sadly, Calgene was a very small company, inexperienced in the business 
of growing and shipping tomatoes, so this product did not last.
In the UK, the company Zeneca produced a tomato paste using similar 
technology. It was clearly labelled ‘genetically modifi ed tomatoes’, but as 
it was cheaper to produce than paste made from conventional tomatoes, 
it out-sold the latter in Sainsbury’s and Safeway supermarkets. Indeed, 
after about two years it held over 70 per cent of the market share, until 
Greenpeace initiated its vociferous opposition to GM crops by dumping 
a truck load of maize on the doorstep of Number 10, Downing Street. 
Within a very short period, sales dropped dramatically to the point 
where the product was removed from the market (Figure 2.1).
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 Figure 2.1  Sales of GM tomato paste in the UK
(Source: Julian Kindelerer)
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I am always amazed by the double standards employed by Europe 
in this area. Before the onset of ‘mad cow disease’ (or BSE, bovine 
spongiform encephalopathy) the animal feed industry used ‘rendered’ 
waste animal material as high-protein ingredients in formulated 
animal feeds. Rendering is a process which converts unwanted 
animal waste at slaughter houses into useful products. Much of this 
is fat, but a large portion is protein for animal and pet feed. After 
the outbreak of BSE this was discontinued and soya became the 
protein supplement of choice in formulations. Where did the soya 
come from? Predominantly Brazil and Argentina, whose soya beans 
are approximately 83 per cent to nearly 100 per cent, respectively, 
GM (James, 2011). So although European farmers may not grow 
GM crops, they may happily import them and feed them to their 
livestock. 
GM cotton
Back in South Africa, Monsanto had applied for general release of Bt 
cotton and SAGENE recommended that they investigate the value 
of the new varieties to smallholder and subsistence farmers. In 1997 
Monsanto convinced four farmers in the Makhatini Flats region of 
northern KwaZulu-Natal to plant some of their Bt cotton seeds. At the 
end of that season the farmers’ results were suffi ciently impressive 
to convince more than 70 more farmers to plant Bt cotton. The next 
year, over 600 followed suit and by 2010 almost all farmers in the 
cotton-growing regions of KwaZulu-Natal were planting Bt cotton. I 
remember receiving an excited phone call from Muffy Koch, who ran 
the SAGENE secretariat. She had just inspected a fi eld trial of Bt 
cotton and told me how, when walking through the fi eld of non-Bt 
cotton, there wasn’t an insect to be seen due to the use of pesticides, 
but in the Bt cotton fi eld she was constantly swatting at all sorts of 
insects buzzing around her face. Moreover, she discovered Prinia bird 
nests among the Bt cotton plants.
From a committee to an Act
The Genetically Modifi ed Organisms Act was published in the 
Government Gazette on 23 May 1997, and marked the beginning of the 
end of SAGENE. The agenda of our last meeting held on 6 February 
1998 showed that applications for trials and general releases were 
starting to fall between two stools. While SAGENE had been made 
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redundant by the Act, the GMO Act could not be implemented until 
the Regulations were approved. Indeed it took until 26 November 
1999 for this to occur, and thus the GMO Act came into effect only on 
1 December 1999. 
Just to give an idea of the number of applications SAGENE was 
handling in 1997, of a total of 27 there were 13 for maize, four for cotton, 
two for soya, one each for canola, strawberry, eucalyptus and apple, 
and four for microorganisms. The applicants included companies such 
as Carnia, Calgene, Infruitec (local), Rhone Poulenc, Pannar (local), 
Monsanto, Delta and Pine Land, Novartis, AgrEvo and Pioneer Hybrid 
International (personal communication, Muffy Koch). The traits that 
were tested included insect resistance, fungal and viral resistance, 
and herbicide resistance. The last of these tests included resistance 
to glyphosate, the active ingredient in the commercially available 
Roundup®. Unlike many herbicides widely used in agriculture, such 
as atrazine, glyphosate is readily biodegradable. Conversely, when 
atrazine is used, maize/soya bean rotation is prevented due to the 
build up of residual herbicide in the soil.
Blocked by bureaucracy
SAGENE made considerable inputs to both the Act and the 
Regulations. We were particularly concerned that the executive 
council, which basically made all the decisions, consisted of 
members of six government departments, these being Agriculture, 
Science and Technology, Environment, Health, Labour, and Trade 
and Industry. We feared, and in hindsight correctly so, that the 
department members would not be well versed in the science of 
GMOs and, being government employees, were very diffi cult to pin 
down to attend meetings. We wanted each department to nominate 
experts to represent them, but this request was turned down. In 
retrospect, one of our initial suggestions—that the Act should fall 
under the Department of the Environment—which we fortunately 
never submitted, would have been disastrous. Our experience 
since the inception of the Act has been that the Department of the 
Environment has done all in its power to stultify the development 
of GM crops in the country. As it is, being administered by the 
Department of Agriculture presents suffi cient diffi culties.
Two fairly recent examples of decisions made by the Department 
of Agriculture will give some idea of the problems applicants face 
(Thomson et al., 2010). More than half a billion people around the 
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world rely on sorghum as a dietary staple. Its tolerance to drought 
and heat make it an important food crop in Africa (it is indigenous to 
Ethiopia and Sudan). However, it lacks certain essential nutrients. 
In order to give it added nutritional value, the Bill and Melinda 
Gates Foundation funded the African Biofortifi ed Sorghum project, 
run by an international consortium under the leadership of Africa 
Harvest, an African-based international non-profi t organisation. 
African biofortifi ed sorghum contains the gene for a high-lysine 
storage protein from barley and has increased levels of vitamin A, 
iron and zinc. 
In 2006, scientists from the CSIR applied to the Registrar of 
the Directorate for Genetic Resources Management in the National 
Department of Agriculture, the body that administers the GMO Act, to 
undertake greenhouse trials of biofortifi ed sorghum. The application 
was denied on the following grounds:
(1) In view of the potential risks pertaining to environmental 
impact (as a result of gene fl ow), the council recommended 
that this experiment be conducted on a non-indigenous 
species with no wild relatives in South Africa. 
(2) Taking into consideration the council’s concerns about gene 
fl ow, the applicant should take note that the possibility of 
obtaining a trial release or general release authorisation 
with this species—as with any other indigenous species—
would be extremely low. 
(3) The council expressed concerns regarding the current 
containment levels of the facilities that would be involved 
in the proposed activities and indicated that such activities 
should be conducted in at least a level 3 containment 
facility. 
This decision was noted internationally. For instance, the Science 
and Development Network wrote on 20 July 2006 under the headline 
‘South Africa halts “super sorghum” study’: ‘South Africa has blocked 
trials of genetically modifi ed sorghum that leaders of a multi-
million-dollar project hope can boost nutrition in Africa’. They quote 
Dr Florence Wambugu, CEO of Africa Harvest, the lead institution in 
this multinational, US$ 18.6 million collaborative project, as saying 
they wished to run their greenhouse trials in South Africa because 
of its legal guidelines and policy framework on genetically modifi ed 
crops, which are so far absent in Kenya. Interestingly, on the same 
day the sorghum project was put on hold in South Africa, the Kenyan 
parliament overwhelmingly defeated a motion by Davies Nakitare, 
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the member of parliament for Saboti, who sought a blanket ban on 
all production, consumption and sale of genetically modifi ed foods 
(http://www.scidev.net/en/news/south-africa-halts-super-sorghum-
study.html). 
In its appeal, the CSIR pointed out that the South African 
Biotechnology Strategy of 2002 had stressed the importance of value-
addition to indigenous crops. However, the decision by the Directorate 
of Genetic Resources Management could be interpreted to mean that 
no research on indigenous crops should be allowed. The CSIR also 
noted that it was prejudging future applications for fi eld trials and/
or general release and was turning down a glasshouse trial in case 
of a possible future application. Finally, the appeal noted that the 
CSIR did, indeed, have a level 3 containment facility that had been 
approved by that very Directorate for Genetic Resources. 
Two appeals were turned down, but fi nally, in 2009, permission 
was granted. However, the damage had already been done by this 
slow and complicated process. The Gates Foundation moved the R&D 
for this project to Kenya, where approval for GM sorghum greenhouse 
trials was obtained within three months and trials began within fi ve 
months. 
The second example of a nonsensically blocked application 
involves potatoes. The larvae of the potato tuber moth (PTM), 
Phthorimaea operculella, bore into potato leaves, stems and tubers, 
causing extensive damage. In addition, fungi and mites can grow 
in the galleries formed by the PTM’s burrowing, resulting in the 
decomposition of the tuber. The impact of the PTM fl uctuates from 
season to season in response to climate, but reoccurs regularly at 
high levels and can cause up to R40 million (about US$ 4.6 million) in 
losses per annum (Visser and Schoeman, 2004). 
In July 2008, an application was submitted by the South African 
Agricultural Research Council (ARC) for a general release of the GM 
potato event, SpuntaG2. This event had been developed by Michigan 
State University and carried the Bt Cry1la1 gene (Douches et al., 2002). 
The required information was submitted, including socio-economic 
impact data and a stewardship plan. However, on 25 August 2009, 
the application was rejected. The reasons for this refusal included: 
(1) Smallholder farmers have many other problems, and 
pests such as PTM might not be the most important.
(2) There is no evidence that other pest management 
strategies against PTM have been considered or compared 
with the release of GM Spunta.
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(3) Entry of these GM potatoes into the formal trade is a 
concern. Segregation of the GM from non-GM would 
require an identity preservation system which is currently 
not in place.
(4) The capacity of small-scale farmers to implement risk-
management measures could potentially be onerous.
(5) Considering the biology of potatoes, vegetative material 
(tubers) may be used for propagation, which may 
complicate risk management.
(6) Rodents, rather than PTM, are a major pest for stored 
potatoes.
These issues were addressed in a reply from the ARC dated 
21 September 2009, appealing the decision:
(1) Information on many of the socio-economic issues can only 
be collected if the application is approved. This approval 
is needed to enable the farmer participatory evaluation, 
which must precede any decision on whether the ARC will 
use this trait for the improvement of South African potato 
varieties. Indeed, farmer participatory trials will help to 
answer many of the questions regarding the impact of the 
trait on potato production and farmers posed by the EC in 
its decision.
(2) No identity preservation system has been required for 
transgenic maize, cotton, soya beans, or canola used in 
South African formal markets for more than 10 years. 
(3) The use of vegetative planting material requires no 
additional effort compared to the use of true seed with 
other crops.
(4) The levels of all potato pests vary from season to season, 
but PTM remains the primary storage pest. 
From the above, it could be argued that the executive council had 
overstepped its mandate when it determined that smallholder 
farmers would not need this technology. It is the mandate of the 
ARC and farmers themselves to assess whether this GM technology 
is appropriate for local use. Weak decision-making processes could 
jeopardise the ongoing funding for this and other public sector 
projects. More than two years on, the appeal is still pending.
One of the unwritten reasons for both these decisions could be 
that the executive council was faced with a decision regarding a new 
crop. All previous permissions granted for fi eld trials or commercial 
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releases had been on GM crops already used in other countries, 
such as maize, cotton or soya beans. But here they were faced with 
nutritionally enhanced sorghum and insect-resistant potatoes, and 
they had no precedent of permission in other countries to fall back 
on. Perhaps, rather than make a mistake by allowing the confi ned 
glasshouse trial and general release to proceed, they used spurious 
excuses to refuse it. 
In February 2012 the National Biotechnology Advisory 
Committee (see Chapter 5) wrote to the Minister of Science and 
Technology pointing out the lengthy period that appeals were taking. 
It recommended that the timeframes for appeals, as laid down in the 
Regulations of the GMO Act, should be adhered to:
An appeal board must be appointed within 60 days from the date of 
receipt of the appeal by the registrar (...) the full decision of an appeal 
board, together with the reasons therefore, shall be reduced to writing 
and furnished to the Minister, the registrar and all parties directly 
involved in the appeal, and made available to the public, within 30 
days after the fi nal decision has been taken. 
According to the Regulations of the GMO Act (26 February 2010), the 
decision-making process ought to take 120 days (90 for the appeal 
board, 30 for the Minister) given a best-case scenario. This means 
that the appeal, from start to fi nish, ought to take at the most 180 
days. Should the Minister, however, deem it necessary, the entire 
process could be extended by a further 30 days, in which case the 
maximum allotted time would be 210 days. 
As the GMO Act falls under the Ministry of Agriculture, the 
committee asked the Minister to bring this matter to the attention 
of her colleague, the honourable Minister Tina Joemat-Pettersson, 
as the decision-maker in the appeal process, ensuring that she 
understood the adverse consequences for agricultural biotechnology 
research, development and implementation in the country were this 
trend to continue. It was imperative that communication between the 
Registrar’s offi ce and the respective applicants was open at all times, 
particularly when unforeseen delays were being experienced. At the 
time of writing the committee has yet to hear the outcome of this letter.
Successes none the less
Despite these problems, South Africa is number eight in world 
plantings of GM crops (James, 2011). Most of the maize produced 
is consumed locally, with commercial farmers producing about 
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96 per cent of the crop. GM maize was introduced in 1997 but became 
commercially adopted on a major scale only in 2000. Plantings have 
increased dramatically during this time. In the 2009/10 production 
season, GM maize contributed 78 per cent of the total commercial area 
planted to maize. Of the white maize crop, 79 per cent was GM, and of 
the yellow crop, it amounted to 77 per cent. The average yield for the 
fi ve years 1990/91 to 1994/95 was 1.9 tons per hectare, whereas that 
for the recent fi ve (2005/6 to 2009/10) was 3.8 tons per hectare. Both 
these periods included a season of drought. Although the increase in 
overall yields is likely to be due to a number of factors, one of these 
must be the increase in GM maize planted (Agricultural Business 
Chamber, 2011).
Economically, soya bean is the most important legume worldwide, 
providing good quality vegetable protein for millions of people and 
animals, as well as ingredients for numerous chemical products. 
Towards the end of the twentieth century and into the present, soya 
has played an important role in helping to alleviate world hunger. 
Although it is currently a relatively small crop in South Africa, a 
survey conducted in October 2010 showed that producers intended 
to increase plantings by approximately 25 per cent, from 311 450 
hectares to 390 000 hectares for the 2010/11 production season. 
Should these intentions be realised, it will be the largest area in 
South Africa planted to soya beans on record. Approximately 85 per 
cent of soya beans produced in South Africa are GM. This began to be 
commercially planted in 2000 and, although the differences are not 
as dramatic as with maize, the yields in this period increased from 
1.2 tons per hectare to 1.7 tons per hectare (Agricultural Business 
Chamber 2011). 
Small-scale farmers in KwaZulu-Natal were quick to take up Bt 
cotton. Following the success of the fi rst four farmers who planted 
this in 1997, 75 took part in 1998. The uptake in 1999 was 411, 644 
in 2000, and by 2002, more than 2000. However, in 2007/8 the nearby 
cotton gin closed down, forcing the farmers to transport their crop 
about 600 kilometres to the closest gin. In addition, the area under 
cultivation is not ideal for the growth of cotton and the crop became 
internationally uncompetitive, even with the addition of the insect-
resistance trait. Understandably, fewer farmers are now growing 
cotton in that region, with only about 300 involved in the 2009/10 
production year (http://www.cottonsa.org.za).
The anti-GMO lobbies, such as Biowatch, were by no means 
silent during this period. A group of them brought to the country a 
Canadian farmer, Percy Schmeiser, to speak about his experience 
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at the hands of Monsanto. He addressed a special parliamentary 
hearing held in Cape Town, to which I was invited. Mr Schmeiser told 
us how in 1997 he discovered that a section of one of his canola fi elds 
in Saskatchewan contained canola that was resistant to the herbicide 
Roundup. Monsanto had been marketing GM canola resistant to 
this brand of herbicide under the name of Roundup Ready. Farmers 
were growing this variety to control weed competition. However, 
Mr Schmeiser, who was vehemently opposed to this technology, had 
not bought any of this seed. The following year, over 95 per cent of 
his crop of approximately 400 hectares (1 000 acres) was identifi ed as 
being of the Roundup Ready variety. Monsanto sued Mr Schmeiser 
for patent infringement, by failing to obtain a licence for their canola 
seeds. Mr Schmeiser’s argument was that Monsanto’s seed must have 
escaped from passing trucks or arisen from accidental pollination. 
Moreover, this seed had now ‘contaminated’ his own strains of canola, 
which had taken him 50 years to develop.
During question time at the parliamentary hearing, the chair gave 
the fl oor to Andries Botha, a maize farmer from the Free State and at 
the time a member of parliament for the Democratic Alliance and the 
shadow Minister of Agriculture. Mr Botha expressed amazement that 
one variety of canola, Roundup Ready, could spread so rapidly across 
a 400-hectare fi eld, while Mr Schmeiser was at the same time able to 
maintain the integrity of his own varieties of canola on other parts 
of his farm. How was this possible? Unfortunately the Canadian was 
unable to answer this simple question from one farmer to another. 
Also, unfortunately for Mr Schmeiser, Canada’s Supreme Court ruled 
in favour of Monsanto.
The International Service for the Acquisition of 
Agribiotech Applications
An organisation that is very helpful in providing statistics on the 
spread and uptake of GM crops worldwide is the International 
Service for the Acquisition of Agribiotech Applications (ISAAA). In 
2001 the president, Clive James, asked me to become a member of his 
board. This exposed me to the state of agricultural biotechnology in 
developing countries other than on the African continent.
For a workshop ISAAA held in Bangkok on intellectual property 
related to GM crops, I was asked to prepare two presentations 
entitled ‘How to keep a laboratory notebook’ and ‘How to monitor 
a genetically modifi ed crop during trials and after general release’. 
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Some years later, the work I put into that workshop paid off when 
I was involved in editing a book on intellectual property. It was 
spearheaded by Anatole Krattiger, who had organised the Bangkok 
workshop, and was jointly organised by the Oxford-based Centre for 
the Management of Intellectual Property in Health Research and 
Development (MIHR) and the University of California-based Public 
Intellectual Property Resource for Agriculture (PIPRA). I remember 
walking with the group of editors to the MIHR offi ces in Oxford 
when Anatole took me aside and asked me if I’d consider chairing the 
meeting. I was amazed, as of the group assembled I probably knew the 
least about the subject. Fortunately, Robert Mahoney, who had played 
a lead role in the establishment of the MIHR, and who oversaw the 
development and implementation of IP management policies for the 
Ford Foundation, co-chaired with me and in 2007 the IP handbook 
was duly published. It runs to a mere 1 998 pages in two volumes 
(Krattiger et al., 2007). I will return to the issue of IP in Chapter 4 as 
it has become a highly contentious issue in the development of GM 
crops, particularly in Africa.
The 2010 ISAAA board meeting was held at Los Banŏs in the 
Philippines, where the head offi ce is situated. During our time there 
we visited fi eld trials of GM insect-resistant, Bt aubergines (also 
known as egg plant and brinjal). We went through a ‘Fort Knox’ type 
clearance to be allowed access and had to put on special boots before 
entering the fenced-off enclosure. We were allowed to walk only along 
the outside perimeter of the fi elds but were able to see the workers 
at their tables. They would harvest every ripe aubergine from both 
the Bt and the control, non-GM plots. Each fruit was weighed, cut in 
half, the insects extracted, measured, their instar noted and then all 
were discarded into separate metal containers: one for the Bt fruit 
and one for the controls. We arrived fairly late in the afternoon so this 
process had been going on all day. You would not have liked to go near 
the container with the control aubergines, they were rotting so badly. 
The Bt brinjals had some insect damage but it was minor. Apparently 
most aubergine farmers, certainly in that region, spray their crops 
every second day with highly toxic insecticides. And to think that the 
Indian government had a few months earlier denied applications for 
the release of Bt aubergines. When one thinks of the health impact on 
the sprayers (let alone the lost income to the farmers), that decision 
has to be little short of criminal.
Interestingly, a few days earlier a van-load of visitors had 
approached the guards at the entrance to the site, requesting 
permission to enter. They were not prepared to give their names 
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or affi liations, so they were denied access. One wonders if they 
had harmful intent—elsewhere in the Philippines, trials had been 
vandalised.
At the time of this visit, Brazil had a completely different 
approach to GM crops. I had attended a meeting in Rio de Janeiro in 
about 2001, organised by the Brazilian Department of Agriculture. 
Its aim had been to come up with a set of recommendations for their 
government as they debated the growing and use of GM crops. How 
different their decision was. Brazil is now the world’s number two 
planter of GM crops, just behind the US, specifi cally in herbicide-
tolerant soya beans, of which they are a major exporter. 
ISAAA’s main claim to fame is as an information agency. It 
produces an annual brief entitled ‘Global status of commercialized 
biotech/GM crops’, which is somewhat of a gold standard on the 
subject. There are chapters on all countries growing significant 
crops of GM plants, describing what is grown, how the numbers 
are increasing, and so on. In the section on South Africa there is 
a detailed account of the established GM crops (maize, soya bean 
and cotton) by trait (insect resistance, herbicide tolerance and 
stacked traits) and an account of approved commercial releases, 
field trials and greenhouse trials. In addition, it relates farmer 
testimonies, such as from Samuel Moloi, who grows 63 hectares 
(156 acres) of maize on land that he rents in the Free State 
province. He plants GM seeds that are both insect resistant and 
tolerant to the Roundup herbicide. He says he spends less on 
diesel by using his tractor less, and less on labour, because he 
doesn’t have to hire workers to cut the weeds. ‘The GM seed is a 
little higher (in cost), but it does a fantastic, a wonderful job for 
me,’ he said. ‘The benefits at the end of the day outweigh the cost 
of the seed itself ’ (James, 2011). 
These benefi ts were echoed in a recent study by Gouse (2012), 
who studied smallholder GM maize farmers in KwaZulu-Natal over 
a period of eight seasons (2001/02 to 2009/10). The results showed 
that Bt adopters enjoyed higher yields than their conventional 
maize-planting counterparts and, in most seasons, were better 
off despite paying more for their seed. In the case of herbicide-
tolerant (HT) maize, farmers also benefi ted through higher yields. 
Interestingly enough, ‘Farmers seem to be willing to pay for the 
weed control convenience of HT maize and, based on adoption 
fi gures, farmers value the yield-increasing and labour-saving 
benefi ts of HT maize higher than the borer control insurance of 
Bt maize’.
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Figure 2.2 Global area of biotech crops 1996–2012
The ISAAA also publishes the Pocket K series on subjects such as 
Bt wheat, Bt rice, marker-free GM plants, and briefs on specialised 
topics, such as the 2009 one, ‘Communicating crop biotechnology: 
stories from stakeholders’, which includes some fascinating accounts 
from farmers who grow GM crops in various parts of the world (www.
isaaa.org). I related one of these stories in Rome when I addressed the 
Pontifi cal Council for Justice and Peace. I had been warned that the 
Italian Minister of Agriculture was opposed to GM crops. He swept in 
with his entourage some time during our deliberations and proceeded 
to inform the audience that it had been proven that GM crops could 
not possibly help smallholder farmers. I spoke after him and said that 
it was a pity he had not arrived an hour earlier as he would then have 
heard a smallholder farmer from South Africa wax eloquent on how 
GM cotton was helping her to improve her productivity. She had told 
the audience that, being a school teacher, she could only spray her 
crops on a Saturday, Sundays being reserved for church attendance, 
and if she missed a Saturday by taking a child to the clinic or some 
other task, she knew she would lose a portion of her crop to insects. 
Now, however, she didn’t have to spray, and ‘Look at my hands’, she 
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had said, ‘… they don’t even look like a farmer’s hands any more!’ The 
minister was not impressed. 
AfricaBio
South Africa has its own version of ISAAA in the form of AfricaBio 
(www.africabio.org). In 1999 I received a call from a former PhD 
student, Jocelyn Webster (also a member of the LMCB), to say she 
wanted to start an organisation aimed at educating government 
offi cials, regulatory authorities, the media and the public at large 
about agricultural biotechnology. Jocelyn had been a member of 
SAGENE and was closely involved in writing our position paper 
on the GMO Act. Her immediate target was South Africans but in 
time she aimed to reach out to other African countries. I joined the 
organisation, together with other academics, farmer organisations, 
grain traders, biotechnology companies, seed companies, food 
manufacturers and retailers, and consumers. AfricaBio was offi cially 
registered as a non-profi t, Section 21 company in 2000. 
Over the years AfricaBio has proven its worth as a provider of 
accurate and objective information on biotechnology to consumers, 
media and decision-makers. It has provided a regular forum for 
exchange of information not only between South Africans but 
between people from many SADC countries. Its workshops, to provide 
information and training to stakeholders from countries such as 
Malawi, Namibia, Zimbabwe and Mozambique, have been particularly 
successful. It has also run training and advice programmes for small-
scale farmers interested in planting GM crops.
In 2002 AfricaBio was awarded South Africa’s prestigious National 
Science and Technology Forum (NSTF) award for its outstanding 
contribution to science and technology. In its citation, the NSTF stated 
that the organisation had provided a forum for informed debate on 
biotechnology issues and the promotion of its safe, responsible and 
ethical use, with signifi cant contributions in the areas of education 
and the public understanding of science, engineering and technology.
Over the years AfricaBio has put out a series of position papers on 
such issues as GM and biodiversity; the impact of GM on biodiversity; 
bio-ethics; intellectual property rights and farmer’s rights; and 
GM impacts on sustainable agriculture. It later produced booklets 
such as Agricultural Biotechnology: Facts for Decision-Makers and 
Biotechnology: Biosafety, Food Safety and Food Aid. For many years 
it has sent out the monthly newsletters called BioLines, followed by 
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GMO Indaba and more recently GMO Insight, which are quick guides 
to what is topical at the time. A few examples of its articles are listed 
below:
 ● The impact of biotechnology on Africa in the 21st century (June 
2001—a meeting held in preparation for the World Summit to 
be held in Johannesburg in September 2002)
 ● China surges ahead of India in Biotech race (February 2002—in 
terms of research and development, not yet commercialisation)
 ● Zambia launches its fi rst biotech outreach society (July 2003—
and they’re still working on it)
 ● SA GMO maize crops set to grow (April 2004—and they are still 
growing)
 ● International pressure group Greenpeace warns Philippine 
authorities that biotechnology ‘can lead to millions of dead 
bodies, sick children, cancer clusters and deformities’ (April 
2004—and still the misinformation keeps coming)
 ● Tanzania jumps on GM bandwagon—Agricultural Ministry 
says they cannot afford to be left behind (March 2005—but it 
seems they are)
 ● Golden rice provides increased Vitamin A (March 2005—but 
needy children in Asia are still waiting for it)
 ● Kenyan minister asks journalists to highlight biotech benefi ts 
(June 2006—and some of them got it right)
 ● UK farmers optimistic about GM crops (February 2008—
unfortunately their politicians think otherwise)
 ● Bt toxin resistance: an evolutionary action (March 2008—
a cautionary note on responsible stewardship of the new 
technology)
 ● Bt awareness campaign for Kenya launched plus Kenya 
approves GMO bill (April 2009—Kenya making great strides 
forward)
 ● Consumer Protection Regulation effective October 2011 
(October 2011—all food in South Africa containing more than 
fi ve per cent GMO ingredients to be labelled)
 ● AfricaBio and partners host successful IRM workshop 
(December 2011—ways to prevent insects from developing 
resistance to the Bt toxin)
Although I am no longer on the board of AfricaBio, I am proud to have 
been part of this impressive organisation.
AfricaBio has also organised a number of debates on the subject of 
GM crops. As luck would have it, an occasion arose when Dr Florence 
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Wambugu, CEO of Africa Harvest, and Vandana Shiva, the Indian 
anti-GMO activist (see Chapter 4), were both in Johannesburg at the 
same time. AfricaBio took the opportunity to arrange a public debate 
in which each was joined by three like-minded colleagues. I was on 
Florence’s team. The chair, a well-known TV presenter, explained the 
ground rules. After opening statements the debate would be open to 
the fl oor. The side to whom the question had been posed would be 
given two minutes to reply, thereafter the other side could comment. 
Florence’s daughter was in the audience and had the following 
question for Vandana Shiva’s side: ‘The pro-GM side has said what 
they plan to do to improve crop production in the next fi ve years. 
What does the anti-GM side plan to do in the same period?’ Ms Shiva’s 
side spoke to the question but after the allotted two minutes the TV 
presenter said: ‘It’s obvious that you cannot answer the question so 
it’s over to the other side to respond.’ At times like this one is grateful 
for a good chair.
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Chapter 3
Into Africa
My fi rst move into Africa north of South Africa’s borders came about 
shortly after our return to South Africa from Boston. In 1977 my 
husband moved to Mochudi, a small village just north of Gaborone, 
the capital of Botswana. He had a Fulbright Fellowship to do his PhD 
there on various aspects of low-cost housing.
Playing in another fi eld
It was not long before I became embroiled in a local scientifi c 
controversy, although this time it had nothing to do with genetic 
engineering. I noticed that Graeme’s many mosquito bites often 
took rather longer to heal than would be expected, and, talking to 
neighbours in Mochudi, discovered that many of them suffered from 
other types of wounds which did not heal easily. Being a microbiologist, 
I wondered if the water was infected with faecal bacteria, such as 
E. coli, the signature bacterium for sewage contamination of drinking 
water. I took some samples back to the lab and, indeed, found some 
indications of E. coli. I contacted the Botswana Department of Health 
but they showed no interest, so I discussed it with friends who 
worked for the local hospital, which treated many TB patients. Their 
sewage sometimes overfl owed into a small stream that ran past the 
hospital and they expressed concern about my preliminary fi ndings. I 
therefore brought a very willing team of postgraduate students from 
Wits University to Botswana to do some sampling in the area.
Their fi rst hurdle came at the border. I had forgotten to tell them 
that Botswana had just banned the import of alcohol across the border 
from South Africa. Being normal students, they had a fair amount 
with them, and, confronted with the problem, proceeded to drink most 
of it there and then. Again, being normal students, they were also 
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impecunious, so what to do about liquid refreshments once they were 
in Botswana? Ever resourceful, one of their number, an experienced 
gambler, solved the problem after one night’s hard work at the local 
casino.
Another hurdle, which I had fortunately anticipated, was how to 
incubate the Petri dishes after we had spread our water samples on 
them. Faecal bacteria grow at body temperature, around 37°C, a far 
cry from the ambient temperature overnight in a Mochudi winter. 
Fortunately, a friend who worked at the local museum allowed us 
to set up a temporary dormitory and ‘laboratory’ in one of his spare 
rooms. We rotated shifts during which each person donated a sleeping 
bag for a few hours, which was draped around a box carrying a few lit 
candles. Rather Heath Robinson, but it worked. 
Back in a proper laboratory, we confi rmed an unacceptably high 
level of faecal bacterial contamination in some of the water samples. 
With the spirited support of some of the local women, I called a 
meeting in the museum to share our results. Imagine our surprise 
when the local chief arrived. And that set the cat among the pigeons 
as word of this reached the ears of the government. Questions were 
asked in parliament and soon I had the Ministry of Health asking 
me to conduct a series of tests in various towns around Botswana. 
Moreover, they would supply me with a mobile lab, a driver and a 
laboratory assistant!
As a result, during the July vacation in 1978 my small band 
visited towns such as Malepolole, Serowe, Mahalapye and Palapye. 
The problem in most cases was that the building regulations that 
demanded certain distances between human habitation and drinking 
water supplies had not been adhered to. The authorities promised to 
prevent this in future and install chlorination plants, but whether 
this actually happened or how long it lasted I never did discover 
(Figure 3.1). Interestingly enough, the water below Mochudi’s hospital 
was relatively clean as the river was very shallow and ran over rocky 
surfaces under Botswana’s brilliant sunshine. As any microbiologist 
will tell you, this is an excellent natural sewage treatment system.
Pariahs stick together
The 80s were extremely barren years for South African scientists 
wanting contact with colleagues in other African countries, and in 
those early years of biotechnology, pariah states like ourselves, 
Taiwan and Israel were forced to stick together. It would appear 
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that Taiwan at least was feeling as isolated as South Africa. In the 
preface to the proceedings of the Republic of China-Japan Symposium 
on Biotechnology, which I attended in 1987, one of the organisers 
wrote: ‘In 1982, the Republic of China decided that biotechnology 
should be one of the eight major thrust areas in scientifi c research 
and technology development of this country.’ He went on to say that 
this symposium was one of the efforts in reaching this goal, and that 
they were able to invite eight distinguished scientists from Japan. 
In addition they were ‘happy to see Dr Jennifer Thomson from the 
Republic of South Africa attend the symposium’.
Similarly with outcast Israel. In 1986 a delegation of South African 
scientists held a joint meeting at the Hebrew University in Jerusalem. 
The timing was superb as it coincided with the 70th birthday of 
Ephraim Katzir, fourth president of Israel and a founder of the 
Figure 3.1 Article appearing in The Star newspaper
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Weizmann Institute of Science, named after Chaim Weizmann, who, 
apart from being the fi rst president of Israel, was a biotechnologist of 
note. During the Second World War, while working in Manchester, he 
developed the Weizmann Process whereby the bacterium Clostridium 
acetobutylicum produces acetone and butanol, much sought-after 
in the manufacture of explosives. It was fi tting that Dave Woods, 
himself a world leader in the genetics of C. acetobutylicum, was a 
member of our team.
Shortly after this Israeli experience, the LMCB (discussed in 
Chapter 1) was disbanded. This left me without a job. But most 
conveniently, Dave Woods, my former PhD supervisor, became 
Deputy Vice-Chancellor of the University of Cape Town, leaving his 
position as Head of the Department of Microbiology vacant. I applied. 
The other three applicants were men and current members of the 
department. Dave’s parting words to me as I left his offi ce for my 
interview were ‘Don’t screw it up’. I didn’t, and on 1 April 1988 I 
took up my new position in Cape Town, back home after an 18-year 
absence.
The potential of African students
A watershed came for South Africa on 2 February 1990, when the 
apartheid government announced that it was unbanning the ANC 
and other political organisations, and would release Nelson Mandela. 
I was visiting one of Cape Town’s black townships on that day, as I 
was involved in opposition politics, and well remember the extreme 
rejoicing in the streets. One of the results of this decision for me was 
that I was invited to act fi rst as external examiner for the University 
of Zimbabwe’s MSc in Biotechnology, and then for the University 
of Botswana’s BSc in Biology. The former had a life-changing effect 
on me and the latter opened my eyes to the harmful effects that 
government policies on tertiary education can have on the quality of 
that education.
The University of Zimbabwe’s Class of 1992 consisted of eight 
students, including three who became successful PhD students in 
my lab. The fi rst was Tichaona Mangwende, who played a vital role 
in the early days of our work on developing maize resistant to the 
African endemic maize streak virus (see Chapter 7). The second was 
Thabane Dube, who, to our great sorrow, died of hepatitis B the day 
after he graduated with his PhD. The third was Dahlia Garwe, who 
pioneered our work on maize tolerant to drought (see Chapter 8). They 
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were followed by two further Zimbabweans, but only Dahlia, who is 
currently the acting managing director of the Tobacco Research Board 
in Harare, has returned to her homeland. The others found nothing 
there to entice them back and are all working in South Africa, a great 
loss to Zimbabwe’s scientifi c community.
All my Zimbabwean postgraduate students were exceptionally 
talented and this led to a rather interesting encounter. In the early 
2000s I was working on a report entitled ‘Realising the promise and 
potential of African agriculture’ commissioned by the InterAcademy 
Council (IAC), a council of national science academies. Members of 
the Southern African Development Community (SADC) involved in 
agriculture were meeting in Pretoria to discuss what should be included 
in this investigation. Each sat behind the name of his or her country, and 
at the fi rst tea break I approached the woman sitting at the Zimbabwe 
table. I extolled the scientifi c excellence of my three PhD students from 
her country, saying what an excellent secondary education they must 
have experienced there and that I hoped Mugabe wouldn’t ‘stuff it up’. 
She was his sister.
Another outcome of my visit to Zimbabwe was an invitation 
from the university there to run a practical course in biotechnology, 
funded by the United Nations Industrial Development Organization 
(UNIDO), during December 1993. About 20 people from a number 
of African countries attended and we tried to expose them to all the 
basic techniques available at the time. This was an eye-opener for me 
into the intense thirst for knowledge and extraordinary capacity for 
hard work shown by students when they are really driven to learn.
Why was my Zimbabwean experience so life-changing? Word began 
to spread through the extremely small biotechnology community in 
the region that Jennifer Thomson’s laboratory was a good place to gain 
experience. Before long I began to attract students from Mauritius, 
Botswana, Kenya and Uganda, and with the students came exposure 
to their home institutions, their supervisors and their colleagues. 
Other organisations helped as well, but that initial exposure in 
Harare was critical. 
My experience in Botswana was not as uplifting. The government 
had just decreed that the size of its tertiary education intake would 
be dramatically increased. By the second and third year of my 
assignment I began to see the effects of this. Lecturers simply could 
not cope, classes became impossible to handle in the space available 
and, inevitably, standards dropped. 
During 1993 I also served on the African Academy of Science’s 
advisory panel for their programme called ‘Educating girls and 
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women in Africa in science’. Ten of us from nine African countries 
(I was the only white woman) met in Nairobi, our chair being Maki 
Mandela, Nelson Mandela’s eldest daughter by his fi rst wife. It was 
fascinating, at such an early time in South Africa’s democracy, to 
be working with women who were vice-chancellors and ministers 
of education. We hoped that the research projects we put in place 
throughout the continent would come up with results that could help 
to change policy in order to enable more girls and women to study and 
embark on careers in science. Apart from the personal achievements 
of successful women scientists, economic development is intimately 
linked to scientifi c and technological development, and to have almost 
half the population often denied access to careers in this fi eld makes 
no sense at all. This was probably my real awakening to the plight of 
women scientists in Africa. 
South African Women in Science and Engineering
With this experience behind me, I was of course receptive to the 
suggestion by a friend at UCT, Lesley Shackleton, that we form South 
African Women in Science and Engineering (SAWISE). As Lesley 
described her reasoning behind this initiative:
Not for the fi rst time we found ourselves, a group of women scientists 
in the Western Cape, talking together at a research-related social event 
about the lot of women in the professional work place. Why were so few 
women heads of departments? Why did so few sit on the major funding 
agency, the Foundation for Research Development (FRD) and other 
committees that held power over our research careers? Why were so few 
of the oral presentations at scientifi c conferences made by women? And 
why were we doing nothing about it? (Shackleton, 1997:12).
An initial meeting, held at UCT in February 1995, was attended by 
some 50 women who gave a clear mandate to an interim committee to 
establish SAWISE. I was elected the fi rst chair of the Western Cape 
branch and a year later the Gauteng branch was formed. 
The aim of SAWISE is to strengthen the role of women in science 
and engineering by:
 ● raising the profi le of women scientists and engineers
 ● highlighting and addressing the problems faced specifi cally by 
women in these fi elds
 ● lobbying for the advancement of women in science and 
engineering
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 ● providing leadership and role models for young people wishing 
to enter the fi elds of science and engineering.
Again, in Lesley’s words:
SAWISE was acutely aware of the importance of science and 
technology for development, and the role women can play. Women 
have the greatest infl uence on the next generation, they set the 
standards for health and hygiene, they comprise the majority of the 
agricultural labour force. Taking science subjects should be seen 
not only as a means to a vocation, but as a means to build up the 
scientifi c and technological culture necessary for development, and a 
way of empowering people to apply basic scientifi c concepts in their 
everyday lives (Shackleton, 1997:12).
In those early days the projects we undertook were those that 
required hard work and enthusiasm, but no funds, as we had none. 
Members ran ‘Nights at the observatory’ to show school girls the 
wonders of astronomy; courses on ‘Gender and professional identity’; 
and workshops for young trainee science teachers to raise their 
awareness of gender in the teaching of science. We were also given 
a donation to award annual Honours bursaries—the Angus SAWISE 
scholarships—and many of the recipients are well on their way to 
successful careers in science and engineering.
Landing in Kenya
Another direct result of the unbanning of the ANC was my introduction 
to Kenya. It was announced that, as the ANC had been unbanned and 
Mandela was to be released, South African Airways (SAA) could start 
fl ying to Kenya. I was on the very fi rst SAA fl ight that was allowed to 
land in Nairobi, where I had been invited to give a series of lectures.
That experience taught me one very important lesson—never 
arrive in a new country on a weekend if you are expecting your visa 
to ‘be waiting for you on arrival’. It wasn’t, and it being a weekend, 
no-one was at work at the University of Nairobi (whose Professor of 
Veterinary Pathology and Microbiology had invited me to lecture), 
and therefore no-one knew anything about me. To make matters 
worse, it was the wedding day of the Attorney General’s daughter, 
and everyone who was anyone, including the Vice-Chancellor, was out 
at the farm. Thus it was decreed by the Department of Immigration 
that I should be put on the fi rst plane back to South Africa. 
Somehow the news of my predicament fi ltered through to my 
extremely anxious friends waiting for me in the arrivals hall. They 
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started to move heaven and earth to get me released, at least into their 
custody, until Monday (it now being Saturday) when they hoped to be 
able to reach the university authorities. No such luck, but at least at 
some time in the small hours of Sunday morning I got a message that 
one of the deputy vice-chancellors had come to the airport to try to 
help, but to no avail.
In the meantime I had settled down to make the best I could 
out of the situation. And the best soon arrived in the form of two 
Ugandan brothers who had just been to visit their aging mother for 
the fi rst time since being driven out of the country by Idi Amin. They 
were both living in Canada and one was a veterinary microbiologist 
in Saskatchewan. On hearing my sorry tale they took pity on me, 
plied me with food and drink (I had no Kenyan currency with me) 
and regaled me with stories of their persecution in, and subsequent 
fl ight from, Uganda. In due course, their fl ight departed. By now the 
barman had heard my story so he kindly settled me in a corner of the 
bar furthest away from customers, covered me with a blanket and 
promised to try and keep the noisiest of the travellers away.
Eventually I was released on the Sunday afternoon. Negotiations 
between the Vice-Chancellor and the Department of Immigration 
were successful and I was free to embark on my lecture series. 
The University Science, Humanities and Engineering 
Partnerships in Africa
Another result of the 1990 unbanning of the ANC was that the 
University of Cape Town in general began to be looked upon by 
academics in the rest of Africa as a potential university to send 
PhD students to. Up until then, promising graduate students were 
often sent to do their PhDs at universities in Europe or the US. The 
chances of their returning to their countries of origin after these 
experiences were slim. Would UCT be different? Dave Woods, as 
Deputy Vice-Chancellor for Research, took up the challenge and, 
together with Lesley Shackleton, my co-founder of SAWISE and 
project director for international students, visited a number of 
universities in sub-Saharan Africa to invite their PhD students to 
UCT. The upshot was a most successful programme, the University 
Science, Humanities and Engineering Partnerships in Africa 
(USHEPiA). 
One of the criteria for acceptance into the programme is the 
guarantee of a job at the home university, so the return rate is 
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excellent and a brain drain is alleviated. By the end of 2012, 53 PhD 
fellows had graduated from home universities in Kenya, Uganda, 
Tanzania, Zambia, Botswana and Zimbabwe. Another strength of the 
programme is that supervisors from UCT are required to travel to meet 
their prospective students, together with their home supervisors, at 
their home institutions, thus forming strong linkages. Accordingly, I 
capitalised on my contacts in Botswana and together with a colleague 
in my department enrolled our fi rst fellow. The programme aims to 
have the student spend about half of his/her time at UCT and the 
rest in the home institution. Unfortunately, we naively embarked on 
a molecular biology project of a rather complicated nature—not the 
wisest choice for the fl edgling programme—and special dispensation 
had to be made for this fi rst student to do virtually all his lab work at 
UCT. However, we learned from the experience and I carefully tailored 
the next USHEPiA projects to allow for adequate time outside UCT.
In 2001, I was asked by the USHEPiA offi ce to spearhead an 
initiative to expand the programme from the current PhD exchange 
to shared research projects in agricultural biotechnology. Over a 
period of a few days at the Jomo Kenyatta University of Agriculture 
and Technology (JKUAT) in Nairobi, colleagues and I put together 
the outlines of a number of joint projects in Kenya. We then went 
on to the University of Dar es Salaam in Tanzania, the University 
of Zambia and Makerere University in Uganda. As a result of these 
visits, Viviene Matiru from Kenya and Betty Owor from Uganda 
completed PhDs in my laboratory. 
Viviene is a senior lecturer in the Department of Microbiology at 
JKUAT, and until recently was its chair. Microbiology is actually a 
sub-department of the Botany Department and principally teaches 
medical microbiology students. I can hear her frustration, which 
reminds me of mine when I was in the Genetics Department at Wits 
University, when she tells me that her aim is to establish a fully 
fl edged Department of Microbiology and Molecular Biology, to be—as 
she says—‘a centre of excellence in microbiology, to be the place of 
choice to study microbiology in Kenya and in the eastern and central 
African regions’.
Betty Owor went to Makerere University in Kampala intending 
to study medicine, but, fortunately for us, landed up in agriculture 
instead. That education stood her in excellent stead for her PhD 
work as it involved fi eld trips to smallholder farmers, commercial 
farmers and factories. At one stage we sent her back home to Uganda 
to sample maize streak virus (see Chapter 7) and she returned with 
what is probably the most extensive such coverage ever undertaken.
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Betty is currently a post-doctoral fellow working under the 
supervision of Prof Sir David Baulcombe, the Royal Society Professor 
of Botany at Cambridge University. She is working on sweet potato 
viruses, together with her alma mater, Makerere University. She fi rst 
connected with David after she met a postdoctoral researcher from 
his Sainsbury Laboratory in Norwich, where he was the head before 
joining Cambridge. She visited him on her way home and managed 
to persuade him to allow her to come to his lab for a few months to 
complete some experiments we were having diffi culties with in our 
lab. When she told me about this coup I was extremely impressed … 
‘Where angels fear to tread’! 
Florence Wambugu
During my frequent visits to Nairobi I met a truly remarkable 
woman, Florence Wambugu, who has single-handedly done more 
for agricultural biotechnology in East Africa than any other person 
I know. She was born one of nine siblings on a small farm in the 
Kenyan highlands and has childhood memories of going to bed 
hungry. She was fortunate to have a wise mother who sold the family 
cow to send Florence to school in the days when educating women 
was often considered a waste of money. She eventually became a 
plant pathologist specialising in viral diseases of potatoes and sweet 
potatoes. However, when I got to know her she was spearheading the 
use of tissue culture to propagate disease-free bananas. 
It was typical of Florence to choose a crop that is considered ‘a 
woman’s crop’. In traditional African farming systems, women manage 
crops that feed their families while men are responsible for crops that 
make money. However, the man owns the land and ultimately decides 
on its use. So a woman’s crop often suffers double blows, especially 
because, unless she can obtain credit, a woman must rely on her man 
to buy her planting material. 
The traditional way of propagating new banana plants is to 
uproot a young sucker from close to the base of a mature plant. This 
is cheap but carries over whatever pests and diseases are present 
in the parent. Tissue culture involves the production of new plant 
material under sterile conditions in a laboratory. This also breaks 
the cycle of infection and can supply a ‘hormonal kick’ in the culture 
media, which results in higher yielding plants (Wambugu, 2001). But 
how was Florence to get these plants to women farmers?
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She was on the board of the International Service for the 
Acquisition of Agribiotech Applications (ISAAA; see Chapter 2), 
and had close ties with the Kenya Agricultural Research Institute. 
Together they made funds available to launch the scheme, and 
the latest available information is that banana productivity has 
increased from 20 to 45 tons per hectare. This translates into an 
increase in income from a basic US$ 1 per day per family to as much 
as US$ 3 (www.absfafrica.org). Florence is currently the CEO of 
Africa Harvest, an organisation she founded.
Venturing into Nigeria
Around this time I was invited to a biotechnology conference in 
Enugu, Nigeria. I was just about the only white person, and certainly 
the only white woman, there. The opening ceremony was a real eye-
opener to the type of life Nigerians lived under their dictator, General 
Abacha. The minister responsible for science and technology was due 
to open the meeting, but after an hour of waiting the local dignitaries 
went ahead with the ceremony in his absence. During the coffee break 
there came the sound of screaming tyres and in drove the convoy 
carrying the minister. Immediately everyone returned to their seats 
and the opening ceremony was repeated. However, the atmosphere 
was completely different and was set by the minister himself, also a 
general, who would not deign to try and adjust the microphone to his 
liking, but gestured to a minion who jumped to the task. The local 
dignitaries also adapted their speeches to suit his presence. After his 
departure I was approached by a TV interviewer who asked me what 
I thought about life in Nigeria. It was one of those moments when you 
watch your life pass before your eyes—just a few weeks previously 
my brother had been arrested for taking part in an illegal protest 
in Johannesburg, demonstrating against the death in custody of the 
Nigerian opposition leader, Ken Saro-Wiwa. I have to confess that 
I chickened out by saying I was there as a scientist and could only 
comment on biotechnology.
Fears around DNA transfer
In the late 1990s I was approached by the World Health Organization 
(WHO) to participate in a workshop on how GM crops could infl uence 
food security on the African continent. They asked me to address 
the question of the transfer of DNA from GM crops to bacteria and 
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to mammalian cells, a talk which I later wrote up for publication 
(Thomson, 2001). There was a major argument at the time as to 
whether it was safe to use antibiotic resistance genetic markers as 
a tool in the selection of GM plants. Could the genes encoding such 
resistance be transferred from the food we eat into bacteria in our 
intestines, or indeed into the cells of our body, and thus result in 
ourselves becoming resistant to these antibiotics?
Gene transfer from a GM plant to a bacterium, or to humans or 
animals, is called horizontal gene transfer. It is the movement of 
genetic information between sexually unrelated organisms (different 
species). This is in contrast to vertical gene transfer, which occurs from 
parent to offspring. Let us consider the processes that would have to 
occur for horizontal gene transfer to take place from a food derived 
from a GM crop, the evidence for such processes occurring, and the 
possible consequences should they occur. I will use the example of a 
gene coding for resistance to an antibiotic.
Firstly the antibiotic resistance gene would have to remain intact 
in the gastrointestinal tract once the food is eaten. Enzymes in this 
tract degrade DNA into small fragments of about 500 base pairs, too 
small to encode antibiotic resistance within an hour. However, should 
a large enough fragment survive it would need to be taken up by 
bacteria or human cells. Although some bacteria can take up DNA 
from the environment by natural transformation processes, such 
transfers have yet to be shown by anaerobic gut bacteria in their 
natural environment.
What about uptake by human cells? All foods contain DNA 
and, although we have not accurately determined the amount that 
consumers ingest on a daily basis, estimates for cows indicate that 
they consume approximately 600 milligrams of DNA per day (Beever 
and Kemp, 2000). Any concerns regarding the presence of novel DNA 
in GM-derived foods must take into consideration that the DNA from 
this source would represent less than 1/250 000 of the total amount 
of DNA consumed. In addition, we are talking about one gene among 
the 20 000 to 40 000 genes found in a crop plant. In view of this and 
the ready digestibility of dietary DNA, there is an extremely low 
probability of transfer of antibiotic resistance genes from GM plants 
to mammalian cells. Indeed, the uptake of any exogenous DNA by 
mammalian cells is very diffi cult to prove.
I wrote this up in an appendix to Genes for Africa (Thomson, 
2002: 187) and concluded by saying that, although the use of antibiotic 
resistance genes in transgenic crops is considered safe by scientists: 
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there is public perception that they could add to the already high 
levels of antibiotic resistance in pathogenic bacteria. Despite the 
fact that there is no scientifi c evidence to support this, scientists and 
regulators working in this fi eld agree that they should use alternative 
transformation technologies that do not introduce antibiotic resistance 
genes in GM crops and foods.
Around the time that I was working on this I was also involved in 
meetings that were to have a profound effect on my future involvement 
with agricultural biotechnology in Africa. I had been invited to speak 
at the World Economic Forum in Davos.
Food for Africa_Chapter 3.indd   61 4/26/13   5:15 PM
Food for Africa_Chapter 3.indd   62 4/26/13   5:15 PM
Chapter 4
To Davos and further into Africa
The World Economic Forum, held in Davos, Switzerland every year, 
is an independent international organisation committed to improving 
the state of the world by engaging business, political, academic and 
other leaders of society to shape global, regional and industry agendas. 
It organises regional forums, and in 1999 I was invited to speak at 
the Southern African Economic Forum at the convention centre in 
Durban. I had no idea what to expect, but gave a run-through of 
my talk to a respected businessman I knew and he gave me lots of 
advice, which must have worked, because the next year I was invited 
to speak in Davos itself.
I was part of a discussion forum in which four speakers were asked to 
express their opinions on genetically modifi ed crops. The audience was 
asked to vote before and after the presentations and there was a pleasing 
increase in the FOR vote at the end. But from my personal perspective, 
the most important interchange was between a member of the audience 
and Prof (now Sir) Gordon Conway, then president of the Rockefeller 
Foundation. ‘Now that the foundation has successfully funded the 
development of genetically engineered vitamin A-enriched rice, what is 
their next target?’ came the question. And his answer was, ‘Drought-
tolerant crops for Africa.’ After the discussion I tapped Prof Conway 
on the shoulder and said, ‘Gordon, can we discuss my research?’ And 
so it happened that I received handsome funding from the Rockefeller 
Foundation from 2001 to 2006. But more of that later in Chapter 8.
I was invited back to Davos the following year and on that occasion 
my most signifi cant experience came on the so-called ‘free Sunday’. I 
had been asked to attend a meeting of the Informal Group of World 
Economic Leaders and on the bus discovered that my two co-speakers 
were Ian Wilmut of the Roslin Institute near Edinburgh, who had 
just cloned the sheep, Dolly, and George Church, a member of the 
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Human Genome Project. Our chair was Lord Robert May, president 
of the Royal Society of London. When I asked him what was expected 
of us he merely replied, ‘Just respond to the questions.’ 
In my session I spotted the South African ministers for Trade and 
Industry (Alec Erwin) and Finance (Trevor Manuel). They kindly sat 
next to me and told me sotto voce who was asking the questions. Although 
we, the speakers, were introduced to the about 20-strong audience, we 
had no idea which world leader we were addressing. It turned out that 
they weren’t that interested in Dolly, didn’t quite realise the implications 
of sequencing the human genome, but certainly wanted to know more 
about GM crops. So I was in the hot seat for most of the two-hour session.
Davos taught me quite a lot about debating with the anti-GMO 
lobby. At the end of my fi rst visit I found myself in a little makeshift 
TV tent together with Vandana Shiva, the Indian anti-GMO activist 
who opposes almost anything to do with big business (see Chapter 2). 
After one comment she made on poor Indian farmers being forced to 
buy seed against their will, I retorted, ‘But that’s a lie.’ The interviewer 
merely smiled broadly, thanked us both and gave Shiva the last word 
on the subject. I realised that truth doesn’t always make for a good 
interview. When I got home I drew up a fact and fi ction table which I 
have found useful in similar situations (Table 4.1).
GM crops have continued to be on the agenda of World Economic 
Forums, especially recently with food shortage scares. In 2010 Bill 
Gates came out in support of the responsible use of the technology, 
especially for disease resistance and drought tolerance in developing 
countries. In 2011, governments of developing countries, together 
with NGOs and multinational food and agricultural companies, 
formed the task force ‘Realising a new vision for agriculture’. However, 
the participants acknowledged that it would take not only innovation 
but a lot of collaboration to get things moving for technology-friendly 
regulations and infrastructure. At the 2012 meeting, Robert Carlson, 
leader of the World Farmers Organisation, noted that the world’s 
agriculture industry had suddenly become one of the largest concerns 
among economic leaders of the world. He went on to say:
Generally, at this forum, I feel the attitude on genetically modifi ed action 
is if your culture will accept (it), and if it works for you and is safe, 
we encourage you to (accept it). The consensus among many of those 
attending is if we don’t have genetically modifi ed crops we won’t be able 
to feed the world and will end up being even more dependent on using 
higher rates of fertiliser and pesticides (http://www.farmandranchguide.
com/news/regional/carlson-representing-agriculture-at-the-the-world-
economic-forum/article_56324758-50e0-b7cd-001871e3cebc.html).
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1 GM crops create 
superweeds
 ● The use of herbicides for decades has not 
resulted in superweeds 
 ● Herbicide rotation has been used for decades 
to prevent build-up of resistance
2 GM crops will 
destroy biodiversity
 ● GM crops are much easier to breed into 
different crop varieties as they only have one 
or a few linked genes added. Thus GM crops 
can increase crop biodiversity
 ● Fewer insecticides are used leading to 
increased insect biodiversity
3 GM crops are 
harmful to the 
environment
 ● Insect-resistant crops have led to a decrease 
in the amount of pesticides used, leading to an 
increase in non-targeted insects
 ● Some pesticides are also toxic to the humans 
who spray them. Insect-resistant crops prevent 
this harm
 ● Herbicide-resistant crops have led to ‘no till’ or 
‘minimal till’ agriculture. Instead of tilling the soil 
before planting to allow weeds to grow, spraying 
them with herbicides and allowing these to 
degrade before planting—leading to loss of top-
soil—farmers now plant, allow the weeds to 
grow, and then spray. Result: soil improvement
 ● Roundup, one of the herbicides that GM crops 
are resistant to, is rapidly biodegraded. Many 
conventional herbicides, such as atrazine, 
remain in the soil for longer periods
FOOD SAFETY FOOD SAFETY
1 GM foods are unsafe 
to eat
 ● No food in the history of humankind has ever 
been subjected to such rigorous safety tests as 
foods derived from GM crops
 ● 2004: Food and Agricultural Organization ‘no 
deleterious effects from consumption of foods 
derived from GM crops discovered anywhere 
in the world’
 ● 2010: EU Commission Directorate for Research 
‘no new risks to human health or the environment 
from any GMO crops commercialized so far’
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FICTION FACT
MARKET ISSUES MARKET ISSUES
1 GM crops are 
just a ploy of the 
multinationals to 
make more money
Farmers are savvy people. They will not buy seeds 
if they don’t give them a profi t. No-one is forcing 
farmers to buy seed from any given company
2 Farmers who plant 
GM crops have to 
buy seed every year
 ● Since the advent of hybrid crops/seeds in the mid-
1920s, farmers who have chosen to plant such 
hybrids have had to buy seed every year. That 
was long before GM crops were even dreamt of
 ● Farmers can choose not to buy hybrid seed 
but plant open-pollinated varieties, or land 
races. These have lower yields, but farmers can 
plant their own seed. These seeds are readily 
available from seed companies
3 GM crops cannot 
help to feed the 
poor
They could if they were allowed to be introduced. 
The developed world has imposed such strict 
regulations, which have to be followed by the 
developing world, that existing GM crops as well as 
new ones in the pipeline with improved nutritional 
content, and resistance to drought and disease, are 
extremely diffi cult and expensive to introduce
4 GM crops won’t 
put more money 
into the pockets of 
smallholder farmers
 ● Currently, in 28 countries where GM crops are 
allowed, approximately 90 per cent are planted 
by smallholder farmers. Ask them why they 
buy GM seeds
 ● In 2009, 87 per cent of the national Indian 
cotton crop was planted by smallholder 
farmers using GM seeds
 ● In China the equivalent fi gure was 68 per cent
 ● Smallholder farmers are the quintessential 
organic farmers as they cannot afford 
herbicides and insecticides; GM crops mean 
that they can improve their yield with seed 
alone, although addition of fertilizers will help
5 Genes can fl ow 
from GM crops and 
‘pollute’ other crops
 ● Gene fl ow takes place between all crops, GM 
or non-GM. Conventional hybrid crops can just 
as readily ‘pollute’ local varieties
The African Agricultural Technology Foundation
In 2001 or 2002 I received an email from a fl edgling organisation called 
the African Agricultural Technology Foundation (AATF), to be based in 
Food for Africa_Chapter 4.indd   66 02/05/13   9:32 AM
 To Davos and further into Africa 67
Nairobi, asking if I would be prepared to have my name put forward 
as a member of their board. I submitted my CV and then forgot all 
about it. Some months later I was informed I had been appointed to 
the board, but I had completely forgotten what the initials AATF stood 
for. I checked on the Internet but all I could fi nd was the ‘American 
Association of Teachers of French’. Ashamedly I admitted my ignorance, 
and they kindly reminded me that this was an organisation funded 
by the Rockefeller Foundation, the UK Department for International 
Development (DFID) and the US Agency for International Development 
(USAID), whose aim was to transfer intellectual property in agricultural 
biotechnology from multinationals to African farmers.
I was unable to attend the fi rst meeting, but discovered on my 
return home that I had been elected vice-chair of the AATF board. 
That was slightly unnerving, but nothing at all compared to the news 
received shortly thereafter that the chair had resigned and that I 
was now chair of the board of an organisation about which I knew 
extremely little. The interim executive director, Eugene Terry, kindly 
visited me in Cape Town to fi ll me in, but I was still pretty nervous 
when I came to chair my fi rst meeting in Nairobi in 2003.
In 2004 the AATF was inaugurated on 16 June (my birthday), 
and was attended by representatives of the donors, many government 
authorities, partners and well-wishers. We had been given property 
on the campus of the International Livestock Research Institute 
(ILRI) in the rolling hills outside the city.
Figure 4.1 Cutting the ribbon with the Kenyan Minister of Agriculture, the Hon 
Kipruto arap Kirwa, at the launch of the AATF on 16 June 2004
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One name stands out in the history of the AATF—that of Sir Gordon 
Conway. As the then president of the Rockefeller Foundation, one of 
the founding funders of the organisation, he was intimately involved 
in its conceptualisation and implementation. When he stepped down 
from that foundation he became involved with the UK Department 
for International Development (DFID), another founding funder. And 
then in 2009 he became a member of the board of trustees where he is 
chair of the development committee and an indefatigable fundraiser. 
His fi rst book, The Doubly Green Revolution: Food for All in the 21st 
Century (Conway, 1997), was a source of inspiration for my second 
book, Seeds for the Future, for which he wrote the foreword. He has 
recently published One Billion Hungry: Can We Feed the World? 
(Conway, 2012) which should be required reading for all interested 
in food security. His continual emphasis on the importance of the 
AATF’s end-users—smallholder farmers—and the improvement of 
their livelihoods keeps the organisation (and its board) focused on its 
primary aim.
Another important player is the current chair of the board, Professor 
Idah Sithole-Niang, from the University of Zimbabwe. Her term of 
offi ce ends in 2013, but she has contributed a deep understanding 
of how academic knowledge can be translated into improvements on 
farmers’ fi elds. She was also chair of the MSc in Biotechnology at 
her university when I was invited to be external examiner in 1992 
(Chapter 3). This excellent course was dropped after a number of 
years, but Idah fought indefatigably for its reinstatement, and she 
fi nally won in 2012.
My involvement with the AATF started one of the most satisfying 
experiences of my life—helping to steer it to develop crops that could 
help smallholder farmers not only to become secure, but also to 
develop into commercial enterprises while, at the same time, helping 
African countries to become food secure. However, to fully understand 
the importance of the AATF I need to expand on the questions of 
intellectual property and the patenting of life forms.
Intellectual property and life forms
For centuries millions of intellectual property rights have been 
granted throughout the world under various IP laws in different 
countries for similar reasons: to encourage an inventor to disclose 
his or her invention to the public, thereby promoting the progress of 
science. This may be looked upon as a contract between a government 
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and the inventor whereby the latter discloses the invention and the 
former provides the inventor with a monopoly for a given period 
of time, currently usually 20 years. This provides incentives for 
innovators to develop new technologies for that society. 
Intellectual Property Rights (IPR) have revolutionised societies 
technologically, industrially and thus socio-economically. The ability 
of inventors to disclose their ideas in return for monopolies has 
facilitated the promotion of scientifi c progress. I recall hearing Ingo 
Potrykus, one of the developers of vitamin-enriched rice, so-called 
‘Golden Rice’, speaking on the subject of patents at an international 
biotechnology meeting in Florida in 2002. He said he was initially 
outraged when he discovered that Golden Rice had made use of 70 
IPRs belonging to 32 different companies and universities. However, 
he later realised that if these patents had not been in place, he would 
have had to have made those inventions himself in order to come up 
with his fi nal product. 
I met Ingo again at a meeting in Ravello, Italy in June 2012 and 
he was an extremely disappointed man. Opposition to Golden Rice, 
led largely by Greenpeace, had prevented its uptake. Golden Rice 
contains beta-carotene, which is converted into vitamin A in humans. 
According to the WHO, between 250 000 and 500 000 children become 
blind every year due to vitamin A defi ciency. Half of these children 
die within a year of going blind. Ingo Potrykus and colleagues 
developed Golden Rice in 1998, but its introduction has been blocked 
by Greenpeace who claim that there are better ways to alleviate this 
defi ciency, such as vitamin A pills and ‘home gardening’. Yet they are 
doing nothing to implement alternative programmes for the millions 
of victims and, in the words of Dr Patrick Moore, the co-founder of 
Greenpeace, this constitutes a ‘crime against humanity’ (Moore, 
2012).
Products and processes involved in GM technology are patentable 
under the international Union for the Protection of New Varieties of 
Plants (UPOV). Such patents have been viewed with great hostility 
in general from detractors of GM crops, including most southern 
African countries, with the exception of Kenya and South Africa, 
which have been members of UPOV since 1978. The arguments 
against this system of protection include the view that it is excessively 
monopolistic and protects the breeder to the disadvantage of farmers’ 
rights in indigenous knowledge. Kenya, however, saw the advantage 
of new plant varieties in horticulture. Access to quality seed and 
horticultural material, such as fl owers and vegetables, has facilitated 
global trade in these commodities (Olembo, 2008) and Kenya is now 
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a major exporter of cut fl owers and fresh vegetables. However, the 
most signifi cant impact of a plant protection system is its stimulation 
of research in agricultural productivity.
Many of the arguments against IPR in African agriculture are 
spelled out in a paper on food security by Kuyek (2002). His arguments 
include the threat of monopolies by multinational companies, placing 
needed products beyond the reach of poor countries. There are also 
fears that patents threaten the freedom of farmers to access seed. 
Indeed it is true that global corporations hold 90 per cent of all 
technology and product patents related to living materials. But that 
is partly due to the expense involved in developing and bringing such 
products to market. It is estimated that to develop and bring a GM 
crop to market costs US$136 million, of which 26 per cent of total cost 
and 37 per cent of time (an average of 13 years) are involved with 
regulatory expenses (Phillips McDougall, 2011).
I noticed the swing away from the involvement of publicly 
funded institutions, such as universities and research institutes, 
towards private corporations, as early as 1990 during meetings of the 
International Symposium on Genetics of Industrial Microorganisms, 
long before the advent of GM crops. Whereas in the early days of 
the symposium, colleagues at universities and research institutes 
readily shared their research results in an open forum, as time went 
by this happened less and less often. The podiums became dominated 
by scientists from private companies who would share data only on 
products and processes that had already been patented. Research is 
expensive and requires considerable time—an estimated 13 years 
from the start of a GM crop to its appearance on the market. It 
requires the use of skills and costly equipment that push up the value 
of the fi nal product. Compensation for such involvement becomes a 
necessity, and securing IPRs provide such a mechanism.
During the October 2002 World Summit on Sustainable 
Development in Johannesburg, heated debates occurred in 
various forms on the ills of IP as a medium for trade (Olembo, 
2008). Claims were made that the multinational seed industry’s 
expansion into Africa had come with intense pressure in favour of 
patented products, but with no intention of making the technology 
freely available to farmers. Some views expressed at this meeting 
were that African agriculture does not require IPR because such 
agriculture is led by farmers, funded by the public sector, and based 
on collective knowledge. Anti-IPR activists claimed that protection 
regimes undermine farmers’ rights, foster dependence on foreign 
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companies, allow piracy of farmer-developed crops, and threaten food 
security and biodiversity. 
The contrasting views were that because of the need to increase 
productivity, the situation in Africa is no longer static; it is evolving 
all the time. Local companies, national research institutions, non-
governmental organisations and farmers’ associations are increasingly 
engaging in biotechnology and other improved agricultural techniques 
for higher agricultural yields (Olembo, 2008). 
Both of these views have validity and somehow must be 
harmonised. In fact, as Klaus Amman points out in his article 
entitled ‘Reconciling traditional knowledge with modern agriculture: 
a guide for building bridges’ (Amman, 2007), the barrier between 
these two approaches is artifi cial. Many scientists depict traditional 
knowledge as closed to conceptual inputs from outside, whereas 
science is open to new thought, precise in its empirically tested 
progress. Critics of science, however, mistrust it for being too 
abstract, analytical and divorced from the needs of real people. The 
reality in both cases is different from these perceptions. Traditional 
knowledge that has accumulated since ancient times and been 
transmitted by oral tradition has often turned out to be strikingly 
precise when tested against empirical observation. Indeed, given 
the test of time, traditional knowledge is verifi ed or falsifi ed by 
experiment and observation. And in Western science, oral tradition 
is certainly present. Scientifi c communities with different views 
and lexicons continue to exist regionally despite the homogenising 
infl uences of the scientifi c literature and the Internet—for instance 
in botanical and ornithological nomenclature.
However, the fact remains that in order for Africa to benefi t 
from these new technologies, and not to be left behind as it was 
in the Green Revolution of Asia in the 1960s and 1970s, African 
countries will have to develop policies to deal with IPR. Apart from 
straightforward negotiations between potential African users and 
IPR owners, in which IP may be acquired through licensing, outright 
purchase or partnerships and the need to minimise costs, particularly to 
deserving poverty-stricken developing countries, may require goodwill 
arrangements. It was with this in mind that the AATF was established.
How the AATF works
The rationale for the establishment of the AATF is spelled out in a paper 
entitled ‘The African Agricultural Technology Foundation approach 
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to IP management’ (Boadi and Bokanga, 2007). The fundamental 
reasoning was to establish links between private and public sector 
institutions owning technological innovations in developed countries, 
and African stakeholders in agricultural development, such as the 
National Agricultural Research Services, farmers’ associations, 
non-governmental organisations, and national, private sector 
agribusinesses, such as seed companies. The goal of the AATF is to 
facilitate access to appropriate scientifi c and technological resources, 
whether proprietary or not, and to promote their adaptation for use in 
specifi c projects intended to increase the productivity of smallholder, 
resource-poor farmers in sub-Saharan Africa.
In order to do this effectively, the AATF fi rst consults with these 
African stakeholders in order to identify what the priority crops and 
the key constraints are for resource-poor farmers. They then consult 
with potential technology providers, in private and public sectors, 
to identify relevant technologies that can address these constraints. 
They must then negotiate with potential partners to develop a project 
business plan that specifi es the role of each partner institution and 
determines how and where the technology will be used. The AATF 
then enters into licensing agreements to access and hold proprietary 
technologies and ensure freedom to operate for all components of the 
technologies. 
Once all this is in place, work proceeds by sublicensing partner 
institutions to carry out the actual research as needed to adapt the 
technologies to smallholder farming conditions in Africa. In some 
cases this will require the gene(s) of interest to be transferred to an 
African crop, such as cowpeas or African varieties of crops such as 
maize. These must be tested for regulatory compliance before the 
products can be produced and distributed to farmers. Once this is 
done, the AATF must put in place systems to monitor compliance 
with the regulations and to minimise the risk of technology failure. 
It further facilitates the work of appropriate partner institutions to 
ensure that links in the value chain are connected, are effective, result 
in technology products that reach farmers and, most importantly, 
allow farmers’ surplus harvests to reach markets. I recall asking some 
farmers during an AATF fi eld visit what their major problems were 
and they identifed ‘drought’ and ‘markets’. To ensure that these efforts 
are sustainable in the long term, the AATF also creates partnerships 
within African countries and with external stakeholders to develop 
the necessary indigenous capacities.
It is clear from this that the AATF operates along the entire 
product value chain, from the transfer and adaptation of technology 
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to farmers’ access to output markets, with each implementation step 
undertaken with the relevant partner organisation. The nature of 
the AATF’s involvement varies from project to project, depending 
on the specifi c requirements and issues that need addressing (see 
Figure 4.2).
IR maize
I will illustrate the AATF’S process of embarking on projects using a 
few examples (for further details see www.aatf-africa.org). Our fi rst 
product was maize resistant to the parasitic weed, Striga, commonly 
called witchweed. It is an extremely pretty, but insidiously dangerous 
plant (fi gures 4.3 and 4.4) which relies on maize for about 40 per cent of 
its nutrients. It sets millions of tiny seeds which can lie dormant in the 
soil for years until maize plants start to germinate. Chemicals released 
into the soil then send signals to the Striga seeds that food is about 
to become available. The seeds in the vicinity of the developing maize 
plants germinate and infi ltrate their roots into the roots of their hosts, 
eventually smothering the plant and effectively preventing farmers 
from getting rid of these intertwined weeds by physical means. Fields 
infected with Striga seeds are left unplanted by maize because farmers 
realise it is useless even to try to plant the maize there. The company 
BASF developed a variety of maize tolerant to the herbicide Imazapyr—
the so-called Imazapyr resistant (IR) maize. They did this not by genetic 
engineering but by classical breeding, and therefore AATF’s fi rst product 
was not a GM crop. This meant that its distribution was unhampered 
by the stringent requirements for the deployment of such crops and 
enabled us to develop it much more rapidly than we would have been 
able to, had it been a GM crop.



































Figure 4.2 AATF’s involvement in the complete product value chain
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Figure 4.3 A fi eld of maize damaged by Striga
Figure 4.4 The difference between cobs derived from Imazapyr-resistant maize (left) 
and sensitive (right) maize
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During one of our board meetings, members fl ew to western Kenya to 
view some of the fi eld trials. The only reason we had been successful 
in distributing the IR seed to farmers was due to our involvement 
with local organisations such as WeRATE, a consortium of NGOs, 
community-based and farmers’ associations. It was thanks to them 
that we were able to stem a potential problem. We had distributed 
the IR maize seeds coated with the herbicide, Imazapyr. But many 
farmers sow seeds by hand and intercrop maize with plants such as 
legumes, so if they planted the legume seeds without fi rst washing 
their hands the legumes would have become covered in Imazapyr. 
Imagine the headlines in The Nation: ‘Biotech maize kills beans!’ The 
AATF rapidly brought out simple brochures in all the local dialects 
and, with the help of the NGOs, distributed them widely, thus 
preventing what could have been a minor disaster. Now Kenya Seed 
Company provides two pairs of gloves with each package of seed, 
together with illustrations on how to handle the seed.
However, the biggest problem with this project has been the 
production of seed. Even today, some seven years after the launch 
of the Striga Control Project, Dr Gospel Omanya, the AATF seed 
systems manager, bemoans the slow output of seeds. This is to some 
extent understandable. The production of these seeds requires that 
they be coated with Imazapyr which, in turn, involves investment in 
costly coating equipment. Production of the seeds has increased, even 
so. During 2010, 30 tonnes of seed were produced in Kenya, up from 
the 20 tonnes in 2008, and could be distributed to farmers through 
the agro-dealer network in western Kenya. The project is being taken 
up across Africa. Tanzania has begun production but the herbicide 
still has to be registered there. In Uganda, on-farm variety trials 
have been carried out to collect data for performance trials, because 
varieties that work in Kenya may not be suitable for the climatic, 
soil and other conditions prevailing in Uganda. Nigeria is working 
towards commercial release. Regional trials in Zimbabwe have yet to 
identify their best adapted lines. 
Bt cowpeas
A second AATF project example, which does involve genetic 
engineering, is the Bt cowpea project. Bacillus thuringiensis is a 
naturally occurring soil bacterium which produces proteins, called Bt 
proteins, that are toxic to certain insects. They cause little or no harm 
to most non-target organisms, including humans and wildlife. They 
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have been used in sprays in conventional and organic agriculture for 
decades with negligible or no ill effects on the environment or human 
health. Thus, Bt toxins are considered an environmentally friendly 
alternative to broad-spectrum insecticides. From the mid-1990s, crops 
expressing Bt genes and hence producing the toxins inside the plant, 
have been commercialised in the US and Bt crops such as cotton and 
maize have been planted commercially in South Africa.
Cowpea (Vigna unguiculata L. Walp) is considered the most important 
food grain legume in the dry savannahs of tropical Africa, where it is 
grown on more than 12.5 million hectares of land. It is rich in high-quality 
protein and has an energy content almost equivalent to that of cereal 
grains. It is a good source of quality fodder for livestock and provides 
cash income. Nearly 200 million people in Africa consume it. However, 
many biotic and abiotic factors greatly reduce cowpea productivity in 
the traditional African farming systems. Among these constraints is the 
pod borer, Maruca vitrata, which perennially damages cowpea pods on 
farmers’ fi elds. In severe infestations, yield losses of between 70 and 80 
per cent have been reported. Control through spraying with insecticide 
has not been widely adopted by farmers due to the prohibitive costs and 
health hazards associated with spraying (www.aatf-africa.org ). 
The cry1Ab gene, coding for one of the many Bt proteins, was 
obtained from Monsanto, and a group at the Commonwealth Scientifi c 
and Industrial Research Organisation (CSIRO) in Australia, led by Dr 
TJ Higgins, transferred it into cowpea. Promising transgenic events 
were selected after thorough laboratory and greenhouse testing. These 
were subjected to confi ned fi eld trials (CFT) in 2008 in Puerto Rico, 
chosen because that country had the required biosafety regulations in 
place. One of the lessons learned there was that natural infestations 
by Maruca could not be relied upon. Indeed, the insect population 
that season was almost too low to evaluate the effectiveness of the 
transgenic lines. CFT began in Nigeria in 2009 in partnership with 
their regulatory authority and the ministry of environment. Again, 
one of the greatest challenges has been in obtaining signifi cant 
Maruca infestations in the fi eld. To solve this, AATF partnered with 
the International Institute of Tropical Agriculture (IITA) in Ibadan 
to train entomologists and technicians to rear the insects in the 
laboratory and then artifi cially infest the larvae into the CFT site. ‘We 
were delighted to note that while the larvae fed on the non-transgenic 
cowpea, they did not attack the transgenic varieties,’ said Dr Misari, 
the project entomologist (AATF Annual Report, 2010). The project has 
had excellent cooperation from the Nigerian authorities to the extent 
that the AATF has established an offi ce there.
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An interesting connection transpired in relation to this project. 
Ed Southern, who had taught me to use Southern blots at the 1978 
course I attended in Basel (see Chapter 1), had made a lot of money, 
not out of his blotting technique, which I daresay he never thought to 
patent, but out of another major technology, that of DNA microarrays. 
You’d think it would be enough to invent one technique that would 
revolutionise molecular biology, but two … ! He had started the 
Kirkhouse Trust, which focuses, inter alia, on agricultural crop 
improvement research for the developing world, specifi cally legumes. 
He decided to support the AATF’s project on insect-resistant cowpeas 
in West Africa, and on hearing of my involvement, paid a visit to the 
University of Cape Town while visiting Ghana (not everyone is aware 
of distances in Africa) to inform our students of the importance of this 
work. So we met up again after some 30 years, under very different 
circumstances, but still with the same aims in mind.
Banana bacterial wilt
A third AATF project is targeted at diseases of bananas. Bananas 
and plantains are an important food source for more than 100 million 
people in sub-Saharan Africa. In the East African highlands and 
most of the Great Lakes region, bananas are a major staple food 
and a source of income for over 50 million smallholder farmers. East 
Africa produces 16.4 million metric tonnes of this crop per year, 
about 20 per cent of the world output. However, many biotic and 
abiotic factors greatly reduce productivity for bananas cultivated 
under traditional African farming systems. For instance, in 2001, an 
outbreak of banana bacterial wilt, caused by Xanthomonas campestris 
pv musacearum, broke out in Uganda, leaving in its wake a trail of crop 
destruction and utter misery among affected farms. It later spread to 
the Democratic Republic of Congo, Rwanda, Tanzania and Kenya, and 
is very destructive, infecting all banana varieties. The International 
Institute of Tropical Agriculture (IITA) estimates economic loss due to 
diseases in Uganda alone to be at a staggering US$ 200 million. The 
AATF is collaborating in a public/private sector partnership project 
to develop banana bacterial wilt-resistant transgenic bananas in East 
African-preferred germplasm (www.aatf-africa.org ).
The genes involved are either those coding for the sweet pepper 
ferrodoxin-like protein (Pfl p) or the hypersensitivity response 
assisting protein (Hrap). The AATF is collaborating with scientists 
from the Academia Sinica in Taiwan, who showed that these 
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genes improved disease resistance of vegetables, including broccoli, 
tomatoes and potatoes. The AATF received a royalty-free licence 
to use these genes in 2006. On 5 October 2010, the AATF, the IITA 
and the National Agricultural Research Organisation (NARO) of 
Uganda planted transgenic lines in a confi ned fi eld trial in Kawanda, 
in south-east Uganda (AATF Annual Report, 2010). It attracted an 
item in the journal Nature, in which Linda Nordling wrote, ‘The new 
variety is part of a wider effort to improve the East African Highland 
banana, a fruit so important to Ugandans that its name, matooke, 
is synonymous with food in one of the local languages’ (Nordling, 
2010). The project partners plan to grow the resistant bananas in 
fi ve countries in the Great Lakes region: Kenya, Uganda, Tanzania, 
Rwanda and Burundi.
Bearing in mind the lessons learned from the Striga project, where 
seed propagation has been a problem, the partners in this project 
are working to ensure that the practitioners on the ground are well 
prepared and skilled for the mass micro-propagation in tissue culture, 
and the dissemination of banana plantlets in the target countries. 
This exercise marked a major step for the project partners towards 
addressing some of the legal roadblocks regarding deployment of GM 
crops in Uganda. In 2010, Uganda’s biosafety law only existed in 
draft, based on a biotechnology and biosafety policy adopted in 2008. 
However, AATF, IITA and NARO worked in partnership to ensure 
compliance to the regulatory requirements and approval by the 
Uganda national biosafety committee. It is hoped that this will in 
time lead to the government passing a Biosafety Act. If not, the words 
of Linda Nordling in her 2010 article in Nature may come back to 
haunt the project: ‘Delays to a law regulating the commercial growing 
of genetically modifi ed food in the country means it is not clear when 
the improved banana could be released to farmers.’ (Nordling, 2010)
Another extremely exciting AATF project involves GM maize 
developed to protect plants against drought. However, this water-
effi cient maize for Africa (WEMA) will be dealt with in Chapter 8.
A major concern of the AATF’s project collaborators, whether they 
are public entities or multinational companies, is liability exposure 
once proprietary technologies have been licensed to the AATF and 
subsequently sublicensed to other parties for use in sub-Saharan 
Africa. A related concern is the possible misuse of the technology 
and associated confi dential information. The AATF has developed a 
proactive product stewardship mechanism to address these concerns. 
It ensures that smallholder farmers and research partners comply 
with all relevant licensing conditions and regulatory requirements. 
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It further protects technology donors from liability through 
indemnifi cation provisions and warranty disclaimers in agreements 
and by conducting a comprehensive risk analysis for each project 
(Boadi and Bokanga, 2007). 
The farmers’ view
One day, I received an email from David Hoisington at the International 
Crops Research Institute for Semi-Arid Tropics (ICRISAT), asking me 
if I would serve on a panel to undertake a review of the institute, which 
is based at Patancheru, near Hyderabad in India. We met in Nairobi, 
where ICRISAT has a regional hub, and visited its research centre on the 
road to Mombasa. There we saw its fi ve main crops—chickpea, pigeon 
pea, sorghum, ground nuts and pearl millet—in breeding trials. We also 
visited a number of farms. On one of them a woman farmer, dressed in 
ragged clothes but carrying a cell phone, showed us the difference in 
yield of the local varieties (landraces) and ICRISAT’s improved lines. 
She told us that she would never plant landraces again. David and I 
couldn’t help smiling at each other—so often in public meetings those 
of us advocating the planting of GM crops are accused by opposition 
activists of forcing local smallholder farmers to stop planting landraces.
Another interesting farming ploy she explained to us was the way 
in which she deals with the problem of birds eating her sorghum and 
pigeon peas, especially during their annual migrations. She intercrops 
them with maize, which grows taller and forms a protective canopy 
during the bird migrations. Afterwards, having harvested the maize, 
her sorghum and pigeon peas are free to mature.
After Nairobi our team split up to visit the various stations 
in Africa, and David and I went to Lilongwe in Malawi. The staff 
took us to meet the local NGO, the National Smallholder Farmers’ 
Association of Malawi (NASFAM), who dealt with both the growing 
and the marketing of farmers’ crops. This was a real eye-opener. The 
NASFAM base we visited was equipped with a large warehouse to 
which farmers brought their groundnuts to be weighed and graded. 
Depending on the grades of the nuts they were either rejected or 
accepted for local, South African or international markets. The grades 
are based, to a large extent, on the presence of afl atoxins, which are 
harmful toxins caused by the infection of certain types of fungi. The 
testing for afl atoxins is done initially at ICRISAT’s labs and later 
in labs in South Africa. One of the reasons for the infection is that, 
after harvesting, the encased nuts are soaked in water to ease the 
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hulling process. Wet nuts, lying under the hot African sun, lead to a 
perfect breeding ground for the afl atoxin-producing Aspergillus fungi. 
We were taken to a village where a woman farmer explained to us her 
farming practices. I asked if she could tell us what she understood 
about afl atoxins, their causes and effects. Her answer would have 
made any of my undergraduate students proud.
Addressing the UN
Another useful opportunity to raise the issue of GM crops in Africa 
came in 2002, when I was asked if I would address the United Nations 
as the guest of the Secretary General, Kofi  Annan. What a question, 
but what to wear? I was in Entebbe, Uganda and in the airport on my 
way home I spotted a rather splendid-looking outfi t outside a souvenir 
shop. I tried it on over my shorts and T-shirt and reckoned that with 
a bit of alteration it would do. Well it did more than ‘do’—when I met 
Kofi  Annan he said, ‘Wow, you are an African!’ 
Kofi  Annan, or SG, as his adoring staff called him, had recently 
instigated a series of lectures for the United Nations ambassadors 
and staff. I was speaking together with a colleague from Chicago, and 
ours was the second in the series. We arrived to have a run-through of 
our presentations in the morning to discover that the auditorium was 
available for only a short time and we would not be able to check our 
talks via the projector, merely load them onto the computer. 
We were ushered into lunch in the SG’s private dining room on the 
top fl oor of the UN with stunning views over the East River and the 
Chrysler Building. The wine steward came round and I at fi rst declined 
but Kofi  Annan quietly told me he thought it would do me good. As the 
lunch drew to a close I began to look nervously at my watch. The SG 
noticed and, patting my hand, said, ‘Don’t worry, nothing will happen 
until I get there.’ That wasn’t quite the point. I was rather concerned 
as the IT set-up in the general assembly chamber was less than ideal 
and there had been no time to see how my presentation, prepared on 
a PC, would appear on an Apple Mac. Wait and see was all I could do. 
However, my fears were for naught and all went well.
It was an open seminar series in which the ambassadors would 
not be sitting behind their country names. One of the fi rst to make 
a comment was the ambassador from Zambia. Earlier that year, 
when people in this country were on the verge of starvation due to 
a prolonged drought, the Zambian government had banned the 
importation and distribution of food aid as it might contain GM 
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maize. President Mwanawasa, in defending this stance, said that this 
maize might be toxic and, in addition, if farmers planted it, instead 
of eating it, this could jeopardise the country’s non-GM status and 
thus its maize exports. (This, in spite of President Thabo Mbeki’s offer 
to have all the maize milled in South Africa, with only maize meal 
being sent to Zambia.) When an opposition member of parliament, 
Vitalis Mooya, challenged this view and reported that three elderly 
women had died of hunger and villagers had resorted to eating toxic 
roots in the Southern Province (Business Day 15 October 2002) he 
was arrested and interrogated for his trouble.
In front of the UN ambassadors, I tried to explain to the Zambians 
that there was no evidence that GM maize was toxic and even if 
farmers were to plant the seeds the maize would inevitably die after 
a few weeks due to African diseases such as maize streak virus to 
which maize from other countries is supremely sensitive. But I am 
afraid my words fell on deaf ears. Indeed, I was later told that when 
a delegation of Zambians visited America to discuss this issue, their 
scientists were not allowed to meet American scientists without the 
presence of politicians. In addition, among the stories the Zambians 
had been told by anti-GM activists in Scandinavia was that if men ate 
GM maize they would become sterile.
Years later, at a meeting in Rome in 2011, I heard the origin of 
this story from Marc van Montagu. Apparently, some scientist had 
fed mice GM maize and claimed to have evidence that some of them 
showed decreased fertility. However, despite the work never having 
been corroborated, it was picked up by the press and a photograph 
was taken showing how the news had been interpreted and spread 
(Figure 4.5).
In 2012 I attended a meeting organised by the African Development 
Bank in Nairobi, where I heard a politician from Zambia saying that 
his government had changed its attitude to GM crops and were now 
keen to allow fi eld trials to test their effi cacy in his country. I doubt 
it had anything to do with my address to the United Nations but it 
would be nice to think it might have played some little part!
L’Oreal/UNESCO award
In 2004 I received the L’Oreal/UNESCO award For Women in Science 
for Africa. This is an annual award which aims to improve the position 
of women in science by recognising outstanding women researchers 
who have contributed to scientifi c progress. Each year the award 
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alternates between life and material sciences, and an international 
jury selects a winner from each of Africa and the Middle East, Asia-
Pacifi c, Europe, Latin America and the Caribbean, as well as North 
America. Pascale Cossart, who had been on the same EMBO course I 
had attended in Basel in 1978, was the fi rst European winner in 1998 
Figure 4.5 Protesters in India: GM foods will make you sterile 
(Source: Greenpeace, India)
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and was on the jury that chose me. Valerie Mizrahi, who had worked 
in my Laboratory for Molecular and Cell Biology in Johannesburg in 
the 1980s, was the African/Middle East winner in 2000. And in 2012 
the winner for this region was Jill Farrant, with whom I share an 
offi ce and a lab at UCT.
I was given the award ‘for work on transgenic plants resistant 
to drought and to viral infections, in an effort to respond to the 
continent’s chronic food shortage’. This was a tremendous honour 
and I was impressed that the judges would vote for someone 
working on GM crops, knowing the antagonism towards this field 
in France, where both L’Oreal and UNESCO are based. Indeed 
years later I learned that the jury had indeed considered the 
potential negative fall-out such an award might have.
In the run-up to the awards, L’Oreal sends a team of video and 
stills photographers to prepare promotional material on each of 
the winners. Mine arrived just before Christmas in 2003 when, 
unfortunately for South African farmers, the country was in the grip 
of a crippling drought and maize seedlings on the country’s farms were 
taking a severe beating (Figure 4.6). However, this was fortunate for 
the team, as one of the projects for which I received the award was 
the development of maize tolerant to drought (see Chapter 8).
Figure 4.6 With Andries Botha on his maize farm in Viljoenskroon, Free State
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The ICGEB project
The fi rst PhD student to work on the drought-tolerance project was 
Dahlia Garwe. She had been a member of the MSc Biotechnology 
class at the University of Zimbabwe I examined in 1992 (see Chapter 
3) and the third of four PhD students I supervised from that country. 
She, alone among them, had returned to Zimbabwe, where she had 
resumed her position at the Tobacco Research Board (she is currently 
their acting managing director). In 2007 the International Centre 
for Genetic Engineering and Biotechnology (ICGEB) put out a call 
for research projects on drought tolerance for developing countries. 
There are 60 ICGEB member states, of which South Africa is one, and 
this call required scientists from these countries to submit proposals 
together with one or more developing countries. I submitted one 
together with Dahlia and a colleague from Kenya and we were among 
the successful candidates asked to submit a more detailed proposal. It 
would require the work to be done at three institutions in Zimbabwe, 
Kenya and South Africa
Before embarking on this phase of the project I thought it would be 
prudent to visit Dahlia’s institution in Zimbabwe and make sure they 
were able to deliver, because Zimbabwean fi nance was in rather a 
parlous position. When I arrived in Harare, I discovered that Dahlia’s 
family hadn’t had bread for three days and there was no water in the 
municipal supply to the area of Kutsaga, where the Tobacco Research 
Board is. Many of the shops were empty and I heard Dahlia on the 
phone to a family member arranging an exchange of cooking oil for 
other items. When I asked what she put into her children’s lunch 
boxes, she said even if they did have bread there was only a bit of jam 
to put on sandwiches. But the hotel I stayed at was like any 4-star 
hotel in Europe or elsewhere, with the breakfast buffet overfl owing 
with bacon and eggs (Dahlia hadn’t seen any of these in months).
Even so, in the Tobacco Research Board laboratory work was on 
the go. Students and technicians were at their benches, the autoclaves 
were being used, despite the fact that water had to be carried in by 
hand from Kutsaga’s local supply, the fridges and deep freezes were 
well stocked with reagents and the tissue culture facility was busy. 
It became clear, however, that although it was called the Tobacco 
Research Board, not much tobacco was coming in as so little was 
being produced, with so many farms no longer functioning. 
I left Zimbabwe feeling reasonably optimistic that we could 
deliver if we received the ICGEB grant. In due course, our project 
was approved and we set to work. The fi rst item on the agenda was 
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recruiting a PhD student from each institution to begin work at UCT. 
My Kenyan colleague found a suitable one working at KARI, the 
Kenya Agricultural Research Institute, but Dahlia had problems as 
her chosen student decided to leave Zimbabwe for more promising 
pastures. She did manage to identify an MSc student and fortunately 
the ICGEB accepted this compromise. However, problems raised 
their heads soon after the two students arrived.
Their hands-on and academic backgrounds were not up to the 
required standards, putting a heavy burden on the other members 
of my lab, who had to spend long hours showing them the various 
techniques. The new students also appeared to have unrealistic 
expectations of what the ICGEB grant meant for their own personal 
fi nances and I soon found that I was dipping into my other open research 
funds to bail out the project. After about nine months I reluctantly 
informed the ICGEB that I wished to terminate the project. The relief 
shown by members of my lab and our administration offi ce who were 
handling, among other things, the fi nances of the project, made me 
realise what a burden I had placed on them. The moral of this sad 
story is: always choose your own postgraduate students. My African 
colleagues were both very understanding as they, too, had not had 
fi rst-hand experience of the students and had just hoped they would 
work out alright when the students were immersed in my lab. This 
is in stark contrast to my excellent experience of supervising PhD 
students under the USHEPiA programme. There, great emphasis 
is placed on meetings between students and supervisors in both 
participating countries well before any research takes place.
The InterAcademy Council
Another organisation I became involved with was the InterAcademy 
Council (IAC), an arm of the InterAcademy Panel that represents all 
the world’s scientifi c academies, such as the Royal Society of London, 
the National Academy of Sciences in the US, the Indian National 
Science Academy, Science Council of Japan, and so on, and includes 
the Academy of Science of South Africa, of which I had been one of 
the founding vice-presidents. The IAC had been asked by Kofi  Annan 
to undertake a study titled ‘Food for Africa: harnessing science and 
technology to increase agricultural productivity in Africa’. We were 
chaired by Speciosa Kazibwe, Vice-President of Uganda and a former 
minister of agriculture, and MS Swaminathan, a former secretary of 
agriculture in India and a winner of the prestigious World Food Prize. 
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One of our recommendations was to bridge the agricultural 
genetic divide between African countries and those in the developed 
world. This would need substantial investment to respond to the 
specifi c needs of African farmers if they are to derive benefi t from 
both conventional breeding and biotechnology. Technology needs 
to be fi ne-tuned to African needs, one of which is the dominance of 
weathered soils and their concomitant poor fertility. We noted the 
long gestation period biotechnology requires before its impact can be 
realised and urged for investment sooner rather than later. 
In 2010 I was asked by the Canadian International Development 
Research Centre (IDRC) and the Canadian International Development 
Agency (CIDA) if I would serve on a committee of assessors to judge 
applications for projects on food security. This was a new programme 
aimed at linking Canadian research institutions with those in 
developing countries and was being jointly managed by the CIOA and 
the IDRC. The fi rst call resulted in more than 300 applications, far 
more than they had expected. Of the fi nally approved 13 projects, 
with an average value of CA$ 2.5 million and expected to produce 
results by the time the projects end in 2015 , some included the use 
of biotechnology in improving vegetables and pulse crops in Nigeria 
and Ethiopia.
One of the most exciting outcomes of all the experiences I have 
had resulting from my exposure to the international biotechnology 
community is how they all come back to the importance of this 
technology for Africa. However, all the technology in the world will 
not help hungry Africans feed themselves unless the authorities in 
each country are willing to accept that, as with all new technologies, 
there are risks that must be balanced with the potential benefi ts. Of 
course, and this is something which is often forgotten, it is equally 
important for those authorities to weigh the costs to their people of 
not accepting a new technology that could help to solve the problems 
of food insecurity, especially in times of climate change. The next two 
chapters will deal with these conundrums.
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A South African National Biotechnology Strategy
In the early days of South Africa’s new democracy, a foresight board 
was established to look into the directions the country should be 
taking in technology research and development. During that exercise 
the chair, Rob Adam, said that the most startling innovations would 
occur at the confluences of three profound scientific currents: quantum 
mechanics, information technology and biotechnology. If we wanted 
to be a competitive country and, indeed, a competitive continent, 
we needed to ride these waves and to know as best we could where 
they would take us (A National Biotechnology Strategy for South 
Africa, 2001). The foresight study indicated that developments in 
information technology and biotechnology would be the cornerstone 
of the knowledge-based economy. 
In due course, the then Department of Arts, Culture, Science 
and Technology (now the Department of Science and Technology) set 
up an expert panel of 10 which assembled in May 2001 and, over 
a period of two weeks, drafted a National Biotechnology Strategy. 
During that intense period, when most of us lived together, eating, 
sleeping and drinking biotechnology, we interviewed 30 people 
including representatives from industry, finance, government and 
even the anti-GMO lobby. Prof Iqbal Parker of the Health Faculty at 
UCT was the chair. Other members included Prof Frikkie Botha, an 
agricultural biotechnologist; Dr Winston Hide, an IT specialist; Dr 
Mohammed Jeenah, an agricultural scientist; Dr Nozibusiso Madolo 
from the National Department of Health; Prof Mbudzeni Sibara, a 
microbiologist; Dr David Walwyn, a technology manager from the 
CSIR (our scribe); Prof Brenda Wingfield, a forestry pathologist; Dr 
John Mugabe, a technology expert; and myself. As our group was 
almost entirely drawn from the academic sector, we took great care to 
interview as many people from the private sector as we could.
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Our report, which was published in June of that year, made three 
major recommendations:
(1) Biotechnology regional innovation centres (BRICs) should 
be established.
(2) A National Biotechnology Advisory Committee should be 
established.
(3) The government should articulate a single policy position 
on biotechnology. 
It seemed to take ages but, at last, the Biotechnology Strategy was 
approved by cabinet. A few weeks later I was at the celebrations in 
parliament for President Thabo Mbeki’s  60th birthday and, when I 
was introduced to him by Thoko Didiza, the Minister of Agriculture, I 
rather impolitely said ‘Mr President, it’s all very well for the Cabinet 
to pass the Biotechnology Strategy, but where’s the money?’ With his 
usual aplomb he assured me that biotechnology was very important 
for South Africa’s economy and it would be funded. I doubt whether 
my intervention played any part in subsequent events, but in due 
course four biotechnology regional innovation centres (BRICs) were 
indeed established.
The Biotechnology Strategy had recommended that the centres 
be regional. And indeed, three of them were, concentrating largely on 
biotechnology issues that were strong in their geographical regions, 
such as mining and veterinary science in Gauteng. However, when 
PlantBio was established it became clear that these activities were in 
no way concentrated on any particular region, but were countrywide. 
Hence the acronym, BRIC, became BIC. The National Bioinformatics 
Network also became a component of the BICs. 
The biotechnology innovation centres
The first BIC was LIFELab, and it was decided to base it in 
Umbogintwini, KwaZulu-Natal, just south of Durban, because this 
was in close proximity to the SA Bioproducts facility. This facility 
was started in 1993 as a joint venture between African Explosives 
and Chemical Industries (AECI) and the Industrial Development 
Corporation (IDC) in order to produce the amino acid lysine. They 
chose Umbogintwini because they already had an established 
manufacturing infrastructure there. It had ready access to its 
source of raw material—sugarcane—and was close to Africa’s 
largest harbour. AECI had diversified in the 1980s into amino acid 
production and they opened the lysine plant in the 1990s. During 
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1998/9 the company underwent restructuring and SABioproducts 
was established as a management buyout of the lysine production 
facility. Later, this company diversified into other amino acids and 
were thus the perfect partner for LIFELab. Apart from their liquid 
fermentation activities for the cultivation of animal, bacterial and 
plant cells, LIFELab concentrated on infectious diseases such as 
HIV/Aids, TB and malaria, as well as bioprocessing.
A second BIC was BioPAD, based in Gauteng, which began with 
a very broad portfolio of projects covering mining, environment, 
industry and animal health, but they soon narrowed it down to health 
biotechnology. Their focus was on diagnostics, drug discovery and 
development, vaccines and bioprocess technologies.
Cape Biotech Trust also concentrated on healthcare products, 
but in addition funded a start-up company, Cape Carotene, which 
produces astaxanthin, the pigment that makes salmon and flamingos 
pink. It uses algal technology developed by members of the UCT 
Department of Chemical Engineering.
The fourth BIC was PlantBio, based in Pietermaritzburg 
in KwaZulu-Natal, focused, as the name implies, on plant 
biotechnology. At its launch, Minister Mosibudi Mangena of the 
Department of Science and Technology was due to officiate. The 
PlantBio CEO, Sagadevan Mundree (the same Saga who played an 
important role in my lab’s development of drought-tolerant maize; 
see Chapter 8) introduced me to him very early in the informal part 
of the proceedings. When I told the minister that I was a member 
of his National Advisory Council for Innovation his response was 
that I was obviously not doing my job as I hadn’t advised him on 
biotechnology! I proceeded to correct that omission and during 
our discussion I mentioned that if South Africa was serious about 
developing an agricultural biotechnology business sector it would 
have to do something about the shortage of skills in the areas of 
plant physiology and plant breeding. To my surprise, he touched on 
this during his speech. Unfortunately, however, these shortcomings 
still exist in the scientific landscape of South Africa.
The study of plant physiology is becoming rarer and rarer at 
South African universities. My research group is extremely unusual 
in having (and very fortunate to have) Jill Farrant, one of South 
Africa’s leading plant physiologists and, as mentioned in the previous 
chapter, the winner of the 2012 L’Oreal/UNESCO Women in Science 
for Africa, as a member of our team. But she is in the Department 
of Molecular and Cell Biology and not in the Department of Botany. 
Unlike plant molecular biology, plant physiology is not seen as ‘sexy’ 
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by university students. Students of plant breeding are also becoming 
rare commodities. This is perhaps understandable as the nature 
of plants is to grow rather slowly, and to complete a three-year (or, 
more usually, four-plus year) PhD on this topic is not easy. Most plant 
breeders work in the private sector and it is therefore also difficult for 
potential PhD students to find academic supervisors.
During its short life, PlantBio helped to fund a cyclotron at the 
University of KwaZulu-Natal to generate useful variants of maize, 
millet and sorghum. It invested in an in vitro plant propagation 
platform, a study to assess the commercial viability of planting 
cassava in northern KZN to supply industrial starch to the South 
African paper-making industry, as well as projects to improve wine 
grape varieties and to protect cassava from Cassava Mosaic Disease. 
The National Biotechnology Advisory Committee
The second recommendation made in the 2001 Biotechnology 
Strategy was the establishment of a National Biotechnology Advisory 
Committee (NBAC). It took rather a long time for this advice to be 
acted upon, firstly because the money for its implementation was 
made available only in 2003, and secondly because the Department 
of Science and Technology wanted all the BICs to get up and running 
without too many ‘bosses’, or committees, pulling them in different 
directions. The BICs were to become established with their own 
boards in place and comfortable with their governance, before the 
NBAC was created. The fear was that the BIC boards might defer 
decisions to the NBAC, which was not its purpose as it was meant to 
provide national strategic direction on biotechnology as a whole.
In November 2006, the NBAC was established as a sub-committee 
of the National Advisory Committee on Innovation (NACI). I was its 
first chair. Its mandate was to advise the Minister of Science and 
Technology on an appropriate course and suitable interventions 
for the development of biotechnology. Of the 10 original committee 
members, seven were still in office in 2012, which I think says a 
great deal about the commitment and enthusiasm of this group for 
their task.
Over the years we have given advice first to Minister Mangena, 
then to Minister Pandor and most recently, to Minister Derek 
Hanekom. I had the advantage of knowing Naledi Pandor when she 
was on the academic staff at the University of Cape Town, and also 
of having taught her daughter, Aisha. Towards the middle of Aisha’s 
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final year of BSc, her mother, then Minister of Education, came out 
with a statement to the effect that if undergraduates were failing 
they must be failed, not put through artificially. This would not 
be fair to the institutions, the students or their parents and could 
potentially lead to a drop in standards. At that time I was about to 
fail Aisha in her mid-year exams! I called her into my office, read 
her the riot act (after all her great-grandfather was the renowned 
academic ZK Matthews), and at the end of that year she passed with 
70+ per cent. She actually wrote me a letter thanking me for giving 
her a wake-up call and she has now completed her PhD in human 
genetics. In 2010, at a meeting of Women in Science and Technology 
where Naledi Pandor was the keynote speaker, she told us that Aisha 
had asked her to babysit her child on a Sunday afternoon to allow her 
to go to the lab, as ‘experiments don’t respect weekends’. ‘I have new 
respect for women,’ she said, ‘especially those with particularly small 
children, who persevere to complete their higher degrees, especially 
in experimental sciences.’
The NBAC has given the ministers advice on topics including 
funding for biotechnology, the regulation of stem cells, understanding 
the impact of public perceptions of biotechnology, and the development 
and retention of human capital for biotechnology. We have pointed 
out problems that were being encountered with decisions made by 
the executive council of the GMO Act (the most recent of these was 
mentioned in Chapter 2), and problems with issues of labelling of 
GMOs in the Consumer Protection Act of 2011. Some of these have 
been acted on, but many require consultation with other government 
departments, so only time will tell how successful these have been.
At its inception the members of the NBAC were mainly academics, 
but as our work progressed we were able to include more members 
from the private sector. This has proven invaluable as these are 
the people who will make a difference in bringing good ideas to the 
market place.
A calamitous development
The third recommendation from the 2001 Biotechnology Strategy 
was that government should articulate a single policy position on 
biotechnology. This has been a theme in many of our advice letters 
and is an issue because biotechnology is a cross-cutting discipline and 
needs close cooperation from many government departments. One 
of the problems with implementing the GMO Act is that the various 
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departments involved—Science and Technology, Agriculture, Water 
Affairs and Forestry, Health, Trade and Industry, Environment and 
Tourism, and Labour—simply do not have a single policy position on 
biotechnology. Ignorance is sometimes the reason for this but when 
AfricaBio, the local version of the International Service for Acquisition 
of Agribiotech Applications (see Chapter 2), tried to run a training 
course for this very purpose, hardly any representatives came. 
Government had been aware of the need for coherent action 
in the area of innovation. Indeed, in the National Research and 
Development Strategy of August 2002, they discussed the need for the 
establishment of a core agency to stimulate and intensify technological 
innovation. This eventually took shape, and on 24 November 2008 the 
Technical Innovation Agency (TIA) Act was passed by the President. 
The objective of the agency ‘is to support the state in stimulating and 
intensifying technological innovation in order to improve economic 
growth and the quality of life of all South Africans by developing and 
exploiting technological innovations’.
By rights this should have been a great step forward for the 
biotechnological community, as the Department of Science and 
Technology’s 10-year innovation plan (for 2008–2018) stated that 
‘over the next decade South Africa must become a world leader in 
biotechnology and the pharmaceuticals’. But has this been the case? 
The department was not unhappy with the functioning of the BICs, 
although there was obviously room for improvement. They wanted a 
more national approach and a more standardised modus operandi. They 
had deliberately allowed the BICs to pursue independent approaches 
with the intention that these would be reviewed over time and lessons 
learned to aid greater standardisation. However, with the advent of 
the TIA, the BICs were to be dissolved and incorporated within the 
new structure. The idea had been that their experience, systems and 
expertise would help to develop and strengthen biotechnology within 
the new organisation. That was the idea, but in practice the disruption 
to the biotechnology community has been little short of disastrous.
As early on as 2008, the NBAC had begun to feel very 
uncomfortable about the form the TIA was taking and the functions 
it was appropriating. Hence an advice letter was presented to the 
minister at a meeting on 15 January 2009. It stated as follows:
(1) It is recommended that under the TIA the skills (expertise) 
in, focus on, and funding of biotechnology, currently 
represented by the BICs, must be maintained.
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(2) It is recommended that the budget allocated to 
biotechnology within the new TIA structure be increased 
significantly.
(3) It is recommended that funding security is guaranteed 
over the medium term (at least 10 years duration) for 
biotechnology.
(4) It is recommended that a formal and functional link be 
established between NBAC and the TIA board.
The notes on the meeting read as follows:
Minister Mangena responded that the advice was timely since TIA 
was in the process of being established. He mentioned that concerns 
similar to that of NBAC had been raised by all other entities due to be 
incorporated into TIA. The new TIA Board would be representative of all 
the entities entering TIA. Advice on the most optimal structure for TIA 
would be useful. The Minister assured the meeting that biotechnology is 
regarded as a very important fi eld and that the Department of Science 
and Technology would make sure that the focus on biotechnology would 
not be lost because of TIA, since the reason behind the establishment of 
TIA was to move forward in this and other fi elds of innovation.
The TIA board was established in July 2009 under the chair of 
Dr Mamphela Ramphele, former Vice-Chancellor of UCT and 
Deputy President of the World Bank. In September 2010 the NBAC 
held a national workshop entitled ‘Feeding the biotechnology 
pipeline’. Participants included researchers, academics, workers in 
international property, and representatives from industry. The aim 
of the workshop was to highlight gaps in the pipeline from the initial 
idea to its commercialisation in the open market. Although many 
gaps were discussed, the major problem identified by almost all 
participants was the TIA, with one of the issues being the sudden 
demise of the BICs. Some scientists more closely involved with these 
four organisations might have been aware that they were to be merged 
into the new structure, but even they were amazed when the BICs 
were summarily closed. Indeed, members of my lab had submitted 
a grant proposal to PlantBio early in 2010, only to receive a short 
letter towards the end of March to say that they would no longer be 
in existence after the end of the month and to please refer all queries 
to the TIA. No contact details were given and no letters or emails to 
the TIA were replied to, nor were phone calls returned. 
The knock-on effects of this to the biotechnology community were 
expressed extremely strongly at the workshop: scientists were being 
retrenched and projects shut down. Moreover the emphasis was only 
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on short-term, low-risk return on investment, whereas in a study 
on the time it takes and the costs involved in getting a good idea 
to the market when the product involves a GM crop, these factors 
were estimated as 13 years and US$ 136 million (see Chapter 4). 
One participant at the NBAC workshop went so far as to say that 
the biotechnology community in South Africa was haemorrhaging 
scientists. 
On the same subject the Vice-Rector (Research) of the University 
of Stellenbosch, Prof Arnold van Zyl, wrote a commentary on the 
role of the TIA in the South African Journal of Science (Van Zyl, 
2011). He noted that the agency, whose object it is to ‘support the 
state in stimulating and intensifying technological innovation’ had 
not apparently done so. ‘On the contrary, quite a number of funding 
initiatives incorporated into the TIA have been abruptly ended, 
leaving research institutions responsible for personnel and running 
costs, and in some cases even resulting in the loss of highly skilled 
personnel.’
Shortly after the workshop, NBAC asked to meet with the CEO of 
the TIA, Simphiwe Duma, to discuss these problems, but to no avail. 
Continued requests were met with silence until eventually we were 
told that he would meet with us on 15 July 2011. I arrived in good 
time from Cape Town, only to be told half an hour before the meeting 
that he was unable to attend. I expressed my extreme displeasure and 
finally, after the other NBAC members had gathered, two members 
of the TIA arrived. The meeting was not particularly helpful as they 
were reluctant to concede that there were any problems. They did, 
however, acknowledge that ‘the process of migrating the BICS to 
TIA took longer than was anticipated and might have inconvenienced 
some stakeholders within the system’ (my italics).
In September 2011, the Agricultural Biotechnology International 
Conference was held in Johannesburg with the title ‘Moving 
towards a bioeconomy—agricultural biotechnology for economic 
development’. I was chair of the scientific organising committee, 
and was extremely relieved when we secured a senior official in the 
TIA, Dr Bongi Gumede, to give a presentation on his organisation’s 
involvement in biotechnology. When I greeted him just before his 
session, to my horror he told me me that instead of him, Caiphus 
Ramoroka, who had been in office for precisely six days, would 
present the talk. The reason Dr Gumede gave was that in future the 
agricultural community would be dealing with Mr Ramoroka. When I 
remonstrated with him, saying we wanted to hear from someone well 
versed in the recent turbulent relationship between the TIA, NBAC 
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and the biotechnology community in general, I was simply told that 
this would not occur. As I anticipated, we were given an extremely 
general overview of the mandate of the TIA with no reference at 
all to the problems being encountered by biotechnologists in South 
Africa. In March 2013 the new Minister of Science and Technology, 
Derek Hanekom, instituted a panel to review TIA. The Bioeconomy 
Strategy Group of NACI was invited to give an oral presentation on 
Friday 8 March, but our meeting was cancelled by the panel. We still 
hope that our voices will be heard.
One of the most successful spin-offs of PlantBio, which has fortunately 
survived within the TIA (although for how long is at present unknown), 
is Biosafety South Africa. Under the able direction of Dr Hennie 
Groenewald it is involved in helping to ensure that regulators and 
technology developers have the necessary information and know-how on 
compliance matters. In 2011 he attended the annual general meeting of 
an organisation called SACAU—the Southern African Confederation of 
Agriculture Unions. He said it was one of the most stimulating meetings 
he had attended in a long time as he was interacting with people who 
really knew, from their own farming experience, what they were talking 
about. After the meeting, SACAU adopted a GMO policy framework 
based on their acknowledgement that ‘GM technology is one of the 
options that can increase production, improve productivity and incomes 
of farmers, and contribute to addressing food security challenges in the 
region’. They recognised the following points: 
 ● The need for evidence-based decision making
 ● The importance of directly involving farmers in R&D and 
related standards
 ● The right of consumers to choose
 ● Cost/benefit analyses should also look at the costs associated 
with non-adoption of GMOs
 ● The need to monitor trade in the region 
 ● The importance of political will and harmonisation of policies 
in the region (SACAU, 2013)
It is the collective voices of farmers’ organisations such as SACAU 
that will be imperative if GM crops are ever to be able to help bring 
about food security in Africa. 
The Bioeconomy Strategy
Early in 2013 the Department of Science and Technology (DST) 
approved a new Bioeconomy Strategy to replace the old 2001 
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Biotechnology Strategy. ‘Bioeconomy’ refers to ‘activities that make 
use of bio-innovations, based on biological sources, materials and 
processes, to generate sustainable economic, social and environmental 
development’.
Under this umbrella the entire innovation system or network, 
from the initial ideas, research and development through to 
production, manufacturing and commercialisation, are coordinated. 
The main problem seen with the original strategy was that it focused 
on harvesting opportunities that represented a quick return on 
investment. It supported commercialisation of technologies close to 
the market. The present strategy is formulated to develop the entire 
value chain for biotechnology-based products.
The DST correctly sees itself as the key driver in this initiative and 
undertakes to coordinate the stakeholders and role players. As one of 
the most serious flaws in the implementation of the GMO Act has been 
the lack of coordination between the various government departments 
involved, it is hoped that this time around these problems will be 
overcome. The document also states, under the section on agriculture, 
that genetic engineering remains a critical technology and presents a 
significant competitive opportunity for sector development. As it often 
appears in the administration of the GMO Act that some government 
departments do not share this opinion, it will be interesting to see 
whether the DST is able to convince them otherwise.
The document compares South Africa’s performance in the 
bioeconomy with countries including Australia, Brazil, Cuba, 
India, Malaysia and Singapore. From this it is clear that we need 
to increase significantly our gross expenditure on relevant research 
and development. It is important, however, that such funding should 
capitalise on our opportunities and strengths such as the fact that we 
are the third most biologically diverse country in the world. 
At the end of the document, under ‘The way forward’, it states: 
The Department of Science and Technology, as the lead agent of this 
strategy, will continue to engage with line departments to promote 
cooperation, facilitate the strategy’s broad implementation, and 
ensure synergy, alignment and better coordination of activities. 
The Department of Science and Technology will drive a consultative 
process to defi ne the roles and responsibilities of various government 
departments, agencies and instruments in implementing the strategy 
(The Department of Science and Technology Bioeconomy Strategy 
[version 9], 11 February 2013).
All strength to their collective aim. 
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Chapter 6
African National Biotechnology Strategies
In 2001 the United Nations Environment Programme (UNEP) and 
the Global Environment Facility (GEF) set up a Global Project for 
the Development of National Biosafety Frameworks. One of their 
aims was to help more than 100 countries worldwide to set up 
frameworks that would enable them to undertake work using GM 
crops. When this project ended in 2006, 23 African countries had 
completed their frameworks. To date about 40 have been finalised. 
As Robert Paarlberg explains (Paarlberg, 2012), most of these 
countries embraced the strongest possible approach, the ‘Level 
One’ approach, following European governments, which requires 
new legislation. Most countries cited the lack of a suitable existing 
law that could serve as a ‘home’ for using this approach. Fewer 
followed the approach taken by the US, which uses existing laws to 
regulate GMOs, the so-called ‘Level Three’ approach. In the three 
other key requirements for the use of GM crops, African countries 
have also followed Europe rather than America. The other three 
requirements are:
(1) the creation of new institutions such as national biosafety 
committees to oversee GM crop management
(2) the use of the ‘precautionary approach’, which allows 
regulators to decline to approve a new technology on the 
grounds of ‘uncertainty’, without any evidence of risk
(3) the requirement for labelling products derived from GMOs 
in the marketplace.
In many ways, Europe’s attitude to GM crops is not based on risks, but 
rather on the absence of any new benefits. The first generation of these 
crops—insect- and herbicide-resistant maize, cotton and soya bean—
benefited farmers, rather than consumers. Moreover, Europe does not 
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have many maize, cotton and soya bean farmers, so the technology 
had few champions. But this is not the case in Africa, where farmers 
are often consumers and maize, in particular, is often the staple diet. 
So why does Africa follow Europe rather than America?
Foreign aid is the greatest external influence in Africa, and Europe 
gives three times more aid than the US. European governments also 
give roughly three times as much as America does to the Global 
Environment Facility, and the international NGOs active against 
GMOs are mainly based in Europe. A fourth channel of external 
influence is cultural. Most policy-making elites in Africa have much 
closer cultural ties to Europe than to the US, and are thus more likely 
to follow the European anti-GMO stand. Finally there is the question 
of international trade. Africa’s farming community’s exports to 
Europe are six times greater than those to the US, and so European 
consumers call the shots. In fact, South African exports have not been 
affected by its plantings of GM crops, but these anxieties influence 
the thinking in many African countries (Paarlberg, 2012).
I personally saw the effect of international NGOs at the 2002 
World Summit on Sustainable Development in Johannesburg when 
European groups instigated a ‘farmers’ march (with little evidence 
of farmers in the foreground) saying ‘NO to GM foods’. In addition, 
Friends of the Earth encouraged their African partners to sign an 
open letter warning that GMOs might cause allergies, chronic toxic 
effects and cancers (Paarlberg, 2012).
In a hard-hitting article, Giddings et al. (2012) argue that the 
Gordian knot binding European plant science through continuing 
policy failure and political timidity will remain uncut unless bold 
action is taken. They quote Jared Diamond, who wrote in Guns, 
Germs and Steel (1998:257):
Any society goes through social movements or fads, in which 
economically useless things become valued or useful things devalued 
temporarily. Nowadays, when almost all societies on Earth are 
connected to each other, we cannot imagine a fad’s going so far that 
an important technology would actually be discarded. A society that 
temporarily turned against a powerful technology would continue to see 
it being used by neighbouring societies and would have the opportunity 
to re-aquire it by diffusion (or would be conquered by neighbors if it 
failed to do so).
Giddings et al. (2012) go on to say that the world has seldom seen a 
greater discrepancy between the inherent hazard of a product and 
the level of regulatory burden imposed on it than exists today for 
crops improved by biotechnology. ‘It is important, here, to be very 
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clear: there is no basis in science (my emphasis) for regulation specific 
to crops and foods improved through biotech or GMOs.’ Indeed, by 
any honest reckoning, ‘the level of scrutiny to which crops improved 
through biotech are subjected is completely unwarranted by the body 
of knowledge acquired over three decades of experience with such 
crops, including 15 years in commercial production’.
They state further, quoting from Brookes and Barfoot (2011), 
that since 1996, farm incomes have increased by US$ 64.7 billion, 
and in 2009, 53.1 per cent of the farm income benefits have been 
earned by developing country farmers. Moreover, between 1996 
and 2009, the cumulative farm income gain derived by developing 
country farmers was 49.2 per cent, equating to US$ 31.85 billion. In 
terms of environmental impact, since 1996 the use of pesticides on 
biotech crops was reduced by 8.7 per cent, and the environmental 
impact associated with herbicide and insecticide use on these crops, 
as measured by the EIQ (environmental impact quotient) indicator, 
has fallen by 17.1 per cent.
Despite this, Europe is still caught in its Gordian knot: ‘Nowhere 
is the chasm between regulatory regimes and the implications of facts 
and experience greater than in Europe.’ But this is the model which 
African countries are following.
Paarlberg identifies three critical factors that must be in place for 
a GM crop to be approved:
(1) There must be a functional national biosafety committee, 
legally constituted in a separate act of parliament, 
according to the ‘Level One’ approach mentioned above.
(2) The GM crop must have demonstrated strong agronomic 
performance, outweighing anything currently available 
using conventional technologies.
(3) There must be strong in-country political support, 
sufficient to overcome the organised opposition.
The development of national biosafety strategies has taken African 
countries many years. Charles Gbedemah was running the UNEP/
GEF programme from his office in the United Nations compound in 
Nairobi between 2001 and 2007, and mid-way during this exercise 
I visited him. I discovered that 132 countries were involved for a 
variety of reasons that included both national development priorities 
and international obligations—for instance, to the Cartagena 
Protocol on Biodiversity. For some countries, however, the primary 
reason for joining the project was to have access to funds from UNEP/
GEF for capacity-building activities. I cynically wondered if these 
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capacity-building activities did not include funding for personal 
travels to and from Nairobi and other international centres for 
‘training purposes’, leading to a lack of urgency to terminate the 
process.
The following six African countries have used slightly different 
approaches to arrive at a National Biosafety Strategy.
Kenya
The first GM crop to be considered for adoption was Bt maize. 
Kenya’s national agricultural research institute (KARI) started 
confined field trials in 1999, but the crop didn’t get any further. In 
this case all three of the above conditions were missing. There was 
no legislation, the crop controlled only the stalk borer pests in part 
of the country and, partly as a result, there were few champions 
(Paarlberg, 2012). 
In 2009 the Biosafety Act (Act No. 2 of 2009) was passed. Margaret 
Karembu and colleagues at the ISAAA AfriCenter in Nairobi have 
written an instructive account of the lessons learned from this 
experience (Karembu et al., 2010). It underlines the importance of 
Paarlberg’s point number 3: strong in-country political support. 
Although the first draft of the bill was ready by the end of 2002 it was 
stopped due to a general election. The new government had lost many 
of the MPs who had been sensitised to the importance of biotechnology, 
so the pro-biotech stakeholders had to acquaint themselves with the 
new MPs in order to cultivate champions among them. The year 
2004 was marked by the clamour for a new constitution, and MPs 
had different issues on their agendas. A silver lining was the creation 
of a Ministry of Science and Technology and the appointment of Dr 
Noah Wekesa, a scientist, to head it. The bill was finally published in 
the Kenya Gazette in 2007, but then widespread violence followed the 
presidential election. 
I experienced some of the effects of this violence, albeit second-
hand. I was about to start a new PhD student from Kenya in January 
2008 and needed documents from her home institution. She managed 
to get a message through to me from her rural home village saying 
it was not safe for her to travel to Nairobi, and asking whether she 
could delay her arrival. That went without saying, but when she 
started at UCT some months later it was clear that the experiences 
had been traumatic.
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After the violence subsided, the biotechnology stakeholders formed 
themselves into the Biosafety Consortium and two new ministers 
came to their aid: Dr Sally Kosgei, from Higher Education, Science 
and Technology, and William Ruto in Agriculture. There was a flurry 
of awareness-creation activities targeting MPs and, in due course, the 
bill was passed and signed by President Kibaki on 12 February 2009, 
ending a journey of almost 10 years.
However, before the Act could be implemented, in order to allow 
the commercialisation of GM crops regulations had to be passed. 
This was delayed by the fact that, in November 2010, William Ruto 
was identified by the International Court in the Hague as among six 
Kenyans to be investigated for crimes against humanity emanating 
from the post-election violence in early 2008. (Ruto was elected Vice-
President of Kenya on 9 March 2013 together with President Uhuru 
Kenyatta, a co-accused at The Hague.) However, the regulations were 
passed by Sally Kosgei in July 2010. Kenya is therefore poised to 
become the fourth country in Africa, after South Africa, Egypt and 
Burkina Faso, to commercialise GM crops. However, at the point of 
going to press, this had yet to happen. 
Uganda
Uganda has had a GMO Act in front of parliament since 2005 but 
it has never been passed. There are a number of reasons for this. 
Firstly, although it cannot commercialise GM crops, it can approve 
glasshouse and field trials. This is done by the Ugandan National 
Council for Science and Technology and they have already approved 
trials for banana, cotton, maize and sweet potato. Uganda has 
therefore put itself into a contented ‘research forever’ situation 
whereby it keeps the grant money coming in, its scientists content 
and the opposition happy.
Who is the opposition? Organic farmers are a strong lobbying 
force in the country. According to Robert Paarlberg (personal 
communication), the National Organic Movement of Uganda claims 
to have 250 different member and partner organisations. Uganda is 
indeed an attractive country for promoters of organic farming because 
most farmers are too poor to use any synthetic fertilisers, making 
them de facto organic and hence easy to certify. This movement is not 
only against GM crops on principle (although I have often wondered 
how a quintessentially organic molecule such as DNA can be classified 
as ‘non-organic’), but also out of commercial fears that European 
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importers would doubt the organic status of products planted in a 
country which allows GM crops to be planted.
Another reason for the Act sitting dormant is the lack of a 
support group pushing for its passage through parliament. Unlike 
neighbouring Kenya, where farmers joined together to form an 
effective lobbying group to encourage the government to pass the 
Biosafety Act, in Uganda very few farmers plant hybrid crops such as 
maize. As GM crops are all hybrids, what is the urgency to use these? 
On the contrary, the Ugandan climate and environment is such that 
in recent years it has been a maize-exporting country, mainly to other 
African countries. In fact, until 1992 there was no national farmers’ 
organisation, and certainly not one to push for the adoption of GM 
crops such as maize.
Finally, by some strange institutional quirk, the ministry 
responsible for the bill is not the Ministry of Agriculture, or of Science 
and Technology, but of Finance, Planning and Economic Development. 
This ministry is an extremely important one and the GMO Act is not 
high on its agenda (Paarlberg, personal communication).
It therefore appears that none of the three requirements 
outlined above, which are critical to ensure some level of urgency 
for the commercialisation of GM crops, is in place. It may transpire, 
therefore, that the GMO Act will continue to sit dormant in the 
Ugandan parliament for the foreseeable future. That might change, 
however, if a new GM crop which has singular benefits for farmers 
appears on the horizon—and that might well be in the form of pest-
resistant bananas, as discussed in Chapter 4, and the bacterial 
wilt-resistant bananas managed by the AATF, as I will outline in 
Chapter 9. 
Tanzania
Tanzania is one of the few African countries to follow, albeit probably 
not intentionally, the lines of the US in not having a separate 
national biosafety law for GMOs, but instead using a multitude of 
existing laws, guidelines and regulations. Tanzania is also different 
from Kenya and Uganda in not having approved any field trials 
for GM crops, and I cannot envisage this situation changing in the 
near future. 
The main reason for this is their ‘strict liability’ system for 
responding to any alleged social damages following the introduction of 
a GM crop. This could put technology providers such as multinational 
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seed companies at a prohibitive risk. Most countries have a ‘fault-
based’ system for finding technology providers liable for damage. 
This requires evidence of bad faith, negligence, and a cause-and-
effect link between an action and the damage (Robert Paarlberg, 
personal communication). The ‘strict liability’ precaution is usually 
reserved for companies handling inherently hazardous substances or 
technologies, such as toxic waste or nuclear power. However, under 
Tanzania’s ‘strict liability’ requirement, if a drought-tolerant GM crop 
failed due to a hurricane or an invasion of locusts, the seed company 
who sold the farmer the crop could be liable for damages. It would 
be just too easy for GMO critics to claim damages and initiate legal 
action.
Even GMO promoters in Tanzania, such as scientists, are happy 
with the status quo, as most of them are focused on permission to 
begin research, not to apply for environmental release. This could 
have a bearing on the testing of drought-tolerant crops, but at the 
moment it appears that no field tests of drought-tolerant maize will 
be carried out in Tanzania. 
Burkina Faso
Burkina Faso surprised many of us by suddenly allowing the 
commercialisation of Bt cotton in 2008. One of the reasons for our 
surprise was that they did not even have a Biosafety Act in place 
when they approved this. However, the country’s legislation had 
passed biosafety legislation to formalise regulatory oversight for both 
the research into, and the commercialisation of, agricultural biotech-
nology products (Vitale et al., 2011). This biosafety law ‘pertaining to 
the security system as regards to biotechnology in Burkina Faso’ was 
passed in 2006, establishing Burkina Faso as the first West African 
country to have enacted such a law. The bill established the National 
Biosafety Agency (NBA) as the regulatory body, with members of 
several government agencies and NGOs. Although not established by 
the law, the NBA is led by and housed in the Ministry of Environment 
(Birner et al., 2007).
From 2003 to 2005, the Institut National de l’Environnement et 
Recherches Agricoles conducted confined field trials that evaluated 
the effectiveness of the crop within the climate and insect conditions 
specific to the country. In 2006 the testing was more widespread and 
the approval came in June 2008 (Vitale et al., 2011). In 2009, following 
a decade of coordinated efforts on behalf of various cotton stakeholders 
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to satisfy a series of technical, legal and business requirements laid 
down by the legislature, farmers planted about 125 000 hectares of 
insect-resistant cotton.
Based on a survey of 160 cotton producers, Vitale et al. found that: 
 ● Bt cotton increased cotton yields by an average of 18.2 per cent
 ● there was no difference in production costs since the increased 
cost of seed was offset by a reduction in insecticide costs
 ● Bt cotton producers earned a profit of US$ 39.00 per hectare, 
which shifted producers’ bottom line from a negative position 
to a positive one.
The authors noted that part of this improvement might have been 
due to the fact that only three cotton companies were connected to 
the vast network of smallholder producers. They compared this to 
a similar situation reported by Gouse at al. (2003) for South Africa 
where a single cotton company provided inputs to producers and 
was the sole buyer of cotton. This immediately raises alarm bells 
with me, as the South African Bt cotton market is currently in a 
downturn, precisely because it was dependent on one company which 
experienced financial difficulties, due partly to mismanagement and 
partly to the uncompetitive nature of the cotton crop (Bt or not) in 
that region. But the involvement of three companies in Burkino Faso 
will, it is hoped, prevent such an unfortunate occurrence, which has 
nothing to do with the GM technology itself.
Reports from plantings in Burkina Faso in 2012 indicate that 
somewhat more than half (51 per cent) of the total 615 795 hectares 
planted to cotton was Bt, involving approximately 100 000 farmers 
(James, 2012). The country is also going ahead with field trials of Bt 
cowpea.
Of some concern is a proposed amendment of the Biosafety Law 
which was recently drafted to give more political autonomy to the 
NBA, but also to provide some strict liability provisions. The strict 
interpretation of these could make it prohibitively costly to deliver 
GM crops to farmers (IFPRI, 2012). 
Ghana
Ghana’s Biosafety Act was passed into law towards the end of 2011. 
This was the culmination of years of outreach activities and advocacy 
for biotechnology, involving a cross-section of Ghanaians, including 
the scientific community, the media, farmer-based organisations, 
consumer associations, religious bodies and legislators supported 
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by donor agents or their representatives (Walter Alhassan, personal 
communication). Speaking at a public meeting in Accra in early 2012 
on behalf of the Forum for Agricultural Research in Africa (FARA), 
Professor Alhassan said that ‘having the law means the work is 
now beginning’ and allows for the production of biotech foods on a 
commercial scale.
Egypt
Of the 23 countries that had completed their National Biosafety 
Frameworks under the United Nations Environment Programme by 
2006, only the relative newcomer, Burkina Faso, was listed in the 
top 28 countries in the world planting GM crops in 2012 (James, 
2012). It comes in at number 14 (0.3 million hectares of cotton). 
South Africa is number eight, with 2.3 million hectares planted to 
GM maize, cotton and soya beans. Egypt, which began planting Bt 
maize in 2008, and has the well-established Agricultural Genetic 
Engineering Research Institute (AGERI), comes in at only number 25 
(<0.1 million hectares). In 2008 they approved the cultivation and 
commercialisation of Bt maize, although this is currently under 
review.
AGERI is very active in the development of GM crops. They 
are working on insect- and virus-resistant potatoes, virus-resistant 
tomatoes and cucurbits, and drought-tolerant wheat. Unsurprisingly 
they also have a keen interest in improving their cotton varieties. 
They are in partnership with Monsanto to cross Egyptian elite 
germplasm with Bollgard II (one of Monsanto’s Bt insect-resistant 
cotton varieties) to form Giza-Bollgard II. They aim to pave the 
way for acceptance of GM cotton in neighbouring African and Asian 
countries.
With so few countries in Africa passing biosafety laws, it would 
seem that Europe is winning its war against the acceptance of 
GM crops on this continent. Although many African countries had 
completed their national biosafety frameworks under the auspices 
of the United Nations programme by 2007, only four are able to 
commercialise such crops. I wonder if the Europeans behind this 
approach would be proud of themselves if they were to visit some 
of the women and men in Africa desperate to use this technology 
to elevate themselves out of the status of subsistence farmers to 
that of commercial farmers. A meeting of stakeholders involved in 
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agricultural biotechnology was held in February 2012 in Nairobi 
under the auspices of the African Development Bank. If the 
Bank were to come out in favour of GM crops this could have an 
enormously positive effect on African countries’ future adoption of 
this technology.
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Chapter 7
The maize streak virus story
The title of our research group’s paper in the Plant Biotechnology 
Journal read ‘Maize streak virus-resistant transgenic maize: a fi rst 
for Africa’ (Shepherd et al., 2007) with a photograph of an infected 
maize cob on the front cover (Figure 7.1). The journal Science led with 
‘GM technology develops in the developing world’ (Figure 7.2; Sinha, 
2007). Success at last, but when we began this project some 20 years 
before, I was woefully ignorant of what it would entail, and if I’d 
known then what I know now I would probably never have embarked 
on the journey. For a start I didn’t realise (and I really should have) 
that you can’t grow maize in the Cape Peninsula—well, not properly, 
so that it can be healthy, vigorous and set seed. And you can’t grow 
GM maize unless you have a computer-controlled glasshouse, and at 
the time we didn’t even have a glasshouse at all. Instead, we grew 
our maize in securely locked, artifi cially lit, growth chambers in the 
basement of our building on the UCT campus.
Maize streak disease (MSD) was fi rst described in 1901 when 
it was found on plants in South Africa in what was then Natal, as 
follows: ‘The disorder of the mealie plant, locally described as “Mealie 
Blight”, “Mealie Yellows” or “Striped Leaf Disease”, belongs to a 
group of plant troubles arising from obscure causes …’ (Fuller, 1901). 
Fuller mistakenly attributed the disease to a soil disorder, but in 
retrospect it is quite clear that the ‘mealie variegation’ he described 
and drew in minute detail can be attributed to maize streak virus 
(MSV, Figure 7.3). In the 112 years since this fi rst report, scientists 
have come a long way in identifying and analysing the causal agent 
of MSD, to the point where in our lab we believed we could design 
effective strategies to control, or even eliminate, the disease in maize.
When I joined UCT as the Head of the Microbiology Department 
in 1988, I inherited a department divided between the second fl oor 
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Figure 7.1 Cover of Plant Biotechnology Journal
Figure 7.2 Headline from Science with photo of transgenic maize 
streak virus-resistant and non-transgenic maize
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bacterial geneticists and the third-fl oor plant virologists. How to 
merge these two rather headstrong groups? Ever since I had met 
Marc van Montagu, one of the trio responsible for the development 
of plant genetic engineering, during the European Molecular Biology 
Organization course in Basel in 1979, and spent time in his lab 
in Ghent, I had wanted to move into this fi eld of research. When 
running the CSIR’s Laboratory for Molecular and Cell Biology, I had 
worked on the bacterium, Agrobacterium tumefaciens, the organism 
Marc and his colleagues had developed as a vector for introducing 
foreign genes into plants. So, although I was familiar with working 
with this bacterium, I had not progressed to using it to genetically 
modify plants. But now I saw my opportunity to do this and I hoped 
to bring the two divisions in the department together. Ed Rybicki, 
then senior lecturer and now professor, was and still is South Africa’s 
leading plant virologist. He and I put our heads together to combine 
our expertise to develop maize resistant to the African endemic maize 
streak virus (MSV).
Figure 7.3 Symptoms caused by MSV on a maize plant
Why were Ed and I so passionate about this project? MSV is the 
most signifi cant pathogen of maize in Africa, resulting in crop yield 
losses of up to 100 per cent. Transmitted by tiny leafhopper insects, 
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Cicadulina mbila, it is indigenous to Africa and neighbouring Indian 
Ocean islands. Despite maize being a crucial staple food crop in Africa, 
the average maize yield per hectare on the continent is the lowest in 
the world, leading to food shortages and famine. A major contributing 
factor to these low yields is MSV (Figure 7.4). Indeed, I have often 
said to small-scale farmers whose fi elds I have visited in Kenya, ‘Why 
do you bother to plant maize? It will just be destroyed by the virus.’ 
Their reply is that ‘Any cob is better than no cob’. 
Figure 7.4 Smallholder farmer in a fi eld of maize infected with MSV
Thus our aim was to develop maize resistant to MSV. However, we 
knew that we had to cut our teeth on something simpler as, in those 
days, nobody had succeeded in using Agrobacterium tumefaciens to 
genetically engineer monocots, such as maize, but only dicots, such 
as tobacco. A. tumefaciens is a soil bacterium which can infect dicot 
plants and, as the name implies, cause a tumour. Marc van Montagu 
and his colleagues discovered that when the bacterium infects a plant 
it transfers part of its DNA into the plant cells where it becomes 
integrated into the plant’s genetic material. Not long after this 
discovery they realised that the introduction of a foreign gene into A. 
tumefaciens DNA would enable its transfer to the plant cell nucleus. 
Moreover, they could remove the genes that caused the tumour 
without affecting the transfer of this genetic material. This is what 
led to the development of dicot plant transformation.
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Ed and I accordingly devised a project to be carried out by a 
willing and very able PhD student, Andy Hackland. Most plant 
viruses have, as their genetic material, RNA, a structurally simpler 
form of the normal genetic material, DNA. One of the genes on this 
RNA molecule codes for the virus coat protein (CP). When a virus 
infects a plant, it injects its RNA, leaving its CP outside. This RNA 
replicates and codes for the proteins required by the virus to infect the 
plant. What scientists had shown was that if they made transgenic 
plants carrying the CP gene, the viruses would not replicate, and 
therefore no infection would occur. The simplest way to think of this 
mechanism is that, as soon as the virus RNA enters the plant cell, the 
CP produced by the plant will recoat the RNA and no replication will 
occur. This is an over-simplifi cation of the mechanism but serves to 
illustrate the point.
The project was therefore to clone the CP genes from caulifl ower 
mosaic virus (CaMV) and tobacco necrosis virus (TNV) and introduce 
them into tobacco using A. tumefaciens. The CaMV CP had been 
shown by others to produce resistance, so we used it as a control. 
TNV-resistant tobacco would be a fi rst and, as this virus causes 
disease in tobacco, it could have commercial interest. However, that 
was not our main aim, which was simply to show that we could carry 
out this research with the people, equipment and facilities we had at 
UCT. Needless to say, the project worked beautifully and Andy duly 
graduated with a PhD in 1993. He then went on to start a plant tissue 
culture company, Frontier Laboratories.
Help from abroad
The next step on our journey was to learn how to transform maize, 
a monocot which, at the time, was resistant to A. tumefaciens 
transformation. Bill Gordon-Kamm, then working for the American 
biotechnology company, DeKalb, in Connecticut had published a 
seminal paper on this subject in July 1990, entitled ‘Transformation 
of maize cells and regeneration of fertile transgenic plants’ (Gordon-
Kamm et al., 1990). I contacted him and asked if I could visit. Bill 
couldn’t have been more helpful, and when I told him that we wanted 
to develop maize resistant to a devastating African endemic virus 
he was most enthusiastic, with an obvious desire to help developing 
countries. I therefore arranged that my tissue culture technical 
assistant, Sandy Lennox, would spend some time in his lab and learn 
the technique.
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Next I visited Ciba-Geigy, whose Ciba Agricultural Biotechnology 
division was based in the Research Triangle Park in North Carolina. 
After a number of mergers, they are now part of Syngenta. Mary-
Dell Chilton, one of the trio who developed A. tumefaciens-based plant 
transformation, was the director, and she kindly facilitated my visit. 
The only fl y in the ointment emerged when her staff took me round 
their glasshouses. These were mind-blowingly sophisticated—and 
they told me in no uncertain terms that I shouldn’t even contemplate 
going into maize transformation if I didn’t have a computer-controlled 
glasshouse. This, they proudly told me, allowed them to set maize 
seed almost 12 months of the year. I couldn’t bring myself to tell them 
that at home I didn’t even have access to a glasshouse!
Back at UCT, what to do about this rather signifi cant shortcoming? 
At the time I served as a senate representative on the University 
Council and so I hesitantly approached the chair with my problem. He 
must have moved a minor mountain because within a year UCT had 
a brand new glasshouse to which I had access. It was not computer-
controlled and, with UCT situated in the lee of Devil’s Peak, lost the 
sun fairly early, especially in winter, but at least it was a glasshouse.
The next problem to be solved was funding. Although I received 
some limited funds from the government-backed National Research 
Foundation, I knew it wouldn’t be suffi cient to embark on this 
ambitious project. The Claude Leon Foundation (known in those 
days as the Claude Harris Leon (CHL) Foundation) had generously 
funded the Departments of Microbiology and Biochemistry for a 
number of years, enabling them to buy expensive state-of-the-art 
equipment. However, when I joined UCT they were indicating that 
this funding would probably end shortly as, over a 10-year period, 
they had supported the departments to the tune of over R1 million. 
I was extremely grateful for the assistance they had given the 
Microbiology Department under my predecessor Prof David Woods, 
and considered the CHL Foundation had every reason to spread their 
largesse. And that would have been the end of it if it hadn’t been 
for the intervention of our then Vice-Chancellor, Stuart Saunders. He 
told me that if I applied to the foundation for funding of my research 
programme specifi cally, instead of general departmental funding, 
I might fi nd a receptive ear. So I did, and thus began six years of 
a most fruitful and benefi cial relationship, which I cherish and am 
immensely grateful for to this day. 
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The Claude Leon Foundation
Claude Leon had made his money as founder and managing director 
of the Elephant Trading Company, a wholesale business based 
in Johannesburg. He also helped to develop several well-known 
South African companies, including Edgars, OK Bazaars and the 
mining house Anglo Transvaal (later Anglovaal). The trustees of the 
foundation, mainly UK-based grandsons of Claude Leon, visited South 
Africa once a year to check up on the projects they were funding. One 
trustee, Brian Yule, was extremely diligent in checking up on my lab’s 
fi nancial situation and required me to present a breakdown of how 
the foundation’s funding fi tted in with the overall funding of research 
in the department—quite a tall order for someone like me, for whom 
fi nance is not a strong suit.
On one occasion, Brian was joined by his wife, Annie, a molecular 
biologist. She was almost as stern as Brian and, during our 
discussions, asked me how many post-doctoral fellows I had in my 
group. When I said, ‘None’, she was clearly horrifi ed and asked me 
how on earth I managed to run a research team without them. I 
explained that there was not a ‘culture’ of post-docs in South Africa, as 
newly graduated PhD students either went abroad to do such a post-
doc, or looked for a job. This turned out to be a seminal discussion for 
South African science, as the next project the foundation funded was 
the awarding of post-doctoral fellowships, which by 2012 (the 15th 
year of the programme) had reached a total of approximately 450. 
They asked the Royal Society of South Africa to help them with the 
evaluations and, for a number of years, I served as a member of the 
panel that undertook this task. 
Learning the technique
With funding secured for our MSV project, the next step was to send 
Sandy Lennox to DeKalb and then to Ciba-Geigy to learn how to 
transform maize. The method used to transform maize in those early 
days is called particle bombardment or biolistics, a word derived from 
the words ‘biological’ and ‘ballistics’. The name is derived from the 
fact that the early prototypes of the apparatus did, indeed, resemble 
a gun and the genes were propelled into the plant by gunpowder. The 
apparatus, although now powered by helium gas and looking very 
ungun-like, is still called a ‘gene gun’. 
To transform plants biolistically, DNA carrying the genes to be 
transformed into the plant is coated onto tiny, chemically inert metal 
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particles, usually gold or tungsten. The gene gun is used to shoot these 
particles into the plant cells. A number of instruments are available 
for use in biolistics, based on various accelerating mechanisms. 
Figure 7.5 shows the most widely used gene gun, currently marketed 
by Bio-Rad, Inc (Biolistics®). After ‘bombardment’ the plant cells are 
regenerated into plants, due to the fact that plant cells are totipotent. 
This means that a single, isolated plant cell can grow into an entirely 
new plant. Thus if a gene is transferred into an isolated plant cell, 
every cell of the regenerated plant will contain this gene.
Not knowing anything about this technology apart from what she 
had read in Bill’s paper, Sandy set off for Mystic, Connecticut towards 
the end of October 1993. Unbeknown to her, Bill had unexpectedly 
resigned while she was in the US on her way to his lab. But, faced 
with a fait accompli, the maize biotechnology research group at 
DeKalb welcomed her most professionally and gave her an excellent 
introduction to the technology.
Sandy went on to Mary-Dell Chilton’s group at Ciba-Geigy in 
North Carolina. The staff in charge of the maize transformation work 
taught her how to excise immature embryos from young maize cobs 
and initiate the development of callus tissue. A painstaking process 
Figure 7.5 The Biolistic® Accell® gene gun
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then followed whereby the appropriate callus is excised out under 
precision microscopy for transfer into the gene gun for bombardment 
of DNA-coated gold particles. Thereafter the transgenic callus had to 
be selected on media containing the herbicide bialaphos which selects 
for those that are transgenic. As bialaphos is very expensive, we were 
extremely grateful that both DeKalb and Ciba-Geigy donated samples 
for our use back at UCT. Following regeneration, the developing 
plantlets have to be hardened off under specifi c growth chamber 
conditions which lead to maize growth, maturation, pollination and, 
fi nally, the setting of seeds.
Getting the equipment 
Sandy returned after four weeks full of ideas and enthusiasm, but fi rst 
we had to acquire the necessary equipment. This included the particle 
gun, laminar fl ow hoods to ensure a sterile working environment, 
dissection microscopes (including one with a camera attachment) and 
suitable shelving and lights for the plant growth rooms. Sandy now 
set to work to ensure we could repeat the processes she had learned 
in America, and it soon became apparent that all was fi ne except for 
getting our regenerated maize plants to set seed. The light intensity 
in the growth rooms (and even in the new glasshouse) was simply not 
high enough for this to take place. As I said earlier, you can’t grow 
maize properly on the Cape Peninsula. We needed help—and into 
this breach stepped the company PANNAR Seed (Pty) Ltd.
PANNAR was founded in 1958 in Greytown, a prosperous 
agricultural community in KwaZulu-Natal, where its head offi ce 
remains to this day. It is a privately owned, independent group of 
companies that is a regional market leader, being the largest seed 
group in Africa, as well as a global player. It owns companies in nine 
African countries, Argentina, Europe and the US, and markets seed 
across the globe. We couldn’t have found a better partner.
It is no exaggeration to say that, had it not been for PANNAR, 
this project would not have succeeded. From a small beginning 
of R22 500 in 1995, the funding is currently somewhat more than 
R5 million. But it was not just money that PANNAR brought to the 
table. They helped us immeasurably in kind—from setting seed, 
making crosses, doing glasshouse trials, and giving advice to offering 
boundless enthusiasm as well as healthy criticism. 
While all this was going on, a new student, Tichaona Mangwende, 
the fi rst of three Zimbabwean PhD students from the MSc course I 
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examined there in 1992, joined the group. He was brave enough to 
take on the task of MSV resistance, and the fi rst question we had to 
answer was what gene to use. The tried and trusted approach used 
for most plant viruses was to transfer the gene coding for the viral 
coat protein into the plant. However, there was evidence that over-
expressing the MSV coat protein would not work, so we decided to use 
the gene coding for the replication associated protein (Rep). MSV has 
a very simple DNA genome, with only three genes. One of them is rep 
which is the fi rst gene to be expressed when the virus infects a plant. 
The Rep proteins form a multimer, consisting of a number of Rep 
molecules, which binds to the virus DNA origin of replication. This is 
a very specifi c sequence which, because the DNA is single-stranded, 
forms a hairpin structure. The Rep complex initiates DNA replication 
at this point, using host proteins to complete the process. Thus, we 
fi gured that if the host plant produced many copies of mutated Rep 
proteins, these would compete with the virus Reps and prevent them 
from initiating replication.
Tichaona made a variety of mutations in regions of the rep gene 
that are essential for its function, thus producing proteins defective in 
replication. He tested these in black Mexican sweetcorn (BMS) cells 
in liquid culture. BMS cells have the advantage of growing in tissue 
culture almost indefi nitely, if treated correctly. As they have many 
of the attributes of maize plants they can be transiently infected 
with wild-type MSV and the virus can be challenged with the Rep 
mutants. Tichaona was able to show that a number of his single and 
double mutants effectively prevented the virus DNA from replicating 
in BMS cells. This suggested that if we expressed the Rep mutants 
in transgenic plants they might make the plants resistant to virus 
infection. 
Wild grasses
Although maize transformation was now a possibility, we knew that 
it was going to be a slow process and were keen to fi nd a system 
that would enable us to test Tichaona’s constructs rapidly in plants. 
Ed suggested we try the grass, Digitaria sanguinalis, which grew 
conveniently wild near UCT’s tennis courts, as MSV originated in wild 
grasses. Although leafhoppers prefer to feed on maize, these insects 
preferentially breed on annual wild grass species (Shepherd et al., 
2010). Approximately 70 per cent of the more than 138 grass species 
on which leafhoppers feed are also MSV hosts, and the density and 
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composition of grass populations in any region almost certainly has 
a major infl uence on maize streak disease epidemiology (Varsani et 
al., 2008). 
Sometimes, however, leafhoppers do mate on maize plants, and 
one of the most fascinating talks I heard on this subject was given 
by William Page, a scientist from Uganda, at a 1997 international 
maize streak disease symposium held in Hazyview in Mpumalanga 
(then the eastern Transvaal). He described an experiment he carried 
out in maize fi elds using yellow sticky traps and suction devices. He 
attached the traps to plants at different heights, and used the suction 
devices to sample the canopy, especially the whorls. He collected the 
leafhoppers caught in this way, and sexed them. His interpretation 
of the results was that the females alight towards the top of plants 
and the males further down. The females emit some sort of acoustic 
signal that attracts the males. After a brief mating they both go their 
separate ways, leaving behind viruses inserted into the plant during 
the insects’ sojourn on the maize. What a legacy of invertebrate 
courtship!
We accordingly set about developing a transformation system for 
D. sanguinalis which proved to be most successful and took only about 
four months from bombardment in tissue culture, to adult plants and 
fi nally seed (Chen et al., 1998). We were now ready to test Tichaona’s 
genetic constructs, concentrating on the ones that showed promise in 
his tissue culture experiments.
It was during Tichaona’s PhD work that I started to become 
concerned about a potential competitor in the person of Margaret 
Boulton at the John Innes Centre in Norwich, UK. She was well known 
to Ed and had published extensively on MSV. So, believing that it is 
better to collaborate than to compete, I set off for Norwich with some 
trepidation. Fortunately, Margaret and I hit it off splendidly and both 
I and those of my students who spent time in her lab learned a great 
deal from her, which helped us considerably in our eventual success. 
A most important person entered the scene in 1997. Dionne Miles, 
later Shepherd, did her PhD with Ed and me. She then became a 
post-doctoral fellow, funded by the Claude Leon Foundation, and 
is currently employed by UCT, although paid by PANNAR, as a 
research offi cer to see the project through to commercialisation. She 
took over where Tichaona had left off and made more mutations 
and deletions in the MSV Rep gene. Like Tichaona, she fi rst tested 
them in BMS suspension cells and then used the D. sanguinalis 
transformation system to test them in transgenic plants.
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The results were quite variable. Some constructs produced plants 
showing excellent resistance, even immunity, to MSV but the transgene 
had deleterious effects on aspects of plant growth and development. 
Fortunately, some produced healthy, fertile plants with good resistance.
At last we were ready to publish. We submitted a paper entitled 
‘Maize streak virus-resistant transgenic maize: a fi rst for Africa’ to 
the Plant Biotechnology Journal. It came back from the reviewers with 
requests for corrections. These were accepted and publication was 
confi rmed on 29 June 2007. The date is signifi cant because of what 
was about to happen. 
Publicity
At the beginning of 2007 I had been contacted by Debby Delmer from 
the Rockefeller Foundation. She had been in charge of the Rockefeller 
funding for our drought-tolerant maize project (see Chapter 8) for 
a number of years. She had followed our MSV work with interest 
and was looking for speakers for the Plant Biology and Botany Joint 
Congress of the American Society of Plant Biologists to be held in 
Chicago in July 2007. I recommended she invite Dionne as I fi gured 
it was time my post-docs and students got their share of the limelight. 
When Dionne presented her paper on July 7 the media immediately 
jumped upon it and she was interviewed by BBC World and Voice 
of America. The work was commented upon by Science (Figure 7.2) 
and when the paper was published in November, complete with a 
front cover picture (Figure 7.1), it created quite a stir in the scientifi c 
community, receiving numerous citations. We were relieved that the 
paper had been accepted before Dionne’s presentation in Chicago, 
as the anti-GMO lobby could well have accused us of ‘publishing’ in 
the media before submitting the work to peer review in a scientifi c 
journal. The fact that the media came to us, rather than vice versa, 
would not have entered such a debate!
The work then entered the breeding and glasshouse testing phase 
at PANNAR, during which the gene was crossed into lines suitable for 
commercialisation in South Africa and elsewhere on the continent. 
The resistance has yet to be confi rmed by conducting confi ned fi eld 
trials. 
As with many developers of new technologies, we decided some 
years ago to have a back-up strategy and that was in the hands 
of Betty Owor. She was inspired by the work of David Baulcombe 
(knighted in 2009), famous for his discovery of a phenomenon called 
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gene silencing in plants. This is a process whereby small pieces of 
RNA can cause genes to be silenced—that is, inactivated. RNA is the 
molecule that is well known as the intermediate in the DNA → RNA 
→ protein process, immortalised as the Central Dogma by Francis 
Crick who, together with James Watson, determined the structure 
of DNA in 1953. These small pieces of RNA, called small interfering 
(si) RNAs, interfere with the expression of specifi c genes and can 
therefore act as antiviral agents. Betty developed just such a system 
for protecting maize from MSV and this is also being tested both in 
our labs and at PANNAR . Time will tell which strategy works.
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Chapter 8
David vs Goliath
One day I was meeting with some potential funders of my research 
group and I was explaining to them that, apart from our work on 
maize resistant to maize streak virus, we were also embarking on 
tolerance to drought. ‘But what if there isn’t a drought?’ asked one of 
them, who lives in the UK. People there who knew me well told me 
they had never before seen me at a loss for words.
Drought is nothing new to sub-Saharan Africa. Newspaper 
headlines in July 2004 read ‘Severe drought depletes SA’. ‘The 
country remains in the grip of one of the worst droughts in recent 
years, costing the government millions of rands in relief funding’ (IOL 
News, 2004). NASA’s earth observatory reported that hot, dry weather 
from January to March 2007 wilted crops in southern Africa. The 
severe drought produced near-record temperatures that, combined 
with a lack of rainfall, caused extensive crop damage. In 2011 the 
eastern parts of the horn of Africa experienced the worst drought in 
several decades, resulting in the most severe food security emergency 
in the world, driven mainly by a combination of food availability and 
access issues. Two consecutive seasons of signifi cantly below-average 
rainfall have resulted in failed crop production, depletion of grazing 
resources and signifi cant livestock mortality (FAO, 2011). 
Rockefeller to the rescue
But I need to backtrack to 1996 in order to explain how the funding 
from the Rockefeller Foundation for our work on drought-tolerant 
maize began. I received a letter from an unknown PhD student who 
was on a Fulbright programme at Auburn University in Alabama. His 
name was Sagadevan Mundree, a former high school teacher from 
Durban. During the course of his thesis research he had developed an 
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ingenious technique to identify genes that are functionally important 
in abiotic stress tolerance, using the bacterium E. coli to detect genes 
from any source (Mundree et al., 2000). He now wished to return to 
South Africa and was looking for a post-doctoral position—could I 
help? It turned out that he had written to every major university and 
research institute in South Africa, without success. I immediately 
wrote back and said he must return as the country needed people 
like him. I indicated that I would do everything possible to fi nd him 
a position. And so, in 1997, Saga arrived to take up a post-doctoral 
fellowship with Jill Farrant in the Botany Department at UCT. The 
Microbiology Department was able to offer him a job soon after and 
he joined us in 1999 as a lecturer. Thus began our partnership, which 
continues to this day.
The fi rst question facing us was where to fi nd interesting genes 
that might confer tolerance to dehydration, but that other groups 
weren’t working on. This was where Jill Farrant made a strong 
contribution. She is an expert on a group of plants called ‘resurrection 
plants’, which can tolerate high levels of desiccation, losing up to 
95 per cent of their water content. They can survive in that dehydrated 
state for months on end and, when given water, ‘resurrect’ within 72 
hours. For various reasons, Jill suggested we try the South African 
indigenous species Xerophyta viscosa (Figures 8.1 and 8.2).
Figure 8.1 The resurrection plant, Xerophyta viscosa, 
in its hydrated state
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Where to fi nd these plants? Enter a former post-doctoral fellow, 
Rachel Saunders, who, with her husband, Rod, ran an indigenous seed 
nursery. She thought they had seen them growing in the Drakensberg 
Mountains in KwaZulu-Natal, somewhere near Cathedral Peak. 
So, with those not-too-specifi c instructions, Saga applied to the 
Department of Nature Conservation for a permit. They were extremely 
helpful and gave us permission to stay at the KwaZulu-Natal Parks 
Board’s Cathedral Peak Nature Reserve’s huts, while also supplying 
us with a guide to help us fi nd the elusive plants. Saga and I set off 
from UCT with a group of six students, driving a minivan and towing 
a trailer in the hope of bringing home the loot. We left our base in 
the foothills of the Drakensberg at fi rst light, climbing up into thick 
low-lying cloud, not knowing how long it would take us to fi nd our 
quarry. We emerged into bright sunlight and then, after negotiating 
a somewhat tricky ledge, were struck with elation as we turned a 
corner to fi nd an enormous bank covered in glorious X. viscosa plants 
(Figure 8.3).
Each of us fi lled our backpack with a single plant and lovingly 
carried it down to camp, where we revelled in the cold mountain stream 
after our somewhat exhausting eight-hour hike. On a subsequent trip 
the weather was not quite so kind, but enabled us to see the plants 
‘resurrecting’ before our eyes. There had been a severe drought and 
Figure 8.2 X. viscosa in its dehydrated state
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fi re in the Drakensberg and the temperatures had been in the high 
30s and up to 40ºC or more. However, it had rained the night before we 
set off and as we reached the ridge in a howling gale, the temperature 
was well below freezing. We could indeed see nature at work as the 
plants started to change from a stick-like state, becoming healthy 
and green. But the going was tough, and when I asked a student 
on the way down whether she was pleased she’d come she replied, 
‘Yeeees, but I’ll never do it again!’ Fortunately, neither she nor anyone 
else ever had to do it again as our technical ‘guru’, Marion, learned 
how to germinate the Xerophyta seeds in the glasshouse. However, 
I still remember fondly the days when it was a rite of passage for 
every graduate student to collect his or her own resurrection plant by 
climbing in the Drakensberg.
It was shortly after this initial stage of our research that I met 
Gordon Conway, president of the Rockefeller Foundation, at the World 
Economic Forum in Davos and our funding started (see Chapter 4). 
The Rockefeller Foundation was a marvellous institution to have as a 
funder. Once they had decided our project was worthwhile, they gave 
us considerable latitude to achieve our objectives. I well remember 
going through an annual progress report with the foundations Joe 
de Vries, to whom I reported in Nairobi, during a break in an African 
Agricultural Technology Foundation board meeting. He commented 
Figure 8.3 X. viscosa growing on a rocky slope in the Drakensberg Mountains 
near Cathedral Peak
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that it was probably the best annual report he’d ever read. When I 
replied that it was only fi ve pages long, he said, ‘That’s probably why.’
After a few years, Debby Delmer took over from Joe and she 
wasn’t as happy with our progress. She urged us to ‘get into maize’ 
as soon as possible. Up until that time we had been content to test 
our genes in model plants such as tobacco and Arabidopsis. However, 
Debby had burned her hands on projects that got hooked on model 
plants and never got as far as the crop of interest. Moreover, she was 
keen that we tried out genes that were unique to X. viscosa, not being 
represented in any of the international gene banks. She suggested 
I contact Prof Jesse Machuka from Kenyatta University, whom she 
thought could help us, especially with maize transformation. And 
that opened up a whole other world.
We had used the ‘biolistics’ particle bombardment transformation 
method for introducing genes into maize for the virus resistance 
project. This was because, at the time we began that project, the 
method Marc van Montagu and his colleagues used to introduce 
genes into plants using the bacterium, Agrobacterium tumefaciens 
(see Chapter 7), worked for dicotyledonous plants only—tobaccos 
and tomatoes—but not cereals such as maize. However, by the early 
2000s, A. tumefaciens could be used to transform monocots, such as 
maize, as well as dicots. In many respects it is a more effective method 
than particle bombardment because it generally delivers a single 
copy of the gene one wishes to introduce. This has many implications 
for biosafety and for ease of subsequent breeding into other maize 
varieties. And this brings me back to Debby’s suggestion that I meet 
Jesse Machuka at Kenyatta University.
Jesse’s set-up was inspiring. Apart from a well-equipped laboratory 
and tissue culture facility, he also had a glasshouse, now a state-of-
the-art biosafety-compliant one and, most important of all, his lab sits 
almost on the equator, making it possible to grow two crops of maize 
a year. Coming from Cape Town, where we can grow maize only in 
a temperature- and light intensity-controlled growth chamber, this 
was little short of miraculous. But best of all, Jesse’s lab staff were 
expert at using Agrobacterium to transform maize, and they were as 
enthusiastic about developing drought-tolerant maize for Africans as 
I was. And so began our partnership to ‘get genes into maize’. The 
genes would be cloned at UCT and the maize transformed in Kenya. 
But things like this don’t happen overnight.
Slowly our team came together. Dahlia Garwe was the fi rst 
Zimbabwean to join. She left her husband and two children at home 
in Harare, and so had a great incentive to work 24/7 in order to return 
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to them as soon as possible. (However, at one point she was forced to 
return home as her husband, a pilot in the Zimbabwean air force, was 
required to help in the war in the Democratic Republic of the Congo.) 
‘Her’ gene was Debby’s favourite, the one with no similarity to any other 
in the available databases. There was great excitement when Dahlia 
found that her gene protected tobacco and Arabidopsis (we were still 
working in model plants at the time) against not only dehydration, but 
also high temperatures (memories of Xerophyta growing at 42°C in the 
Drakensberg) and salinity. Could we similarly protect maize from a 
number of different abiotic stresses with Dahlia’s gene?
Then came the genes of Alice (she also came from Zimabwe), and 
of the South Africans, Kershini and Revel. (I have always found it 
easier to refer to the genes by the student’s name, but of course, they 
all have scientifi c names as well.) There were others on the way, 
some of which gave heart-breakingly negative results. For instance, 
Shaheen, from Mauritius, worked on a very promising gene that coded 
for an antioxidant protein. As many readers will know, antioxidants 
are implicated in the ageing process, which can be an extremely 
stressful condition. But the results sadly showed that this particular 
antioxidant could not protect plants from environmental stresses.
Thus we honed in on four genes. We had fi rst called Dahlia’s gene 
XvCor1, Xv for X. viscosa, and Cor for cold responsive, as we fi rst 
thought the gene was switched on primarily as a response to low 
temperatures. When it became clear that it responded to a variety of 
abiotic stresses we changed the name to XvSap1, for stress associated 
protein. We didn’t know how it acted, only that it had six cross-
membrane regions (regions of hydrophobicity) and also had some 
signal-transduction motifs in its DNA, as if parts of it could transmit 
signals regarding abiotic stresses to the interior of the cell. Alice’s 
was called XvAld1, as it codes for the enzyme aldose reductase, which 
converts glucose to sorbitol, an osmoprotectant. This sugar could act 
to ‘shore up’ the interior of the cell in times of osmotic stress due to 
lack of water. Kershini’s was XvPer2, being the second antioxidant. 
This type is called a peroxiredoxin—hence the name. G6 is another 
unknown which is induced by cold stress but whose protein levels 
also increase signifi cantly under dehydration. 
However, as we decided on these genes, another strategy 
emerged. A number of scientists were fi nding that genes which could 
potentially protect plants from dehydration could, if switched on 
continuously, also cause them to grow rather poorly under normal, 
non-stressed conditions. This is because their expression could result 
in a physiological load. The situation when a gene is switched on all 
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the time is called constitutive gene expression. The alternative is 
inducible gene expression, when the gene is switched on only under 
certain conditions (in this case under conditions of abiotic stress, such 
as dehydration).
The region of a gene that determines whether it is expressed 
constitutively or inducibly is called the promoter. This is a region of 
DNA upstream of the gene which ‘instructs’ it fi rst to be transcribed 
into RNA and then translated into the protein that would carry out 
its function (in our case resistance to dehydration). 
Richard Odour was a former USHEPiA PhD student from Jesse’s 
lab. He is now running our research programme at Kenyatta University 
as a member of their academic staff. His PhD was to develop a 
promoter that could be used to switch on our four genes when the 
plant was stressed. Soon after Richard started work, our Rockefeller 
Foundation grant ground to a halt. All Rockefeller grantees in 
Debby Delmer’s ‘biotech’ portfolio received a letter from her towards 
the end of 2006 indicating that no more work on transgenic crops 
would be funded. We had indeed seen this coming when the new 
president, Judith Rodin, took over from Gordon Conway. The African 
Agricultural Technology Foundation had a meeting with its donors 
and partners at the foundation’s offi ces in New York in 2007, shortly 
after Judith had taken over. She briefl y welcomed us, but it was clear 
that she was not at all comfortable dealing with an organisation that 
promoted GM crops. It had been decided that as a gesture from the 
board, I would present her with a copy of my book Seeds for the Future, 
which I only just managed to do, as she left the room so abruptly 
after her short interaction with us. Gordon told me later that I was 
probably not being ‘politically correct’ when I told her that he had 
written the foreword.
The South African Maize Trust
As luck would have it, shortly after I had discovered the Rockefeller 
Foundation as a funding source I also discovered the South African 
Maize Trust. It was founded in 1998 to promote the maize industry, 
partly by funding research on crop improvements. I had met a 
member of a related organisation, Grain SA, at a local conference and 
when I told him that not only did I not know the Maize Trust existed, 
I certainly didn’t know that they supported research, he encouraged 
me to apply. Members of the trust visited us a few years after they 
had started funding our work. They were particularly excited about 
Food for Africa_Chapter 8.indd   127 02/05/13   9:33 AM
Food for Africa: The life and work of a scientist in GM crops128
our use of a South African resurrection plant as a source of genes for 
drought tolerance and one of them, a farmer from the north of the 
country, was convinced that he had seen Xerophyta plants growing 
on his farm. 
As the project developed, one glaring problem emerged—our 
glasshouse and growth chambers were totally inadequate for growing 
maize to the point of setting seed. I had solved this problem with 
our MSV project by sending the plantlets up to PANNAR Seeds in 
KwaZulu-Natal where they could set seed, but PANNAR wasn’t 
involved in our drought-tolerance project. We would need to buy 
a specially controlled environment growth chamber, a Conviron, 
in which the light intensity could be set to a high enough level for 
maize to grow properly. And this cost money—a lot of money. UCT 
made a generous donation, but getting it installed was something 
of a nightmare. The doors to our building had to be removed and 
once it was inside and the wooden boards surrounding it removed, 
we discovered that it had been severely damaged during transit from 
Canada. Eventually, with the Maize Trust’s assistance, everything 
was in place. It continues to work well, but the space is very small so I 
was hugely relieved when, in 2010, we eventually transferred all our 
maize growing to Jesse Machuka’s Kenyatta lab in Nairobi.
The other aspect of our research which particularly interested 
the Maize Trust was our promoter work. From the start of our 
investigations into drought-tolerant maize, we were aware of the 
many other groups worldwide working on similar projects. Indeed, 
it was the large Shinozaki group in the world-renowned RIKEN 
research institute in Japan who fi rst alerted our attention to the 
problems of constitutive gene expression in transgenic plants (Kasuga 
et al., 1999). I’ve always operated along the lines that it’s good to be 
on friendly terms with the opposition, so on a visit to Japan I spent 
a day in Prof Shinozaki’s lab. Although he had been diffi cult to talk 
to at international conferences (the general opinion was that he was 
not very friendly), on his home turf it was completely different. He 
couldn’t have been more welcoming and, although he didn’t share 
any work that was unpublished, he was perfectly happy to comment 
on our research. He certainly reinforced the importance of using a 
stress-inducible promoter.
So Richard Odour began to work on developing the promoter of 
Dahlia’s XvSap1 gene for use as a signal to switch on a variety of genes 
and it was this that the Maize Trust decided to patent. Patenting is 
not for the faint-hearted! I was extremely fortunate to have Revel 
Iyer working for me. Apart from having a PhD in molecular biology, 
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he also has a law degree and an MBA. Between him and the UCT 
Patent Offi ce, who together with the Maize Trust footed the bill for 
the rather costly exercise, the patent was fi nally fi led. Although the 
Maize Trust will allow farmers in South Africa access, royalty free, 
to any research they have funded, we all agreed that if commercial 
farmers in other countries wanted to use it they should pay. 
Monsanto, our Goliath
It was around about this time that I became aware of the giant of 
drought-tolerant maize. I was approached by Monsanto via the 
African Technology Foundation (AATF), to help publicise their Water 
Effi cient Maize for Africa (WEMA) project. This is funded by the Bill 
and Melinda Gates Foundation and brings together a number of 
different organisations. The gene cspB has been donated royalty-free 
by Monsanto and encodes a cold shock protein from the bacterium 
Bacillus subtilis (Castiglioni et al., 2008) which has been shown by 
them to confer tolerance to dehydration in transgenic maize. The 
gene has been introduced into African maize varieties by CYMMIT, 
the international maize and wheat breeding organisation, which, 
although based in Mexico, also has centres in Africa. These plants 
are being subjected to confi ned fi eld trials (CFT) by the National 
Agricultural Research Services of the partner countries, Kenya, 
Mozambique, South Africa, Tanzania and Uganda. The project is 
being managed by the AATF, and Monsanto asked if I would speak on 
it at an agricultural meeting in Rome. Although the WEMA project 
is vastly better resourced than ours and far further along the road 
to farmers’ fi elds, I fi rmly believe that it is a good idea to have more 
than one approach to a problem. The WEMA project may deliver 
everything maize farmers in Africa need for drought alleviation in 
the years of global warming to come, but it might not. On the other 
hand, our project might fail completely, but then again, it might not. 
So I went to Rome and spoke glowingly about the WEMA project, 
although as I said to my lab, the cspB gene in their transgenic maize 
is, unlike ours, driven by a constitutive promoter. This, then, is the 
origin of the title of this chapter, David vs Goliath.
I became further involved in Monsanto’s WEMA project when, 
in December 2010, I was asked by the South African Agricultural 
Research Council (ARC) to speak at a community meeting in Lutzville 
where the WEMA project was undertaking fi eld trials. Lutzville is a 
tiny village about four hours’ drive from Cape Town up the west coast. 
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It is a predominantly grape-growing area where little, if any, maize 
is grown. This, together with the fact that it is usually reliably dry in 
the summer months, was why it had been chosen as the location for 
fi eld trials. The ARC wanted me to speak on alternative approaches 
to drought tolerance, which I thought was pretty broad-minded of 
this Goliath project. On arrival at the community hall in the town I 
rapidly discovered two things that the ARC had not communicated 
to me. Firstly, very few among the gathering of local farmers spoke 
or understood English (I had never previously given a scientifi c talk 
in Afrikaans), and secondly, as growers of mainly organic vegetables 
(they had found a niche market for themselves), they couldn’t care 
less about maize and even less about GM maize. On the contrary it 
became increasingly clear that they were extremely angry with the 
ARC for not caring about their problems, and for foisting on them 
something they neither needed nor wanted. And, of course, this 
translated into anti-GM crops sentiment. The over-riding message 
from this experience was ‘do your homework on your target audience’ 
if you don’t want the whole exercise to explode in your face.
Two weeks after this meeting the heavens opened up. It didn’t 
just rain on Lutzville; there was a deluge which succeeded in washing 
away the main (and almost only) road in the town. The WEMA crops 
survived but their drought tolerance was temporarily irrelevant. 
Such are the vagaries of working with nature.
Subsequent to this somewhat stormy meeting with community 
leaders, the possibility of a follow-up stakeholder meeting was 
discussed. However, the leaders of the group cancelled the meeting 
and any further engagement with WEMA and later registered an 
objection to the WEMA trials with the South African regulatory 
authorities. This reaction was sparked by a public announcement in 
the daily newspaper that Monsanto intended to carry out another 
WEMA trial in Lutzville. A public announcement is a requirement by 
the regulatory authorities for anyone applying for a permit to conduct 
a GM trial (personal communication, H Mignouna, AATF). 
In my opinion this shows the importance of assessing the needs 
and aspirations of the local farmers, who, in the Lutzville case, had 
absolutely no interest in maize, and to bear these in mind when 
holding meetings with them before and during trials. Perhaps the 
WEMA project was unpopular in Lutzville because the local farming 
community has extremely deep-seated resentments against what 
they perceive as the racial agenda of the South African Agricultural 
Research Council (ARC), the organisation carrying out the trials. In 
their eyes, under the apartheid regime the old ARC favoured white 
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farmers only. Now the new ARC, under the ANC government, is seen 
as giving preference to black farmers. The farmers in Lutzville are 
coloured and feel that once again they are being left out. 
However, on a positive note, at a more recent community meeting 
(November 2011) the ARC invited an expert on vegetable growing and 
the atmosphere was far more amicable and constructive (personal 
communication; BioSafety SA).
In the meantime, work continues in Jesse’s and my lab on the use 
of X. viscosa genes to confer drought tolerance on African varieties 
of maize. Richard Odour is back in Jesse Machuka’s lab at Kenyatta 
University, where he is supervising our work. In February 2012 I saw 
the fi rst developing cobs of 2nd generation GM plants. It is projects 
such as these that might pave the way to increased acceptance of GM 
crops in Africa. 
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Food for Africa 
The InterAcademy Council book entitled Realizing the Promise and 
Potential of African Agriculture (InterAcademy Council, 2004) had 
stated, as one of its recommendations, that the bridge across the 
agricultural genetic divide between African countries and those in 
the developed world needed to be crossed. This divide separates the 
genetically improved varieties—derived either from conventional 
breeding or from the various tools of modern biotechnology—available 
to the developed world from those being used by resource-poor farmers 
in Africa.
The book concluded that there would need to be substantial 
investment to respond to the specifi c needs of African farmers if 
they were to derive benefi t from both conventional breeding and 
modern biotechnology. Technology needed to be fi ne-tuned to African 
needs. We noted the long gestation period biotechnology required 
before its impact could be realised, and urged for investment sooner 
rather than later. Some of these calls have been answered and the 
outcomes will be discussed in this chapter. 
Can GM crops help feed the hungry in Africa?
But before I go into these examples, the question must be posed: 
can GM crops help to feed hungry people in Africa? And if so, will 
Africans accept GM crops? There are still doubts in certain sectors of 
African society about the safety of such crops and the foods derived 
from them. I discussed some of the reasons for this in Chapter 6, 
specifi cally identifying the infl uence that European thinking has on 
Africans. However, it is essential to know that there has not yet been 
any documented evidence that approved GMOs have posed any new 
risks either to human health or to the environment. This is the view 
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not just of the proponents of GM technology, but also of scientifi c 
communities and, signifi cantly, even in Europe. 
For instance, the Royal Society stated in 2004: 
We conducted a major review of the evidence about GM plants and 
human health last year, and we have not seen any evidence since 
then that changes our original conclusions. If credible evidence 
does exist that GM foods are more harmful to people than non-GM 
foods, we should like to know why it has not been made public (Royal 
Society, 2004). 
Likewise the European Union (EU) Research Directorate wrote in 2001: 
‘Research on GM plants and derived products so far developed and 
marketed, following usual risk assessment procedures, has not shown 
any new risks on human health or the environment.’ This statement 
was based on a study of 81 separate scientifi c studies conducted over 
a 15-year period, all fi nanced by the EU rather than private industry, 
aimed at determining whether GM products were unsafe, insuffi ciently 
tested, or under-regulated. It was on the basis of this study that the 
EU made its statement (Kessler and Economidis, 2001).
Interestingly, in the light of the extreme opposition to GM crops 
among the French, the French Academy of Medicine and the French 
Academy of Sciences came out in 2002 with statements confi rming 
the safety of foods derived from such crops. The former announced 
it had found no evidence of health problems in the countries where 
GMOs have been widely eaten for several years and the latter stated: 
‘All the criticisms against GMOs can be set aside based for the 
most part on strictly scientifi c criteria.’ More recently, in November 
2011, France’s highest court, the Conseil d’Etat, confi rmed that the 
European Court of Justice’s judgement that the 2008 French ban 
on the cultivation of GM crops was illegal. Both courts overturned 
the national ban, declaring that the French government presented 
no scientifi c evidence of any risk to health or the environment from 
these crops (http://www.europabio.org).
Commenting on this fi nding, EuropaBio’s director of Green 
Biotechnology Europe, wrote:
These judgments from the highest European court and the highest French 
court send out a message loud and clear: bans of GM crops cannot be 
based on political dogma. As both judgments state, no ban on planting 
GM crops can be declared without valid scientifi c evidence, something 
that France and other European countries have not produced (ibid).
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The Union of German Academies of Science and Humanities also 
expressed their support (Helt, 2004): ‘According to present scientifi c 
knowledge it is most unlikely that the consumption of the well 
characterised transgenic DNA from approved GMO food harbours 
any recognisable health risk.’
More recently a group of European scientists have published an 
article entitled ‘Assessment of the health impact of GM plant diets in 
long-term and multigenerational animal feeding trials: a literature 
review’ (Snell et al., 2011). The aim of this systematic review was 
to collect data concerning the effects of diets containing GM maize, 
potato, soya bean, rice or triticale on animal health. They examined 
12 long-term studies, of more than 90 days and up to two years in 
duration, as well as 12 multigenerational studies from two to fi ve 
generations. Results from all 24 studies did not suggest any health 
hazards and, in general, there were no statistically signifi cant 
differences within parameters observed. What small differences were 
observed fell within the normal variation range of the considered 
parameter and thus had no biological or toxicological signifi cance. 
The studies concluded ‘that GM plants are nutritionally equivalent to 
their non-GM counterparts and can be safely used in food and feed’. 
Furthermore, they state that a 90-day feeding study performed on 
rodents, according to the Organisation for Economic Cooperation 
and Development (OECD) test guidelines, is generally considered 
suffi cient in order to evaluate the health effects of GM feed.
Despite all this overwhelming evidence of the food safety of GM 
crops, as Robert Paarlberg, the author of Starved for Science: How 
Biotechnology is Being Kept Out of Africa (2008), has written: ‘Skeptics 
who remain fearful sometimes respond that absence of evidence is not 
the same thing as evidence of absence.’ Yet if you look for something 
for 15 years and fail to fi nd it, that must surely be accepted as evidence 
of absence. It may not be proof that risks are absent, but proving 
something is absent (proving a negative) is known to be logically 
impossible (Paarlberg, 2012).
It is interesting to compare the acceptance of GM products for 
human healthcare with the problems relating to GM crops. The cover 
of Time magazine in 1977 showed an evil-looking scientist ‘tinkering 
with life’. A mere four years later Herb Boyer appeared on the cover 
of the same magazine looking positively cherubic and obviously 
enjoying the fruits of ‘The boom in genetic engineering’. It is clear 
that when the product is a necessary medicine, people’s attitudes are 
very different from their response to a product that is merely food, 
which can be taken or left by the consumer. The sad fact is, however, 
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that in some parts of the world, ‘mere food’ can make the difference 
between life and death to smallholder farmers who, together with 
their families, are both producers and consumers. 
Environmental effects
If GM crops are safe for humans and animals to eat, what are their 
effects on the environment? One of the most striking effects has been 
associated with insecticide and herbicide use. Since 1996, the use of 
pesticides on crops has reduced by 8.7 per cent, largely due to the 
planting of GM Bt cotton, a crop which, without GM, has traditionally 
been an intensive user of insecticides. Planting of herbicide-resistant 
crops has led to a decrease in the overall environmental impact of 
16 per cent (Brookes, 2012). This is largely due to a switch to active 
ingredients with a more environmentally benign profi le than the 
ones generally used in conventional crops. In addition GM crops 
are contributing to lower levels of greenhouse gas emissions by two 
principle means. Firstly, there is a reduction in fuel use due to less 
frequent herbicide and insecticide applications. Secondly, there is a 
contribution due to the switch to ‘no-till’ or conservation tilling. Under 
normal tilling farmers will plough the soil, prior to planting seeds, 
in order to allow weeds to grow. They then spray with herbicides, 
but before they can plant they have to allow the toxic chemicals to 
dissipate, a process which can obviously contribute to the loss of top 
soil. When planting GM seeds, crops and weeds can grow together 
and the farmer can spray when he or she sees fi t.
Most of these farming practices do not apply to many smallholder 
African farmers, few of whom can afford insecticides or herbicides. 
However, there are those who do use pesticides, specifi cally on cotton, 
which requires frequent treatment. A study on smallholder farmers 
in India shows that Bt cotton has reduced pesticide applications 
by 50 per cent, with the largest reductions (70 per cent) occurring 
in the most toxic types of chemicals. Results confi rm that this has 
notably reduced the incidence of acute pesticide poisoning among 
cotton growers. These effects have become more pronounced with 
increasing technology adoption rates. Bt cotton now helps to avoid 
several million cases of pesticide poisoning in India every year, which 
also entails sizeable health cost savings (Kouser and Qaim, 2011). 
To quote an African woman farmer from KwaZulu-Natal, farming Bt 
cotton, who addressed the audience at a meeting at the Vatican: ‘Look 
at my hands—they don’t look like a farmer’s anymore!’
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In order for African countries to feel compelled to accept GM crops, 
such crops must have demonstrated strong agronomic performance, 
outweighing anything currently available using conventional 
technologies. It would also help if some of the traits involved 
improvements to consumers’ health. So let’s have a look at what’s in 
the pipeline. While doing so we may be able to answer the question I 
posed above: Can GM crops help to feed hungry people in Africa? 
Insect-resistant (Bt) cowpea
As discussed in Chapter 4, the African Agricultural Technology 
Foundation (AATF) is spearheading a project to protect cowpeas from 
infestation by the borer, Maruca vitrata, which can decrease the yield 
from a potential 2–2.5 to 0.05–0.5 tonnes per hectare (Figure 9.1). 
The cowpea is one of the most important food legume crops in the 
semi-arid tropics. This plant is drought tolerant and hence well 
adapted to the drier regions of the tropics. Being a legume, it fi xes 
atmospheric nitrogen through its root nodules but, unlike many 
other legumes, its green leaves and pods can also be eaten before crop 
maturity, which helps to bridge the hunger gap between harvests. It 
grows well in poor soils with more than 85 per cent sand and with less 
than 0.2 per cent organic matter and low levels of phosphorus (Singh, 
2003). In addition, it is shade-tolerant and can therefore be used in 
intercropping, a farming method popular in many parts of Africa. 
Cowpeas can be intercropped with maize, millet, sorghum, sugarcane 
and cotton and are consumed by approximately 200 million people 
in Africa. Confi ned fi eld trials (CFT) have now been carried out in 
Nigeria and Burkina Faso (Figures 9.2 and 9.3). 
The high level of insect pressure introduced into the fi eld trials has 
so far shown very encouraging results. There is a clear and striking 
difference between the non-transgenic and the transgenic plants 
(Figure 9.3). The level of fl oral, pod and leaf damage is pronounced 
in the former and no damage has been observed on the latter. Only 
dead fi rst instar larvae were observed inside the fl owers of transgenic 
events, showing that these plants are resistant to Maruca infestation 
(personal communication: P Addae, AATF).
What are the potential impacts of Maruca-resistant cowpea 
varieties? Baseline studies and ex-ante impact assessments made 
by the AATF indicate that yields will increase from 0.35 tonnes 
per hectare (without the use of insecticides) to about 0.5 tonnes per 
hectare. This represents an anticipated yield increase of 20 to 
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Figure 9.2 Fenced trial site with a sign for no unauthorised entry at Farako Ba, 
Burkina Faso (Source: AATF)
Figure 9.1 Damage to cowpea caused by the borer Maruca vitrata
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40 per cent. Health benefi ts will accrue from the expected reduction 
in the use of insecticides and, while diffi cult to measure, the costs 
associated with harmful environmental impacts of insecticide use 
will also decline (AATF Frequently Asked Questions). 
Disease-resistant bananas
To most Westerners, bananas are soft and sweet, the so-called 
‘dessert banana’. However, in Africa the banana cultivars grown are 
of a fi rmer, starchier consistency and are called plantains or ‘cooking 
bananas’. They are a major food source and a major income source 
for smallholder farmers in East Africa. In countries such as Uganda, 
Burundi and Rwanda, per capita consumption has been estimated at 
45 kilograms per year, the highest in the world. I remember during 
a stay in Uganda reading a newspaper article by a visiting Kenyan 
journalist in which he wrote: ‘If I have to eat another plantain I 
think I will go mad. Please give me maize!’ The difference in food 
preferences—even among neighbouring African countries—is 
remarkable.
Figure 9.3 Field trials showing (left) transgenic and (right) non-transgenic 
cowpea plants
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Cultivated bananas are parthenocarpic, which literally means 
virgin fruit—the fruit are produced without fertilisation, and are 
thus seedless and sterile. This has major advantages when it comes 
to fi eld trials of GM varieties. If there is no possibility of a GM crop 
cross-pollinating other plants of the same crop, fi eld trials can be 
conducted in areas where that crop is normally grown. Otherwise, 
as in the Lutzville fi eld trials of drought-tolerant maize in South 
Africa (the AATF WEMA project trials), these have to be undertaken 
in areas where that crop is not grown. Often that puts the trials at 
a disadvantage, as the climatic and soil conditions at the fi eld site 
might not be ideal for that crop. 
Propagation of bananas involves farmers removing and planting a 
sucker, a vertical shoot that develops from the base of the plant. If the 
sucker is removed before it has elongated, the process is even easier, 
as these suckers can be left out of the ground for up to two weeks.
As discussed in Chapter 4, the AATF is managing a project to 
protect bananas from the devastating disease called banana bacterial 
wilt, caused by the bacterium Xanthomonas campestris. Prospects 
of developing varieties with resistance to bacterial wilt through 
conventional breeding are limited, as no source of germplasm 
exhibiting resistance against the disease has been identifi ed (personal 
communication, H Mignouna, AATF). Thus the Pfl p and Hrap genes 
have been taken from the sweet pepper and introduced into bananas. 
Confi ned fi eld trials are being carried out in Uganda using lines that 
showed enhanced resistance in screen house trials.
Black Sigatoka is a leaf spot disease caused by the fungus, 
Mycosphaerella fi jiensis. The disease was fi rst identifi ed in the 
Sigatoka Valley in Fiji, where an outbreak of this disease reached 
epidemic proportions from 1912 to 1923 (Marín et al., 2003). It is 
particularly prevalent in parts of Uganda. When spores of the fungus 
are deposited on a susceptible banana leaf they germinate within 
three hours if there is a fi lm of water present or if the humidity is 
high. This impedes photosynthesis by blackening parts of the leaves, 
eventually killing the entire leaf. Starved for energy, fruit production 
falls by 50 per cent or more and the bananas that do grow, ripen 
prematurely. The fungus is particularly resistant to treatment by 
antifungal sprays, which, in any case, are usually too expensive for 
smallholder farmers in East Africa.
As in the above case, the pfl p and hrap defence genes can provide 
resistance against this pathogen. Under the management of the 
Ugandan National Agricultural Research Organisation (NARO), 
transgenic bananas are being assessed for resistance to this fungal 
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disease (personal communication, A Kiggundu, NARO). When the 
trials began in 2007, they received supportive comment in the journal 
Nature (Dauwers, 2007). 
Cassava resistant to cassava mosaic virus (CMV)
Cassava, or manioc, is extensively cultivated as an annual crop in 
parts of Africa for its edible starchy tuberous root, a major source 
of carbohydrates, with the crop accounting for up to 30 per cent of 
the daily calorie intake of Ghanaians. The plant does well in poor 
soils and with low rainfalls, and, because it is a perennial, it can be 
harvested as required over time. This wide harvesting window allows 
it to act as a famine reserve. The importance of cassava to many 
Africans is epitomised in Ewe (a language spoken in Ghana, Togo and 
Benin), where the name for the plant is agbeli, meaning ‘there is life’.
Cassava mosaic virus (CMV) is related to maize streak virus (see 
Chapter 7) and causes the leaves to wither, limiting the growth of the 
root. The virus caused a major African famine in the 1920s. Sometime 
in the late 1980s a mutation occurred in Uganda which made the 
virus even more harmful, causing the complete loss of leaves. This 
mutated virus has been spreading at a rate of 80 kilometres per year. 
I realised the danger of this disease when I fi rst met Betty Owor 
at the Ugandan branch of the International Institute for Tropical 
Agriculture. She was to become an important player in my maize 
streak virus resistance team at UCT, bringing her expertise on the 
CMV to bear on our problem. She pointed to a map on the laboratory 
wall which showed the encroachment of CMV into Nigeria via the 
Democratic Republic of Congo and neighbouring countries. Nigeria, 
as the world’s largest producer of cassava, was starting to become 
seriously concerned.
CMV-resistant cassava is being tackled by Claude Fauquet and 
his team at the Donald Danforth Plant Research Institute in St Louis, 
Missouri. They are using RNA interference (RNAi) technology via the 
replication associated AC1 gene from the East African strain of CMV 
isolated in Uganda. This technology can be described as a natural 
defence mechanism of plants and other organisms, and consists of 
‘teaching’ the plant to recognise virus genetic sequences in advance, 
so that the plant is ready to act when the real virus attacks. Indeed, 
it can be thought of as a type of vaccination. 
The transgenic lines have been tested extensively under 
glasshouse conditions in the US. The National Agricultural Research 
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Organisation of Uganda is now undertaking confi ned fi eld trials in 
Namulonge, a known hotspot for CMV (personal communication; A 
Kiggundu, NARO). 
Drought-tolerant maize
The WEMA (Water Effi cient Maize for Africa) project has been 
extensively covered in Chapter 8, but recently three additional 
potential open quarantine sites for carrying out confi ned fi eld trials 
under random stress in drought-prone areas have been identifi ed in 
the Limpopo Province in South Africa. These are in a maize-growing 
area of the country where local farmers will be keenly interested in 
the outcome of the trials. This is in contrast to the trials carried out 
in Lutzville, a grape-growing area in the Western Cape. Possibly the 
new trials in Limpopo, where maize is an extremely important crop, 
will have a better chance of public acceptance. 
WEMA trials are being carried out in most of the partner countries. 
In addition to those in South Africa, trials are underway in Kenya 
and Uganda, and sites for future testing have been identifi ed in 
Mozambique and Tanzania. By 2010 the partners had earmarked 12 
hybrid drought-tolerant maize varieties developed through the project 
for CFTs. But, as Dr Sylvester Oikeh, the AATF project manager wrote 
in their annual report: ‘Our application for permits to conduct CFTs in 
Kenya, Uganda and Tanzania progressed much slower and in a more 
complex way than we would have wished. However, we worked closely 
with the regulatory authorities in the different countries and were 
vigilant in their requirements.’
The process was aided by mock trials conducted by the WEMA 
partners in Kenya and Tanzania under the supervision of biosafety 
inspectors. The offi cials then monitored the harvested crop at two-week 
intervals until they were satisfi ed that all post-harvest requirements 
had been satisfi ed. As a result, CFTs have been undertaken in Uganda 
and Kenya, as well as in South Africa. Tanzania and Mozambique have 
yet to approve trials in their countries and the jury will need some 
years of data before they can come to a verdict on the effectiveness of 
the cspB gene. 
Improved rice varieties
One doesn’t readily think of rice and Africa in the same breath, but it 
is an important staple food and a commodity of strategic signifi cance 
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across much of the continent, but particularly in humid West Africa. 
The demand for rice is growing faster in this region than anywhere 
else    in    the    world    (http://www.scienceinafrica.co.za/nerica.htm: 
accessed 29 October 2011). However, the yield is low, due in part to 
abiotic factors such as nitrogen defi ciency and drought, while high 
salinity is also a problem in many rice-growing areas. 
To overcome these problems the AATF is coordinating a multiple-
partner collaboration involving Arcadia Biosciences in California, 
the Public Intellectual Property Resource for Agriculture (also based 
in California) the International Centre for Tropical Agriculture in 
Colombia and the African National Agricultural Research Systems 
in the countries involved. This work is still in the laboratory stage 
where transgenic plants are being tested for homozygosity of the 
genes ready for shipment to countries such as Ghana. 
Striga-resistant maize
Striga is a major parasitic weed that infests about 20 million hectares 
of arable land in sub-Saharan Africa. As discussed in Chapter 4, the 
AATF has facilitated the delivery of StrigAway® seeds, coated with 
the herbicide Imazapyr, to farmers in Kenya and Tanzania, where 
commercial seed production began in 2006 and 2010 respectively. 
Variety testing is ongoing in Uganda and Nigeria. One of the reasons 
for the early success of this product is that it is not a GM variety, 
hence none of those attendant regulatory hurdles had to be met. 
However, a number of useful lessons were learned from this exercise: 
(1) The capacity of seed companies to produce suffi cient 
quantities of certifi ed seed was limited due to inadequate 
land, irrigation and seed coating facilities.
(2) Many agro-dealers near the Striga-infested farmlands have 
little capital, and hence reduced seed-stocking capacity.
(3) Even though there are no GM regulations to deal with, 
there are elaborate herbicide registration requirements 
and these may delay the sale of StrigAway® seed.
To overcome these problems the following steps need to be taken:
(1) A credit access system for seed companies, agro-dealers 
and farmers is required.
(2) Strategic outreach and awareness programmes are needed 
to disseminate information on new varieties.
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(3) Linkages are required involving both private and public 
sector institutions—for example, seed banks, seed companies 
and NGOs (personal communication, H Mignouna, AATF).
What are the anticipated impacts of Striga-resistant maize which 
has been named ‘UaKayongo’, Swahili for ‘kill the Striga weed’? 
The AATF estimates that when fully adopted in Kenya, where 
about 210 000 hectares of land are infested with the weed, it will 
lead to an extra 62 000 million tonnes of maize with a value of 
about US$ 11.2 million at 2011 prices. Data from on-farm trials 
indicate that average yields due to the improved seeds have 
increased from 500 kilograms per hectare to 3000 kilograms 
per hectare. The expected net benefi t-to-cost ratio for use of 
StrigAway® seeds for an average farmer is around 45:1, a return 
of 45 per cent. Moreover, because using the technology reduces the 
weed seed bank over time, abandoned farmland can be recovered 
and once again cultivated. The results being achieved in Kenya 
could be replicated in other countries where Striga has similar 
negative impacts on crop productivity (AATF Frequently Asked 
Questions). 
Vitamin-enhanced crops
Vitamin A defi ciency is common in developing countries. One of its 
earliest manifestations is night blindness, which is often found in 
malnourished pregnant women and children. Many of these children 
die within a year of becoming blind. In an effort to help overcome this 
problem in Asian countries where rice is the staple food, Ingo Potrykus 
and Peter Beyer genetically engineered a variety of rice that produced 
beta-carotene, a precursor of vitamin A. The fi rst version produced 
only low levels of the micronutrient, but a subsequent version contains 
suffi cient amounts to provide the entire dietary requirement of the 
nutrient to people who eat about 75 grams of this Golden Rice per day 
(Paine et al., 2005). It is called Golden Rice because beta-carotene has 
a yellow colour.
Many people who oppose the use of GM crops cite patents as one 
of the stumbling blocks in their development and deployment to poor 
farmers. Ingo Potrykus said that if his team had not been able to 
‘piggy back’ on the research covered by these patents they would 
never have been able to develop Golden Rice, certainly not in the time 
that it took them.
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This was fi ne for the research; when it came to deployment 
that was another matter. The team had received funding from the 
European Commission’s ‘Carotene Plus’ research programme and 
they were required by law to give the rights to their discovery to 
the corporate sponsors, Syngenta. Free licences were required from 
all these patent holders so that Syngenta and the humanitarian 
partners in the project could use Golden Rice in breeding 
programmes for release (Potrykus, 2001). Fortunately, these were 
quickly granted due to the positive publicity Golden Rice received, 
as it was said to be the fi rst GM crop that had benefi ts for the 
consumer, not just the farmer. Monsanto was one of the fi rst to 
grant free licences.
So why is Golden Rice not available for vitamin A-starved 
children in Asia? Anti-GM crop movements, in particular 
Greenpeace, have effectively blocked it for all these years. 
Speaking at a Manitoba Special Crops Symposium in February 
2012, Dr Patrick Moore, a co-founder of Greenpeace, explained 
why he is particularly concerned about Greenpeace’s success in 
blocking its introduction. ‘GM rice varieties are able to eliminate 
micronutrient defi ciency in rice-eating countries, which affl icts 
hundreds of millions of people, and actually causes between 
a quarter and half a million children to go blind and die young 
each year because of vitamin A defi ciency because there is no 
beta-carotene in rice. We can put beta-carotene in rice through 




BIOtechNOW accessed 28 March 2012). 
Sorghum
How to deal with vitamin A defi ciency in Africa? Golden maize 
would not be an option because, throughout Africa, yellow maize is 
used as fodder for livestock, while people eat white maize. Why not 
use sorghum as a source of this micronutrient? In terms of tonnage, 
sorghum is Africa’s second most important crop. The continent 
produces about 20 million tonnes per annum—about one third of the 
world crop. 
However, these fi gures do not do justice to the importance of 
sorghum in Africa. It is the only viable food grain for many of the 
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world’s most food insecure people, and is uniquely adapted to Africa’s 
climate, being both drought resistant and able to withstand periods 
of water-logging. Sorghum originated in Africa and Africans know 
how to plant, cook and eat it. It is processed into a wide variety of 
attractive and nutritious traditional foods, such as semi-leavened 
bread, couscous, dumplings and fermented and non-fermented 
porridges. New sorghum products, such as instant soft porridge 
and malt extracts, are proving to be great successes. In the competitive 
environment of multinational enterprises, sorghum has proven 
to be the best alternative to barley for lager beer brewing (http://
biosorghum.org/articles.php?id=80).
Florence Wambugu, Head of Africa Harvest, set up the African 
Biofortifi ed Sorghum project consortium to work on the problem of 
vitamin enrichment. The beauty of this consortium is that it leverages 
the best private and public partnerships to deliver the technology as 
follows:
 ● The national agricultural research institutes in the partner 
countries in East and southern Africa bring their expertise in 
fi eld trials and breeding.
 ● Pioneer donated the technology, estimated to be worth US$ 4.8 
million. They invested in African capacity building, ensuring 
Africa’s contribution would not be token, but strengthened for 
future sustainability. Over 70 scientists have been involved in 
the project.
 ● The technology and research organisations in the partner 
countries became the African technology recipients to enhance 
and customise the technology in intellectual property for use 
in Africa.
 ● The universities involved added infrastructure and human 
resources for the analytical work involved.
 ● Institutions such as the AATF, Africa Harvest and WECARD 
(West and Central African Council for Agricultural Research 
and Development) help infl uence national policies across 
country borders through advocacy for stakeholder awareness 
and technology acceptance (http://biosorghum.org/articles.
php?id=74).
As discussed in Chapter 2, the fi rst glasshouse trials of the transgenic 
plants were to have been performed in South Africa but the regulatory 
authorities refused permission. As a result the trials and further 
work are being carried out in Kenya.
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In the hands of the politicians
With all these exciting developments in the pipeline, together with the 
already established GM crops widely grown in South Africa (insect- 
and herbicide-resistant maize, insect-resistant cotton and herbicide-
resistant soya beans), I think the answer to my earlier question ‘Can 
GM crops help to feed hungry people in Africa?’ is a resounding ‘Yes’. 
However, there still remains the question: Will GM crops help to 
feed hungry people in Africa? To a great extent that depends on the 
politicians.
As we have seen throughout this book, and as was so clearly seen 
in the case of Kenya regarding the Biosafety Act and Regulations 
(see Chapter 6), politicians can make or break this technology. I was 
recently contacted by my former PhD student, Dahlia Garwe (see 
Chapter 8), now acting general manager of the Zimbabwe Tobacco 
Research Board. She had heard from the Zimbabwean Secretary for 
the Ministry of Science and Technology Development, Prof Gudyanga, 
who had returned from an African Development Bank meeting in 
Nairobi in February 2012. He was fi red up by the possibilities that GM 
crops could hold for his country, despite the Minister of Agriculture 
having given it a resounding ‘NO’. She told me that she had been 
asked to produce a paper for cabinet on the subject and was asking 
for ‘ammunition’. Time will tell the outcome of this.
Robert Paarlberg also discusses the role of politicians in his book 
Starved for Science: How Biotechnology is Being Kept Out of Africa 
(Paarlberg, 2008). He concludes as follows: ‘So in the end it is not the 
citizens of Africa who are rejecting agricultural biotechnology. The 
technology is being kept out of Africa by a careless and distracted 
political leadership class that pays closer attention to urban interests 
and to inducements from outsiders ... than to the needs of their own 
rural poor.’
If this continues to be the case it could indeed be a tragedy for 
the rural poor. Food riots have been hitting African countries such 
as Cameroon, Burkina Faso and Mozambique since 2008. Later they 
spread to Haiti, Bolivia and even Israel and Iceland. The world is 
simply going to have to wake up and realise that more food will have 
to be produced on the same amount of land at cheaper costs. And one 
of the ways to do this is to use technologies that enable farmers to 
grow better crops. One day, perhaps, even Europeans will wake up 
and realise that their perception that GM crops put money only into 
the pockets of seed companies and farmers and not into the mouths of 
consumers is not necessarily true.
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The views of Africans themselves
But what do the African people themselves think? What are the 
sociological factors infl uencing the adoption of GM crops in sub-
Saharan Africa? A group of researchers recently asked this question 
of 91 people in fi ve African countries. They found that there were 
four recurring factors: communication, culture and religion, capacity 
building and commercialisation (Ezezika et al., 2012). 
Poor communication has led to a limited understanding of GM crops 
by the public. One stakeholder is quoted as saying: ‘My understanding 
is that a number of people, including politicians and some decision-
makers, do not know really what GM is.’ There is a feeling that 
communication both from the media and from researchers, especially 
to grassroots communities, tends to be elitist—‘a little above the 
common man’. A need for ‘barefoot extension offi cers’ was suggested. 
Attention was drawn to the fact that anti-GM crops interest groups 
have the capacity for widespread dissemination of information at the 
grassroots level and can spread misinformation, creating extensive 
public concern and distrust for agbiotech initiatives.
Another common theme is the importance of cultural and 
religious issues. The different roles of women and men in agriculture 
were highlighted. Most farmers are women, yet women have limited 
decision-making roles. Women are the primary agriculturalists 
where men are involved in the secondary work of buying and selling 
agricultural products. Men decide on new technologies but it is the 
women who must implement them. Stakeholders indicated that for 
agbiotech to be successful, changes must be made to the current 
system to involve women in leading the decision-making process to 
ensure that GM products reach women farmers and consumers.
Linked to the theme of cultural issues was the concern that 
modern agbiotech practices and business models could adversely 
affect traditional seed systems, including seed selection and breeding, 
seed sharing and lead to the loss of indigenous varieties. However, 
other stakeholders hoped that the new agbiotech approaches would 
be adaptable to traditional seed systems and provide safeguards to 
traditional seeds that have been cultivated over the years. On the 
religious side, participants described the perceptions held by many 
Africans that agbiotech is unnatural, as interfering with nature. Genetic 
engineering may be regarded by some as taking on the role of God.
Regulatory offi cials in Kenya, Uganda, Mozambique and 
Tanzania, in particular, identifi ed inadequate training and expertise 
as a major constraint. They saw the urgent need for capacity building 
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at the graduate and postgraduate levels of people with expertise in 
biotechnological applications. This was linked to the need for more 
local product development. Some participants felt that products were 
being imposed upon them by Americans and Europeans. In contrast, 
a product developed within the country is considered more acceptable. 
Indeed some considered agbiotech as being an ‘effort by the Western 
world to come and take advantage of poor Africans’. Distrust of the 
private sector, particularly multinational companies, is a major factor 
in the resistance to agbiotech adoption. 
Finally, on the issue of commercialisation of GM crops, it was 
agreed that there was a need to see some sort of benefi t, in yield, health 
outcomes or other tangible advantages, as a key factor in adoption. 
One stakeholder is quoted as saying: ‘If the (agricultural) technology 
is more effi cient, it will be adopted. Farmers are not sentimental.’ 
This harks back to the point made by Paarlberg that in order for a GM 
crop to be accepted its advantages must outweigh anything currently 
available using conventional technologies. In addition, the products 
of GM crops must be culturally appropriate in terms of appearance, 
taste, texture, processing qualities and storability.
While considering the advantages of GM crops we must also take 
into account potential disadvantages to the farmer. One that springs 
to mind is that the use of Bt crops could result in the development 
of insects that are resistant to this toxin. This is by no means a new 
concern. Indeed, it was expressed by both opponents and proponents 
of insect-resistant crops from their earliest deployment. Farmers 
are well aware that insects can develop resistance to chemical 
pesticides—so why not to Bt crops? Constant exposure to any toxin 
creates evolutionary pressure for pests to become resistant. One 
method of reducing resistance is to create non-Bt crop refuges to allow 
some insects to survive, even though they are susceptible, and thus 
maintain a susceptible population, so that any resistance genes that 
arise will become greatly diluted. Thus farmers buying Bt maize seeds 
are informed of the importance of planting fi elds of non-transgenic 
plants, refuges adjacent to fi elds of the Bt variety.
Is this working? On the whole, yes, but pockets of resistance have 
been noted, one being in South Africa. Recently AfricaBio, together 
with Crop Life International, held a workshop to discuss this problem. 
Delegates came from six African countries: Burkina Faso, Ghana, 
Kenya, Nigeria, Uganda and South Africa. Clearly this is a problem 
they wish to avert and they concluded that an effective and functional 
insect-resistance management system for Africa is essential if the 
continent is to derive maximum benefi t from this technology.
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In 2010 I was surprised to be invited to be a keynote speaker at a 
‘summit’ on climate change held by the iLembe district municipality 
in KwaZulu-Natal. I was surprised because fi rstly, they had chosen 
to hear about the role that GM crops could play in climate change, 
but secondly, they had specifi cally asked me to talk on our work on 
the development of maize resistant to maize streak virus. This is a 
sugarcane-growing region.
I stood up to speak with some trepidation, not knowing what 
kind of reception I would receive from this very local audience, but 
I needn’t have been concerned. The response was overwhelmingly 
positive, with one of the loudest refrains being: ‘Can this technology 
also be applied to sugarcane? And if so let’s make it happen!’ I left 
feeling really buoyant because I realised that ordinary citizens do 
still have a voice when it comes to their own interests. And if they 
feel strongly enough about this new technology it does indeed have a 
chance of happening in Africa. 
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Glossary
Anaerobe: organism capable of growing in the absence of oxygen
ATP: adenosine-5’-triphosphate, the molecule that provides energy to 
an organism
Bacteriophages: viruses which grow in bacteria
Bacteriophage vectors: bacterial viruses able to introduce foreign 
genes into bacteria
Biolistics: the process whereby genes are ‘shot’ into plant cells using a 
device powered by helium gas; the word ‘biolistics’ is derived from the 
words ‘biological’ and ‘ballistics’, as early versions of the apparatus 
looked like guns and were powered by gunpowder; the device is still 
called a ‘gene gun’
Callus: undifferentiated plant cells which can be transformed with 
DNA and regenerate into whole plants
Clone: an identical copy of something [from the Greek word for ‘twig’ 
or ‘slip’]
Collagenolytic: able to break down collagen, the main protein of 
animal hides
Constitutive gene expression: the situation when a gene is switched 
on to make RNA and protein continuously
Cyclotron: an apparatus in which charged atomic and subatomic 
particles are accelerated by an alternating electric field while 
following an outward spiral or circular path in a magnetic field; this 
can be used to introduce mutations
Dicot/dicotyledonous plant: a flowering plant with an embryo that 
bears two cotyledons (seed leaves), typically with broad, stalked 
leaves with netlike veins
Eukaryotes: organisms containing ‘true nuclei’, ranging from yeasts 
to humans, as opposed to prokaryotes, organisms containing ‘pre-
nuclei’, such as bacteria
Event: a single genetic transformation result whereby a specific gene, 
or set of genes, is introduced into a plant variety
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Gene bank: a ‘bank’ of hybrid plasmids carrying every gene from a 
given organism
Genetic engineering: the science of introducing foreign genes into an 
organism, be it a bacterium, a plant or an animal 
Hybrid plasmid: a plasmid carrying one or more additional genes 
and able to be transferred into a bacterial strain, in this case E. coli 
lacking the Pfk gene
Inducible gene expression: the situation when a gene is only 
switched on under certain conditions
In vitro transcription/translation extract: an extract of E. coli 
cells that is capable of supporting the transcription and subsequent 
translation of one or more genes
Liquid scintillation counter: a machine that measures the radioactivity 
of all the samples placed in it and provides a printout of the results
Monocot/monocotyledonous plant: a flowering plant with an embryo 
that bears a single cotyledon (seed leaf), typically with elongated 
stalkless leaves with parallel veins
Osmoprotectant: a compound that protects an organism from osmotic 
shock
Phosphorylation: introduction of a phosphoric group into a molecule, 
a process which traps energy for use by the organism
Plant vectors: agents, such as bacterial vectors, that can introduce 
foreign genes into plants
Plasmid: a small circle of DNA that is capable of replicating 
independently of the chromosome in a bacterium and can be used as 
a vector to introduce genes into other bacteria
Recombinant DNA molecule: any fragments of DNA from the same or 
different species that have been purposefully recombined to generate 
a new DNA molecule
Restriction enzyme: an enzyme that cuts DNA at specific sequences, 
called restriction sites, very often producing single-stranded (sticky) 
ends
Stem cells: undifferentiated cells of a multicellular organism that are 
capable of giving rise to indefinitely more cells of the same type
Totipotent: the ability of a single cell to form a complete organism; a 
single plant cell can develop into an adult plant because its cells are 
totipotent
Transcription: the conversion of DNA into RNA
Transformation: the introduction of a foreign gene into a plant
Transgenic plant : any plant carrying foreign gene(s) made by genetic 
engineering
Translation: the conversion of RNA into protein
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